BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zaki MH, Boyd KL, Vogel P, Kastan MB, Lamkanfi M, Kanneganti TD. The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. Immunity 2010;32:379-91. [PMID: 20303296 DOI: 10.1016/j.immuni.2010.03.003] [Cited by in Crossref: 674] [Cited by in F6Publishing: 706] [Article Influence: 51.8] [Reference Citation Analysis]
Number Citing Articles
1 Kim JS, Kim HK, Lee J, Jang S, Cho E, Mun SJ, Yoon S, Yang CS. Inhibition of CD82 improves colitis by increasing NLRP3 deubiquitination by BRCC3. Cell Mol Immunol 2023;20:189-200. [PMID: 36600050 DOI: 10.1038/s41423-022-00971-1] [Reference Citation Analysis]
2 Sharma BR, Kanneganti TD. Inflammasome signaling in colorectal cancer. Transl Res 2023;252:45-52. [PMID: 36150688 DOI: 10.1016/j.trsl.2022.09.002] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Ning W, Gao G, Zhou Y, Li WQ, Yang HH, Duan XB, Li X, Gong YB, Li D, Guo R. Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation. Int Immunopharmacol 2023;116:109747. [PMID: 36706592 DOI: 10.1016/j.intimp.2023.109747] [Reference Citation Analysis]
4 Xu Y, Zhang H, Wu S, Liu J, Liu H, Wang D, Zhang Y, Niu H, Su X, Sun J, Shen L. PLZF restricts intestinal ILC3 function in gut defense. Cell Mol Immunol 2023. [PMID: 36693920 DOI: 10.1038/s41423-023-00975-5] [Reference Citation Analysis]
5 Keestra-gounder AM, Nagao PE. Inflammasome activation by Gram-positive bacteria: Mechanisms of activation and regulation. Front Immunol 2023;14. [DOI: 10.3389/fimmu.2023.1075834] [Reference Citation Analysis]
6 Li N, Xu S, Zhang S, Zhu Q, Meng X, An W, Fu B, Zhong M, Yang Y, Lin Z, Liu X, Xia J, Wang J, You T, Yan C, Tang H, Zhuang G, Peng Z. MSI2 deficiency in ILC3s attenuates DSS-induced colitis by affecting the intestinal microbiota. Front Immunol 2022;13:963379. [PMID: 36713428 DOI: 10.3389/fimmu.2022.963379] [Reference Citation Analysis]
7 Duan X, Cai H, Hu T, Lin L, Zeng L, Wang H, Cao L, Li X. Ginsenoside Rg3 treats acute radiation proctitis through the TLR4/MyD88/NF-κB pathway and regulation of intestinal flora. Front Cell Infect Microbiol 2022;12:1028576. [PMID: 36683687 DOI: 10.3389/fcimb.2022.1028576] [Reference Citation Analysis]
8 Accogli T, Hibos C, Vegran F. Canonical and non-canonical functions of NLRP3. J Adv Res 2023:S2090-1232(23)00001-2. [PMID: 36610670 DOI: 10.1016/j.jare.2023.01.001] [Reference Citation Analysis]
9 Rébé C, Perrichet A, Ghiringhelli F. Inflammasomes and cancer. Inflammasome Biology 2023. [DOI: 10.1016/b978-0-323-91802-2.00009-8] [Reference Citation Analysis]
10 Maciak K, Dziedzic A, Saluk J. Possible role of the NLRP3 inflammasome and the gut-brain axis in multiple sclerosis-related depression. FASEB J 2023;37:e22687. [PMID: 36459154 DOI: 10.1096/fj.202201348R] [Reference Citation Analysis]
11 Tsakem EL, Mukherjee S, Theiss AL, Venuprasad K. Cellular signaling, molecular activation, and regulation of the NLRP6 inflammasome. Inflammasome Biology 2023. [DOI: 10.1016/b978-0-323-91802-2.00023-2] [Reference Citation Analysis]
12 Szydłowska A, Sionek B. Probiotics and Postbiotics as the Functional Food Components Affecting the Immune Response. Microorganisms 2022;11. [PMID: 36677396 DOI: 10.3390/microorganisms11010104] [Reference Citation Analysis]
13 Sun CC, Li L, Tao HQ, Jiang ZC, Wang L, Wang HJ. The role of NLRP3 inflammasome in digestive system malignancy. Front Cell Dev Biol 2022;10:1051612. [PMID: 36619871 DOI: 10.3389/fcell.2022.1051612] [Reference Citation Analysis]
14 Flood P, Fanning A, Woznicki JA, Crowley T, Christopher A, Vaccaro A, Houston A, McSweeney S, Ross S, Hogan A, Brint E, Skowyra A, Bustamante M, Ambrose M, Moloney G, MacSharry J, Hammarström ML, Hurley M, Fitzgibbons C, Quigley EMM, Shanahan F, Zulquernain SA, McCarthy J, Dodson GS, Dabbagh K, McRae BL, Melgar S, Nally K. DNA sensor-associated type I interferon signaling is increased in ulcerative colitis and induces JAK-dependent inflammatory cell death in colonic organoids. Am J Physiol Gastrointest Liver Physiol 2022;323:G439-60. [PMID: 36165492 DOI: 10.1152/ajpgi.00104.2022] [Reference Citation Analysis]
15 Jiang W, Wu J, Zhu S, Xin L, Yu C, Shen Z. The Role of Short Chain Fatty Acids in Irritable Bowel Syndrome. J Neurogastroenterol Motil 2022;28:540-8. [PMID: 36250361 DOI: 10.5056/jnm22093] [Reference Citation Analysis]
16 Qiang R, Li Y, Dai X, Lv W. NLRP3 inflammasome in digestive diseases: From mechanism to therapy. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.978190] [Reference Citation Analysis]
17 Di Filippo M, Hennig P, Karakaya T, Slaufova M, Beer HD. NLRP1 in Cutaneous SCCs: An Example of the Complex Roles of Inflammasomes in Cancer Development. Int J Mol Sci 2022;23:12308. [PMID: 36293159 DOI: 10.3390/ijms232012308] [Reference Citation Analysis]
18 Zhang J, Cen L, Zhang X, Tang C, Chen Y, Zhang Y, Yu M, Lu C, Li M, Li S, Lin B, Zhang T, Song X, Yu C, Wu H, Shen Z. MPST deficiency promotes intestinal epithelial cell apoptosis and aggravates inflammatory bowel disease via AKT. Redox Biol 2022;56:102469. [PMID: 36126419 DOI: 10.1016/j.redox.2022.102469] [Reference Citation Analysis]
19 Zhang T, Zhang B, Tian W, Wang F, Zhang J, Ma X, Wei Y, Tang X. Research trends in ulcerative colitis: A bibliometric and visualized study from 2011 to 2021. Front Pharmacol 2022;13:951004. [DOI: 10.3389/fphar.2022.951004] [Reference Citation Analysis]
20 Hong Z, Cheng J, Ye Y, Chen X, Zhang F. MicroRNA-451 Attenuates the Inflammatory Response of Activated Microglia by Downregulating Nucleotide Binding Oligomerization Domain-Like Receptor Protein 3. World Neurosurg 2022:S1878-8750(22)01252-9. [PMID: 36087911 DOI: 10.1016/j.wneu.2022.08.139] [Reference Citation Analysis]
21 Özsoy M, Stummer N, Zimmermann FA, Feichtinger RG, Sperl W, Weghuber D, Schneider AM. Role of Energy Metabolism and Mitochondrial Function in Inflammatory Bowel Disease. Inflamm Bowel Dis 2022;28:1443-50. [PMID: 35247048 DOI: 10.1093/ibd/izac024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Yu Y, Gamez-belmonte R, Patankar JV, Liebing E, Becker C. The Role of Programmed Necrosis in Colorectal Cancer. Cancers 2022;14:4295. [DOI: 10.3390/cancers14174295] [Reference Citation Analysis]
23 Shao M, Yan Y, Zhu F, Yang X, Qi Q, Yang F, Hao T, Lin Z, He P, Zhou Y, Tang W, He S, Zuo J. Artemisinin analog SM934 alleviates epithelial barrier dysfunction via inhibiting apoptosis and caspase-1-mediated pyroptosis in experimental colitis. Front Pharmacol 2022;13:849014. [DOI: 10.3389/fphar.2022.849014] [Reference Citation Analysis]
24 Liu Y, Wei W, Liang S, Fang H, Cao J. Esculentoside A Alleviates Intestinal Dysmotility in Ulcerative Colitis by Regulating H2S/CSE and NO/nNOS Systems. Evidence-Based Complementary and Alternative Medicine 2022;2022:1-9. [DOI: 10.1155/2022/7757833] [Reference Citation Analysis]
25 Spivak I, Fluhr L, Elinav E. Local and systemic effects of microbiome‐derived metabolites. EMBO Reports 2022. [DOI: 10.15252/embr.202255664] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Xu Q, Sun W, Zhang J, Mei Y, Bao J, Hou S, Zhou X, Mao L. Inflammasome-targeting natural compounds in inflammatory bowel disease: Mechanisms and therapeutic potential. Front Immunol 2022;13:963291. [DOI: 10.3389/fimmu.2022.963291] [Reference Citation Analysis]
27 Cambui RAG, Fernandes FP, Leal VNC, Reis EC, de Lima DS, do Espírito Santo GF, Elias RM, Pontillo A. The Ala134Thr variant in TMEM176B exerts a beneficial role in colorectal cancer prognosis by increasing NLRP3 inflammasome activation. J Cancer Res Clin Oncol 2022. [PMID: 35980484 DOI: 10.1007/s00432-022-04284-8] [Reference Citation Analysis]
28 Qing F, Xie T, Xie L, Guo T, Liu Z. How Gut Microbiota Are Shaped by Pattern Recognition Receptors in Colitis and Colorectal Cancer. Cancers (Basel) 2022;14:3821. [PMID: 35954484 DOI: 10.3390/cancers14153821] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Khan I, Bai Y, Ullah N, Liu G, Rajoka MSR, Zhang C. Differential Susceptibility of the Gut Microbiota to DSS Treatment Interferes in the Conserved Microbiome Association in Mouse Models of Colitis and Is Related to the Initial Gut Microbiota Difference. Advanced Gut & Microbiome Research 2022;2022:1-20. [DOI: 10.1155/2022/7813278] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 Zeng B, Huang Y, Chen S, Xu R, Xu L, Qiu J, Shi F, Liu S, Zha Q, Ouyang D, He X. Dextran sodium sulfate potentiates NLRP3 inflammasome activation by modulating the KCa3.1 potassium channel in a mouse model of colitis. Cell Mol Immunol 2022;19:925-943. [DOI: 10.1038/s41423-022-00891-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
31 Lu L, Zhang Y, Tan X, Merkher Y, Leonov S, Zhu L, Deng Y, Zhang H, Zhu D, Tan Y, Fu Y, Liu T, Chen Y. Emerging mechanisms of pyroptosis and its therapeutic strategy in cancer. Cell Death Discov 2022;8:338. [PMID: 35896522 DOI: 10.1038/s41420-022-01101-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Bilal M, Ashraf S, Zhao X. Dietary Component-Induced Inflammation and Its Amelioration by Prebiotics, Probiotics, and Synbiotics. Front Nutr 2022;9:931458. [DOI: 10.3389/fnut.2022.931458] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Mao X, Liu S, Ge L, Du H, Yue D, Hou L, Huang K, Chen X. mTOR-Mediated Autophagy Regulates Fumonisin B1-Induced Intestinal Inflammation via Pyroptosis In Vivo and In Vitro. J Agric Food Chem 2022. [PMID: 35830273 DOI: 10.1021/acs.jafc.2c03025] [Reference Citation Analysis]
34 Busch M, Ramachandran H, Wahle T, Rossi A, Schins RPF. Investigating the Role of the NLRP3 Inflammasome Pathway in Acute Intestinal Inflammation: Use of THP-1 Knockout Cell Lines in an Advanced Triple Culture Model. Front Immunol 2022;13:898039. [DOI: 10.3389/fimmu.2022.898039] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Ma X, Di Q, Li X, Zhao X, Zhang R, Xiao Y, Li X, Wu H, Tang H, Quan J, Wu Z, Xiao W, Chen W. Munronoid I Ameliorates DSS-Induced Mouse Colitis by Inhibiting NLRP3 Inflammasome Activation and Pyroptosis Via Modulation of NLRP3. Front Immunol 2022;13:853194. [DOI: 10.3389/fimmu.2022.853194] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
36 Blevins HM, Xu Y, Biby S, Zhang S. The NLRP3 Inflammasome Pathway: A Review of Mechanisms and Inhibitors for the Treatment of Inflammatory Diseases. Front Aging Neurosci 2022;14:879021. [PMID: 35754962 DOI: 10.3389/fnagi.2022.879021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
37 Papaefthymiou A, Potamianos S, Goulas A, Doulberis M, Kountouras J, Polyzos SA. Inflammatory Bowel Disease-associated Fatty Liver Disease: the Potential Effect of Biologic Agents. J Crohns Colitis 2022;16:852-62. [PMID: 34972203 DOI: 10.1093/ecco-jcc/jjab212] [Reference Citation Analysis]
38 Li Y, Lin X, Wang W, Wang W, Cheng S, Huang Y, Zou Y, Ke J, Zhu L. The Proinflammatory Role of Guanylate-Binding Protein 5 in Inflammatory Bowel Diseases. Front Microbiol 2022;13:926915. [PMID: 35722277 DOI: 10.3389/fmicb.2022.926915] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Smith AP, Creagh EM. Caspase-4 and -5 Biology in the Pathogenesis of Inflammatory Bowel Disease. Front Pharmacol 2022;13:919567. [PMID: 35712726 DOI: 10.3389/fphar.2022.919567] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Zheng J, Jiang Z, Song Y, Huang S, Du Y, Yang X, Xiao Y, Ma Z, Xu D, Li J. 3,4-Methylenedioxy-β-Nitrostyrene Alleviates Dextran Sulfate Sodium–Induced Mouse Colitis by Inhibiting the NLRP3 Inflammasome. Front Pharmacol 2022;13:866228. [DOI: 10.3389/fphar.2022.866228] [Reference Citation Analysis]
41 Vafaei S, Taheri H, Hajimomeni Y, Fakhre Yaseri A, Abolhasani Zadeh F. The role of NLRP3 inflammasome in colorectal cancer: potential therapeutic target. Clin Transl Oncol 2022. [PMID: 35689136 DOI: 10.1007/s12094-022-02861-4] [Reference Citation Analysis]
42 Zhang S, Liang Y, Yao J, Li DF, Wang LS. Role of Pyroptosis in Inflammatory Bowel Disease (IBD): From Gasdermins to DAMPs. Front Pharmacol 2022;13:833588. [PMID: 35677444 DOI: 10.3389/fphar.2022.833588] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
43 Yang X, Wang Z, Niu J, Zhai R, Xue X, Wu G, Meng G, Yuan H, Zhao L, Zhang C. Pathobionts from chemically disrupted gut microbiota induce insulin-dependent diabetes in mice.. [DOI: 10.1101/2022.06.05.494898] [Reference Citation Analysis]
44 Liu D, Zhong Z, Karin M. NF-κB: A Double-Edged Sword Controlling Inflammation. Biomedicines 2022;10:1250. [DOI: 10.3390/biomedicines10061250] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
45 de Graaf DM, Wang RX, Amo-aparicio J, Lee JS, Dowdell AS, Tengesdal IW, Marchetti C, Colgan SP, Joosten LAB, Dinarello CA. IL-38 Gene Deletion Worsens Murine Colitis. Front Immunol 2022;13:840719. [DOI: 10.3389/fimmu.2022.840719] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
46 Lin Y, Li Z, Wang Y, Tian T, Jia P, Ye Y, He M, Yang Z, Li C, Guo D, Hou P. CCDC50 suppresses NLRP3 inflammasome activity by mediating autophagic degradation of NLRP3. EMBO Rep 2022;23:e54453. [PMID: 35343634 DOI: 10.15252/embr.202154453] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Abraham C, Abreu MT, Turner JR. Pattern Recognition Receptor Signaling and Cytokine Networks in Microbial Defenses and Regulation of Intestinal Barriers: Implications for Inflammatory Bowel Disease. Gastroenterology 2022;162:1602-1616.e6. [PMID: 35149024 DOI: 10.1053/j.gastro.2021.12.288] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
48 Pretre V, Papadopoulos D, Regard J, Pelletier M, Woo J. Interleukin-1 (IL-1) and the inflammasome in cancer. Cytokine 2022;153:155850. [DOI: 10.1016/j.cyto.2022.155850] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
49 Li C, Liang Y, Qiao Y. Messengers From the Gut: Gut Microbiota-Derived Metabolites on Host Regulation. Front Microbiol 2022;13:863407. [DOI: 10.3389/fmicb.2022.863407] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
50 Shi H, Zhou ZM, Zhu L, Chen L, Jiang ZL, Wu XT. Underlying Mechanisms and Related Diseases Behind the Complex Regulatory Role of NOD-Like Receptor X1. DNA Cell Biol 2022. [PMID: 35363060 DOI: 10.1089/dna.2022.0051] [Reference Citation Analysis]
51 Thomas JP, Modos D, Rushbrook SM, Powell N, Korcsmaros T. The Emerging Role of Bile Acids in the Pathogenesis of Inflammatory Bowel Disease. Front Immunol 2022;13:829525. [PMID: 35185922 DOI: 10.3389/fimmu.2022.829525] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
52 Man SM, Jenkins BJ. Context-dependent functions of pattern recognition receptors in cancer. Nat Rev Cancer 2022. [PMID: 35355007 DOI: 10.1038/s41568-022-00462-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
53 Long X, Yu X, Gong P, Wang X, Tian L. Identification of WT161 as a Potent Agent for the Treatment of Colitis by Targeting the Nucleotide-Binding Domain-Like Receptor Family Pyrin Domain Containing 3 Inflammasome. Front Pharmacol 2022;13:780179. [PMID: 35330829 DOI: 10.3389/fphar.2022.780179] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 Santana PT, Rosas SLB, Ribeiro BE, Marinho Y, de Souza HSP. Dysbiosis in Inflammatory Bowel Disease: Pathogenic Role and Potential Therapeutic Targets. Int J Mol Sci 2022;23:3464. [PMID: 35408838 DOI: 10.3390/ijms23073464] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
55 West AJ, Deswaerte V, West AC, Gearing LJ, Tan P, Jenkins BJ. Inflammasome-Associated Gastric Tumorigenesis Is Independent of the NLRP3 Pattern Recognition Receptor. Front Oncol 2022;12:830350. [PMID: 35299732 DOI: 10.3389/fonc.2022.830350] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
56 Yao H, Yan J, Yin L, Chen W. Picroside II alleviates DSS-induced ulcerative colitis by suppressing the production of NLRP3 inflammasomes through NF-κB signaling pathway. Immunopharmacol Immunotoxicol 2022;:1-23. [PMID: 35293848 DOI: 10.1080/08923973.2022.2054425] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Jiang RY, Wang T, Lan QY, Qin YC, Man TT, Sun H, Li ZL, Zhong XT, Mo CM, Rong Z. BuFeiXiaoJiYin ameliorates the NLRP3 inflammation response and gut microbiota in mice with lung cancer companied with Qi-yin deficiency. Cancer Cell Int 2022;22:121. [PMID: 35292015 DOI: 10.1186/s12935-022-02543-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Ohto U, Kamitsukasa Y, Ishida H, Zhang Z, Murakami K, Hirama C, Maekawa S, Shimizu T. Structural basis for the oligomerization-mediated regulation of NLRP3 inflammasome activation. Proc Natl Acad Sci U S A 2022;119:e2121353119. [DOI: 10.1073/pnas.2121353119] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
59 Zhang Y, Tao M, Chen C, Zhao X, Feng Q, Chen G, Fu Y. BAFF Blockade Attenuates DSS-Induced Chronic Colitis via Inhibiting NLRP3 Inflammasome and NF-κB Activation. Front Immunol 2022;13:783254. [DOI: 10.3389/fimmu.2022.783254] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
60 Akbar N, Khan NA, Muhammad JS, Siddiqui R. The role of gut microbiome in cancer genesis and cancer prevention. Health Sciences Review 2022;2:100010. [DOI: 10.1016/j.hsr.2021.100010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
61 Bauset C, Lis-lopez L, Coll S, Gisbert-ferrándiz L, Macias-ceja DC, Seco-cervera M, Navarro F, Esplugues JV, Calatayud S, Ortiz-masia D, Barrachina MD, Cosín-roger J. SUCNR1 Mediates the Priming Step of the Inflammasome in Intestinal Epithelial Cells: Relevance in Ulcerative Colitis. Biomedicines 2022;10:532. [DOI: 10.3390/biomedicines10030532] [Reference Citation Analysis]
62 Peng Z, Tang J. Intestinal Infection of Candida albicans: Preventing the Formation of Biofilm by C. albicans and Protecting the Intestinal Epithelial Barrier. Front Microbiol 2021;12:783010. [PMID: 35185813 DOI: 10.3389/fmicb.2021.783010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
63 Ruan J, Schlüter D, Naumann M, Waisman A, Wang X. Ubiquitin-modifying enzymes as regulators of colitis. Trends Mol Med 2022:S1471-4914(22)00025-9. [PMID: 35177326 DOI: 10.1016/j.molmed.2022.01.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
64 Wu B, Qiang L, Zhang Y, Fu Y, Zhao M, Lei Z, Lu Z, Wei YG, Dai H, Ge Y, Liu M, Zhou X, Peng Z, Li H, Cui CP, Wang J, Zheng H, Liu CH, Zhang L. The deubiquitinase OTUD1 inhibits colonic inflammation by suppressing RIPK1-mediated NF-κB signaling. Cell Mol Immunol 2022;19:276-89. [PMID: 34876703 DOI: 10.1038/s41423-021-00810-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
65 Pan Y, Cai W, Cheng A, Wang M, Yin Z, Jia R. Flaviviruses: Innate Immunity, Inflammasome Activation, Inflammatory Cell Death, and Cytokines. Front Immunol 2022;13:829433. [DOI: 10.3389/fimmu.2022.829433] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
66 Jia Y, Li L, Lin YH, Gopal P, Shen S, Zhou K, Yu X, Sharma T, Zhang Y, Siegwart DJ, Ready JM, Zhu H. In vivo CRISPR screening identifies BAZ2 chromatin remodelers as druggable regulators of mammalian liver regeneration. Cell Stem Cell 2022:S1934-5909(22)00001-7. [PMID: 35090595 DOI: 10.1016/j.stem.2022.01.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
67 Ghanawat M, Arjmand B, Rahim F. The Pro-tumor and Anti-tumor Effects of NLRP3 Inflammasome as a New Therapeutic Option for Colon Cancer: a Meta-analysis of Pre-clinical Studies. J Gastrointest Cancer 2022. [PMID: 35072914 DOI: 10.1007/s12029-022-00805-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
68 Privitera G, Rana N, Scaldaferri F, Armuzzi A, Pizarro TT. Novel Insights Into the Interactions Between the Gut Microbiome, Inflammasomes, and Gasdermins During Colorectal Cancer. Front Cell Infect Microbiol 2022;11:806680. [DOI: 10.3389/fcimb.2021.806680] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
69 Nogal A, Valdes AM, Menni C. The role of short-chain fatty acids in the interplay between gut microbiota and diet in cardio-metabolic health. Gut Microbes 2021;13:1-24. [PMID: 33764858 DOI: 10.1080/19490976.2021.1897212] [Cited by in Crossref: 78] [Cited by in F6Publishing: 77] [Article Influence: 78.0] [Reference Citation Analysis]
70 Xiao J, Sun K, Wang C, Abu-amer Y, Mbalaviele G. Compound loss of GSDMD and GSDME function is necessary to achieve maximal therapeutic effect in colitis. Journal of Translational Autoimmunity 2022;5:100162. [DOI: 10.1016/j.jtauto.2022.100162] [Reference Citation Analysis]
71 Sarmento A, Simões CD. Gut Microbiota Dysbiosis and Chronic Intestinal Inflammation. Comprehensive Gut Microbiota 2022. [DOI: 10.1016/b978-0-12-819265-8.00057-7] [Reference Citation Analysis]
72 Das NC, Patra R, Dey A, Mukherjee S. Probiotics as Efficacious Therapeutic Option for Treating Gut-Related Diseases: Molecular and Immunobiological Perspectives. Prebiotics, Probiotics and Nutraceuticals 2022. [DOI: 10.1007/978-981-16-8990-1_5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
73 Wu KC, Lee DY, Hsu JT, Cheng CF, Lan JL, Chiu SC, Cho DY, Hsu JL. Evaluations and Mechanistic Interrogation of Natural Products Isolated From Paeonia suffruticosa for the Treatment of Inflammatory Bowel Disease. Front Pharmacol 2021;12:696158. [PMID: 34938175 DOI: 10.3389/fphar.2021.696158] [Reference Citation Analysis]
74 Scarfe L, Mackie GM, Maslowski KM. Inflammasome-independent functions of NAIPs and NLRs in the intestinal epithelium. Biochem Soc Trans 2021;49:2601-10. [PMID: 34854889 DOI: 10.1042/BST20210365] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
75 Sun S, Xu X, Liang L, Wang X, Bai X, Zhu L, He Q, Liang H, Xin X, Wang L, Lou C, Cao X, Chen X, Li B, Wang B, Zhao J. Lactic Acid-Producing Probiotic Saccharomyces cerevisiae Attenuates Ulcerative Colitis via Suppressing Macrophage Pyroptosis and Modulating Gut Microbiota. Front Immunol 2021;12:777665. [PMID: 34899735 DOI: 10.3389/fimmu.2021.777665] [Cited by in Crossref: 8] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
76 Piotrowska M, Binienda A, Fichna J. The role of fatty acids in Crohn's disease pathophysiology - An overview. Mol Cell Endocrinol 2021;538:111448. [PMID: 34480991 DOI: 10.1016/j.mce.2021.111448] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
77 Hou J, Hsu JM, Hung MC. Molecular mechanisms and functions of pyroptosis in inflammation and antitumor immunity. Mol Cell 2021;81:4579-90. [PMID: 34562371 DOI: 10.1016/j.molcel.2021.09.003] [Cited by in Crossref: 27] [Cited by in F6Publishing: 32] [Article Influence: 13.5] [Reference Citation Analysis]
78 Pattnaik S, Maharana L, Sethi M. Pathogenicity Mechanism of Candida albicans. Advances in Candida albicans 2021. [DOI: 10.5772/intechopen.99737] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
79 Wang Q, Lyu J, Zhang W, Shi F, Ren Y, Mao Q, Liu Y, Li Y, Wang S. Immunological and clinical immunotherapy implications of NLRP3 mutations in melanoma. Aging (Albany NY) 2021;13:24271-89. [PMID: 34747716 DOI: 10.18632/aging.203678] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
80 Miao P, Ruiqing T, Yanrong L, Zhuwen S, Huan Y, Qiong W, Yongnian L, Chao S. Pyroptosis: A possible link between obesity-related inflammation and inflammatory diseases. J Cell Physiol 2021. [PMID: 34751453 DOI: 10.1002/jcp.30627] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
81 Johnson AM, Ou ZA, Gordon R, Saminathan H. Environmental neurotoxicants and inflammasome activation in Parkinson's disease - A focus on the gut-brain axis. Int J Biochem Cell Biol 2021;142:106113. [PMID: 34737076 DOI: 10.1016/j.biocel.2021.106113] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
82 Gao H, Cao M, Yao Y, Hu W, Sun H, Zhang Y, Zeng C, Tang J, Luan S, Chen P. Dysregulated Microbiota-Driven Gasdermin D Activation Promotes Colitis Development by Mediating IL-18 Release. Front Immunol 2021;12:750841. [PMID: 34721422 DOI: 10.3389/fimmu.2021.750841] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
83 Zhao L, Wang F, Cai Z, Zhou Q, Chen B, Zhang C, Liu H, Hong L, Zhang T, Zhong J, Cui W, Wang Z. Improving drug utilization platform with injectable mucoadhesive hydrogel for treating ulcerative colitis. Chemical Engineering Journal 2021;424:130464. [DOI: 10.1016/j.cej.2021.130464] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
84 Qu S, Fan L, Qi Y, Xu C, Hu Y, Chen S, Liu W, Liu W, Si J. Akkermansia muciniphila Alleviates Dextran Sulfate Sodium (DSS)-Induced Acute Colitis by NLRP3 Activation. Microbiol Spectr 2021;9:e0073021. [PMID: 34612661 DOI: 10.1128/Spectrum.00730-21] [Cited by in Crossref: 21] [Cited by in F6Publishing: 29] [Article Influence: 10.5] [Reference Citation Analysis]
85 Zheng X, Liu L, Meng G, Zhu S, Zhou R, Jiang W. IL-18 maintains the homeostasis of mucosal immune system via inflammasome-independent but microbiota-dependent manner. Sci Bull (Beijing) 2021;66:2115-23. [PMID: 36654269 DOI: 10.1016/j.scib.2021.01.025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
86 Watanabe D, Guo Y, Kamada N. Interaction between the inflammasome and commensal microorganisms in gastrointestinal health and disease. EMBO Mol Med 2021;:e13452. [PMID: 34705319 DOI: 10.15252/emmm.202013452] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
87 Deng Z, Yang Z, Peng J. Role of bioactive peptides derived from food proteins in programmed cell death to treat inflammatory diseases and cancer. Crit Rev Food Sci Nutr 2021;:1-19. [PMID: 34694177 DOI: 10.1080/10408398.2021.1992606] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
88 Schlender J, Behrens F, McParland V, Müller D, Wilck N, Bartolomaeus H, Holle J. Bacterial metabolites and cardiovascular risk in children with chronic kidney disease. Mol Cell Pediatr 2021;8:17. [PMID: 34677718 DOI: 10.1186/s40348-021-00126-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
89 Lee S, Cho HJ, Ryu JH. Innate Immunity and Cell Death in Alzheimer's Disease. ASN Neuro 2021;13:17590914211051908. [PMID: 34668411 DOI: 10.1177/17590914211051908] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
90 Zhao S, Zhu L, Feng W, Zhang L, Chen DD, Hu YC, Shen H. MicroRNA-602 prevents the development of inflammatory bowel diseases in a microbiota-dependent manner. Exp Ther Med 2021;22:1373. [PMID: 34659519 DOI: 10.3892/etm.2021.10808] [Reference Citation Analysis]
91 Wei Y, Yang L, Pandeya A, Cui J, Zhang Y, Li Z. Pyroptosis-Induced Inflammation and Tissue Damage. J Mol Biol 2021;:167301. [PMID: 34653436 DOI: 10.1016/j.jmb.2021.167301] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
92 Li C, Wang M, Sui J, Zhou Y, Chen W. Protective mechanisms of Agrimonia pilosa Ledeb in dextran sodium sulfate-induced colitis as determined by a network pharmacology approach. Acta Biochim Biophys Sin (Shanghai) 2021;53:1342-53. [PMID: 34523667 DOI: 10.1093/abbs/gmab116] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
93 de Jesus JCR, Murari ASP, Radloff K, de Moraes RCM, Figuerêdo RG, Pessoa AFM, Rosa-Neto JC, Matos-Neto EM, Alcântara PSM, Tokeshi F, Maximiano LF, Bin FC, Formiga FB, Otoch JP, Seelaender M. Activation of the Adipose Tissue NLRP3 Inflammasome Pathway in Cancer Cachexia. Front Immunol 2021;12:729182. [PMID: 34630405 DOI: 10.3389/fimmu.2021.729182] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
94 Tsujikawa Y, Suzuki M, Sakane I. Isolation, identification, and impact on intestinal barrier integrity of Lactiplantibacillus plantarum from fresh tea leaves (Camellia sinensis). Biosci Microbiota Food Health 2021;40:186-95. [PMID: 34631330 DOI: 10.12938/bmfh.2020-083] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
95 Churchill MJ, Mitchell PS, Rauch I. Epithelial Pyroptosis in Host Defense. J Mol Biol 2021;:167278. [PMID: 34627788 DOI: 10.1016/j.jmb.2021.167278] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
96 Bruland T, Østvik AE, Sandvik AK, Hansen MD. Host-Viral Interactions in the Pathogenesis of Ulcerative Colitis. Int J Mol Sci 2021;22:10851. [PMID: 34639191 DOI: 10.3390/ijms221910851] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
97 Eshleman EM, Alenghat T. Epithelial sensing of microbiota-derived signals. Genes Immun 2021;22:237-46. [PMID: 33824498 DOI: 10.1038/s41435-021-00124-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
98 Linares R, Francés R, Gutiérrez A, Juanola O. Bacterial Translocation as Inflammatory Driver in Crohn's Disease. Front Cell Dev Biol 2021;9:703310. [PMID: 34557484 DOI: 10.3389/fcell.2021.703310] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
99 Lee HH, Kim D, Jung J, Kang H, Cho H. NLRP3 Deficiency in Hepatocellular Carcinoma Enhances Surveillance of NK-92 through a Modulation of MICA/B. Int J Mol Sci 2021;22:9285. [PMID: 34502191 DOI: 10.3390/ijms22179285] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
100 Keshavarz Shahbaz S, Koushki K, Ayati SH, Bland AR, Bezsonov EE, Sahebkar A. Inflammasomes and Colorectal Cancer. Cells 2021;10:2172. [PMID: 34571825 DOI: 10.3390/cells10092172] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
101 Wu B, Zhou Q, He Z, Wang X, Sun X, Chen Y. Protective Effect of the Abelmoschus manihot Flower Extract on DSS-Induced Ulcerative Colitis in Mice. Evid Based Complement Alternat Med 2021;2021:7422792. [PMID: 34408782 DOI: 10.1155/2021/7422792] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
102 Shabgah AG, Suksatan W, Achmad MH, Bokov DO, Abdelbasset WK, Ezzatifar F, Hemmati S, Mohammadi H, Soleimani D, Jadidi-Niaragh F, Ahmadi M, Navashenaq JG. Arctigenin, an anti-tumor agent; a cutting-edge topic and up-to-the-minute approach in cancer treatment. Eur J Pharmacol 2021;909:174419. [PMID: 34391770 DOI: 10.1016/j.ejphar.2021.174419] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
103 Yoganathan P, Rossel JB, Jordi SBU, Franc Y, Biedermann L, Misselwitz B, Hausmann M, Rogler G, Scharl M, Frey-Wagner I; Swiss IBD cohort study group. Genotype-phenotype associations of polymorphisms within the gene locus of NOD-like receptor pyrin domain containing 3 in Swiss inflammatory bowel disease patients. BMC Gastroenterol 2021;21:310. [PMID: 34344313 DOI: 10.1186/s12876-021-01880-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
104 Cheng J, Hao J, Jiang X, Ji J, Wu T, Chen X, Zhang F. Ameliorative effects of miR-423-5p against polarization of microglial cells of the M1 phenotype by targeting a NLRP3 inflammasome signaling pathway. Int Immunopharmacol 2021;99:108006. [PMID: 34339965 DOI: 10.1016/j.intimp.2021.108006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
105 Cai X, Zhang ZY, Yuan JT, Ocansey DKW, Tu Q, Zhang X, Qian H, Xu WR, Qiu W, Mao F. hucMSC-derived exosomes attenuate colitis by regulating macrophage pyroptosis via the miR-378a-5p/NLRP3 axis. Stem Cell Res Ther 2021;12:416. [PMID: 34294138 DOI: 10.1186/s13287-021-02492-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 9.5] [Reference Citation Analysis]
106 Khatri V, Kalyanasundaram R. Therapeutic implications of inflammasome in inflammatory bowel disease. FASEB J 2021;35:e21439. [PMID: 33774860 DOI: 10.1096/fj.202002622R] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
107 Mohapatra G, Eisenberg-Lerner A, Merbl Y. Gatekeepers of the Gut: The Roles of Proteasomes at the Gastrointestinal Barrier. Biomolecules 2021;11:989. [PMID: 34356615 DOI: 10.3390/biom11070989] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
108 Hamza KH, Dunér E, Ulmert I, Arias A, Sorobetea D, Lahl K. Minor alterations in the intestinal microbiota composition upon Rotavirus infection do not affect susceptibility to DSS colitis. Sci Rep 2021;11:13485. [PMID: 34188111 DOI: 10.1038/s41598-021-92796-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
109 Zhang G, Chen H, Guo Y, Zhang W, Jiang Q, Zhang S, Han L, Chen S, Xue R. Activation of Platelet NLRP3 Inflammasome in Crohn's Disease. Front Pharmacol 2021;12:705325. [PMID: 34262463 DOI: 10.3389/fphar.2021.705325] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
110 Xiao Z, Deng Q, Zhou W, Zhang Y. Immune activities of polysaccharides isolated from Lycium barbarum L. What do we know so far? Pharmacol Ther 2021;:107921. [PMID: 34174277 DOI: 10.1016/j.pharmthera.2021.107921] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
111 Yang S, He X, Zhao J, Wang D, Guo S, Gao T, Wang G, Jin C, Yan Z, Wang N, Wang Y, Zhao Y, Xing J, Huang Q. Mitochondrial transcription factor A plays opposite roles in the initiation and progression of colitis-associated cancer. Cancer Commun (Lond) 2021;41:695-714. [PMID: 34160895 DOI: 10.1002/cac2.12184] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
112 Zhang Z, Xue Z, Yang H, Zhao F, Liu C, Chen J, Lu S, Zou Z, Zhou Y, Zhang X. Differential effects of EPA and DHA on DSS-induced colitis in mice and possible mechanisms involved. Food Funct 2021;12:1803-17. [PMID: 33523066 DOI: 10.1039/d0fo02308f] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
113 Tan G, Huang C, Chen J, Chen B, Zhi F. Gasdermin-E-mediated pyroptosis participates in the pathogenesis of Crohn's disease by promoting intestinal inflammation. Cell Rep 2021;35:109265. [PMID: 34133932 DOI: 10.1016/j.celrep.2021.109265] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
114 Ruiz Castro PA, Yepiskoposyan H, Gubian S, Calvino-Martin F, Kogel U, Renggli K, Peitsch MC, Hoeng J, Talikka M. Systems biology approach highlights mechanistic differences between Crohn's disease and ulcerative colitis. Sci Rep 2021;11:11519. [PMID: 34075172 DOI: 10.1038/s41598-021-91124-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
115 Chen Y, He H, Lin B, Chen Y, Deng X, Jiang W, Zhou R. RRx-001 ameliorates inflammatory diseases by acting as a potent covalent NLRP3 inhibitor. Cell Mol Immunol 2021;18:1425-36. [PMID: 33972740 DOI: 10.1038/s41423-021-00683-y] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 12.5] [Reference Citation Analysis]
116 Yun Y, Baek A, Kim D. Autophagy down-regulates NLRP3-dependent inflammatory response of intestinal epithelial cells under nutrient deprivation. BMB Rep 2021;54:260-265. [DOI: 10.5483/bmbrep.2021.54.5.211] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
117 Dhingra A, Sharp RC, Kim T, Popov AV, Ying GS, Pietrofesa RA, Park K, Christofidou-Solomidou M, Boesze-Battaglia K. Assessment of a Small Molecule Synthetic Lignan in Enhancing Oxidative Balance and Decreasing Lipid Accumulation in Human Retinal Pigment Epithelia. Int J Mol Sci 2021;22:5764. [PMID: 34071220 DOI: 10.3390/ijms22115764] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
118 Na SW, Jang YJ, Hong MH, Yoon JJ, Lee HS, Kim HY, Kang DG. Protective Effect of Joa-Gui Em through the Improvement of the NLRP3 and TLR4/NF-κb Signaling by Ischemia/Reperfusion-Induced Acute Renal Failure Rats. Evid Based Complement Alternat Med 2021;2021:7178868. [PMID: 34135984 DOI: 10.1155/2021/7178868] [Reference Citation Analysis]
119 Smallwood TB, Navarro S, Cristofori-Armstrong B, Watkins TS, Tungatt K, Ryan RYM, Haigh OL, Lutzky VP, Mulvenna JP, Rosengren KJ, Loukas A, Miles JJ, Clark RJ. Synthetic hookworm-derived peptides are potent modulators of primary human immune cell function that protect against experimental colitis in vivo. J Biol Chem 2021;297:100834. [PMID: 34051231 DOI: 10.1016/j.jbc.2021.100834] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
120 Missiroli S, Perrone M, Boncompagni C, Borghi C, Campagnaro A, Marchetti F, Anania G, Greco P, Fiorica F, Pinton P, Giorgi C. Targeting the NLRP3 Inflammasome as a New Therapeutic Option for Overcoming Cancer. Cancers (Basel) 2021;13:2297. [PMID: 34064909 DOI: 10.3390/cancers13102297] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
121 Jimenez-Duran G, Triantafilou M. Metabolic regulators of enigmatic inflammasomes in autoimmune diseases and crosstalk with innate immune receptors. Immunology 2021;163:348-62. [PMID: 33682108 DOI: 10.1111/imm.13326] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
122 Sharma BR, Kanneganti TD. NLRP3 inflammasome in cancer and metabolic diseases. Nat Immunol 2021;22:550-9. [PMID: 33707781 DOI: 10.1038/s41590-021-00886-5] [Cited by in Crossref: 172] [Cited by in F6Publishing: 170] [Article Influence: 86.0] [Reference Citation Analysis]
123 Carretta MD, Quiroga J, López R, Hidalgo MA, Burgos RA. Participation of Short-Chain Fatty Acids and Their Receptors in Gut Inflammation and Colon Cancer. Front Physiol 2021;12:662739. [PMID: 33897470 DOI: 10.3389/fphys.2021.662739] [Cited by in Crossref: 20] [Cited by in F6Publishing: 26] [Article Influence: 10.0] [Reference Citation Analysis]
124 Looi CK, Hii LW, Chung FF, Mai CW, Lim WM, Leong CO. Roles of Inflammasomes in Epstein-Barr Virus-Associated Nasopharyngeal Cancer. Cancers (Basel) 2021;13:1786. [PMID: 33918087 DOI: 10.3390/cancers13081786] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
125 Venuprasad K, Theiss AL. NLRP6 in host defense and intestinal inflammation. Cell Rep 2021;35:109043. [PMID: 33910012 DOI: 10.1016/j.celrep.2021.109043] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
126 Song Y, Zhao Y, Ma Y, Wang Z, Rong L, Wang B, Zhang N. Biological functions of NLRP3 inflammasome: A therapeutic target in inflammatory bowel disease. Cytokine Growth Factor Rev 2021;60:61-75. [PMID: 33773897 DOI: 10.1016/j.cytogfr.2021.03.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
127 Yu P, Zhang X, Liu N, Tang L, Peng C, Chen X. Pyroptosis: mechanisms and diseases. Signal Transduct Target Ther 2021;6:128. [PMID: 33776057 DOI: 10.1038/s41392-021-00507-5] [Cited by in Crossref: 286] [Cited by in F6Publishing: 278] [Article Influence: 143.0] [Reference Citation Analysis]
128 González MI, Vannan D, Eksteen B, Reyes JL. NLRP3 receptor contributes to protection against experimental antigen-mediated cholangitis. Biosci Rep 2020;40:BSR20200689. [PMID: 32716024 DOI: 10.1042/BSR20200689] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
129 Choudhury SKM, Ma X, Abdullah SW, Zheng H. Activation and Inhibition of the NLRP3 Inflammasome by RNA Viruses. J Inflamm Res 2021;14:1145-63. [PMID: 33814921 DOI: 10.2147/JIR.S295706] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
130 Xu Q, Zhou X, Strober W, Mao L. Inflammasome Regulation: Therapeutic Potential for Inflammatory Bowel Disease. Molecules 2021;26:1725. [PMID: 33808793 DOI: 10.3390/molecules26061725] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
131 Wu T, Gao J, Liu W, Cui J, Yang M, Guo W, Wang FY. NLRP3 protects mice from radiation-induced colon and skin damage via attenuating cGAS-STING signaling. Toxicol Appl Pharmacol 2021;418:115495. [PMID: 33741346 DOI: 10.1016/j.taap.2021.115495] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
132 Guo H, Gibson SA, Ting JPY. Gut microbiota, NLR proteins, and intestinal homeostasis. J Exp Med 2020;217:e20181832. [PMID: 32941596 DOI: 10.1084/jem.20181832] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
133 Moreno-García L, Miana-Mena FJ, Moreno-Martínez L, de la Torre M, Lunetta C, Tarlarini C, Zaragoza P, Calvo AC, Osta R. Inflammasome in ALS Skeletal Muscle: NLRP3 as a Potential Biomarker. Int J Mol Sci 2021;22:2523. [PMID: 33802349 DOI: 10.3390/ijms22052523] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
134 Higashimori A, Watanabe T, Nadatani Y, Nakata A, Otani K, Hosomi S, Tanaka F, Kamata N, Taira K, Nagami Y, Tanigawa T, Fujiwara Y. Role of nucleotide binding oligomerization domain-like receptor protein 3 inflammasome in stress-induced gastric injury. J Gastroenterol Hepatol 2021;36:740-50. [PMID: 32918847 DOI: 10.1111/jgh.15257] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
135 Zhang W, Fu X, Xie J, Pan H, Han W, Huang W. miR-26a attenuates colitis and colitis-associated cancer by targeting the multiple intestinal inflammatory pathways. Mol Ther Nucleic Acids 2021;24:264-73. [PMID: 33815939 DOI: 10.1016/j.omtn.2021.02.029] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
136 Brandl C, Bucci L, Schett G, Zaiss MM. Crossing the barriers: Revisiting the gut feeling in rheumatoid arthritis. Eur J Immunol 2021;51:798-810. [PMID: 33594693 DOI: 10.1002/eji.202048876] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
137 Jain T, Sharma P, Are AC, Vickers SM, Dudeja V. New Insights Into the Cancer-Microbiome-Immune Axis: Decrypting a Decade of Discoveries. Front Immunol 2021;12:622064. [PMID: 33708214 DOI: 10.3389/fimmu.2021.622064] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 19.5] [Reference Citation Analysis]
138 Vong CT, Tseng HHL, Yao P, Yu H, Wang S, Zhong Z, Wang Y. Specific NLRP3 inflammasome inhibitors: promising therapeutic agents for inflammatory diseases. Drug Discov Today 2021;26:1394-408. [PMID: 33636340 DOI: 10.1016/j.drudis.2021.02.018] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
139 Li Z, McCafferty KJ, Judd RL. Role of HCA2 in Regulating Intestinal Homeostasis and Suppressing Colon Carcinogenesis. Front Immunol 2021;12:606384. [PMID: 33708203 DOI: 10.3389/fimmu.2021.606384] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
140 Leon G, Hussey S, Walsh PT. The Diverse Roles of the IL-36 Family in Gastrointestinal Inflammation and Resolution. Inflamm Bowel Dis 2021;27:440-50. [PMID: 32860042 DOI: 10.1093/ibd/izaa232] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
141 Tummala P, Rooke M, Dahlstrom JE, Takahashi S, Casarotto MG, Fernando N, Hughes MM, O'Neill LAJ, Board PG. Glutathione transferase Omega 1 confers protection against azoxymethane-induced colorectal tumour formation. Carcinogenesis 2021;42:853-63. [PMID: 33564842 DOI: 10.1093/carcin/bgab008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
142 Seok JK, Kang HC, Cho YY, Lee HS, Lee JY. Therapeutic regulation of the NLRP3 inflammasome in chronic inflammatory diseases. Arch Pharm Res 2021;44:16-35. [PMID: 33534121 DOI: 10.1007/s12272-021-01307-9] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 15.0] [Reference Citation Analysis]
143 Li J, Qu C, Li F, Chen Y, Zheng J, Xiao Y, Jin Q, Jin G, Huang X, Jin D. Inonotus obliquus Polysaccharide Ameliorates Azoxymethane/Dextran Sulfate Sodium-Induced Colitis-Associated Cancer in Mice via Activation of the NLRP3 Inflammasome. Front Pharmacol 2020;11:621835. [PMID: 33603669 DOI: 10.3389/fphar.2020.621835] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
144 Zhu HZ, Liang YD, Hao WZ, Ma QY, Li XJ, Li YM, Chen JX. Xiaoyaosan Exerts Therapeutic Effects on the Colon of Chronic Restraint Stress Model Rats via the Regulation of Immunoinflammatory Activation Induced by the TLR4/NLRP3 Inflammasome Signaling Pathway. Evid Based Complement Alternat Med 2021;2021:6673538. [PMID: 33505499 DOI: 10.1155/2021/6673538] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
145 Sundaram B, Kanneganti TD. Advances in Understanding Activation and Function of the NLRC4 Inflammasome. Int J Mol Sci 2021;22:1048. [PMID: 33494299 DOI: 10.3390/ijms22031048] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 8.0] [Reference Citation Analysis]
146 Shen G, Wu J, Ye BC, Qi N. Gut Microbiota-Derived Metabolites in the Development of Diseases. Can J Infect Dis Med Microbiol 2021;2021:6658674. [PMID: 33505541 DOI: 10.1155/2021/6658674] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
147 Gu BH, Kim M, Yun CH. Regulation of Gastrointestinal Immunity by Metabolites. Nutrients 2021;13:E167. [PMID: 33430497 DOI: 10.3390/nu13010167] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
148 Iljazovic A, Roy U, Gálvez EJC, Lesker TR, Zhao B, Gronow A, Amend L, Will SE, Hofmann JD, Pils MC, Schmidt-Hohagen K, Neumann-Schaal M, Strowig T. Perturbation of the gut microbiome by Prevotella spp. enhances host susceptibility to mucosal inflammation. Mucosal Immunol 2021;14:113-24. [PMID: 32433514 DOI: 10.1038/s41385-020-0296-4] [Cited by in Crossref: 135] [Cited by in F6Publishing: 136] [Article Influence: 67.5] [Reference Citation Analysis]
149 Dawson R, Jenkins BJ. Unravelling the pro-tumorigenic role of innate immune pattern recognition receptors in the gastric compartment. Research and Clinical Applications of Targeting Gastric Neoplasms 2021. [DOI: 10.1016/b978-0-323-85563-1.00007-1] [Reference Citation Analysis]
150 Briard B, Fontaine T, Samir P, Place DE, Muszkieta L, Malireddi RKS, Karki R, Christgen S, Bomme P, Vogel P, Beau R, Mellado E, Ibrahim-Granet O, Henrissat B, Kalathur RC, Robinson C, Latgé JP, Kanneganti TD. Galactosaminogalactan activates the inflammasome to provide host protection. Nature 2020;588:688-92. [PMID: 33268895 DOI: 10.1038/s41586-020-2996-z] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 12.0] [Reference Citation Analysis]
151 Guan X, Li W, Meng H. A double-edged sword: Role of butyrate in the oral cavity and the gut. Mol Oral Microbiol 2021;36:121-31. [PMID: 33155411 DOI: 10.1111/omi.12322] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
152 Yeh CF, Chen YH, Liu SF, Kao HL, Wu MS, Yang KC, Wu WK. Mutual Interplay of Host Immune System and Gut Microbiota in the Immunopathology of Atherosclerosis. Int J Mol Sci 2020;21:E8729. [PMID: 33227973 DOI: 10.3390/ijms21228729] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
153 Saba E, Lee YY, Rhee MH, Kim SD. Alleviation of Ulcerative Colitis Potentially through th1/th2 Cytokine Balance by a Mixture of Rg3-enriched Korean Red Ginseng Extract and Persicaria tinctoria. Molecules 2020;25:E5230. [PMID: 33182623 DOI: 10.3390/molecules25225230] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
154 Zhang F, Zhao W, Zhou J, Wang W, Luo J, Feng Y, Wu J, Li M, Wang K, Niu J, Miao Y. Heat shock transcription factor 2 reduces the secretion of IL-1β by inhibiting NLRP3 inflammasome activation in ulcerative colitis. Gene 2021;768:145299. [PMID: 33181254 DOI: 10.1016/j.gene.2020.145299] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
155 Lapiere A, Geiger M, Robert V, Demarquay C, Auger S, Chadi S, Benadjaoud M, Fernandes G, Milliat F, Langella P, Benderitter M, Chatel JM, Sémont A. Prophylactic Faecalibacterium prausnitzii treatment prevents the acute breakdown of colonic epithelial barrier in a preclinical model of pelvic radiation disease. Gut Microbes 2020;12:1-15. [PMID: 32985332 DOI: 10.1080/19490976.2020.1812867] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
156 Ding W, Ding Z, Wang Y, Zhu Y, Gao Q, Cao W, Du R. Evodiamine Attenuates Experimental Colitis Injury Via Activating Autophagy and Inhibiting NLRP3 Inflammasome Assembly. Front Pharmacol 2020;11:573870. [PMID: 33240089 DOI: 10.3389/fphar.2020.573870] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
157 Pujari R, Banerjee G. Impact of prebiotics on immune response: from the bench to the clinic. Immunol Cell Biol 2021;99:255-73. [PMID: 32996638 DOI: 10.1111/imcb.12409] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 7.3] [Reference Citation Analysis]
158 Zhao Z, Su Z, Liang P, Liu D, Yang S, Wu Y, Ma L, Feng J, Zhang X, Wu C, Huang J, Cui J. USP38 Couples Histone Ubiquitination and Methylation via KDM5B to Resolve Inflammation. Adv Sci (Weinh) 2020;7:2002680. [PMID: 33240782 DOI: 10.1002/advs.202002680] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
159 Wagatsuma K, Nakase H. Contradictory Effects of NLRP3 Inflammasome Regulatory Mechanisms in Colitis. Int J Mol Sci 2020;21:E8145. [PMID: 33143375 DOI: 10.3390/ijms21218145] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
160 Camilli G, Griffiths JS, Ho J, Richardson JP, Naglik JR. Some like it hot: Candida activation of inflammasomes. PLoS Pathog 2020;16:e1008975. [PMID: 33119702 DOI: 10.1371/journal.ppat.1008975] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
161 Cui S, Wang C, Bai W, Li J, Pan Y, Huang X, Yang H, Feng Z, Xiang Q, Fei L, Zheng L, Huang J, Zhang Q, Wu Y, Chen Y. CD1d1 intrinsic signaling in macrophages controls NLRP3 inflammasome expression during inflammation. Sci Adv 2020;6:eaaz7290. [PMID: 33087357 DOI: 10.1126/sciadv.aaz7290] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
162 Lee S, Channappanavar R, Kanneganti TD. Coronaviruses: Innate Immunity, Inflammasome Activation, Inflammatory Cell Death, and Cytokines.Trends Immunol. 2020;41:1083-1099. [PMID: 33153908 DOI: 10.1016/j.it.2020.10.005] [Cited by in Crossref: 96] [Cited by in F6Publishing: 107] [Article Influence: 32.0] [Reference Citation Analysis]
163 Chen TF, Hsu JT, Wu KC, Hsiao CF, Lin JA, Cheng YH, Liu YH, Lee DY, Chang HH, Cho DY, Hsu JL. A systematic identification of anti-inflammatory active components derived from Mu Dan Pi and their applications in inflammatory bowel disease. Sci Rep 2020;10:17238. [PMID: 33057107 DOI: 10.1038/s41598-020-74201-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
164 Pirr S, Viemann D. Host Factors of Favorable Intestinal Microbial Colonization. Front Immunol 2020;11:584288. [PMID: 33117398 DOI: 10.3389/fimmu.2020.584288] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
165 Qiao S, Lv C, Tao Y, Miao Y, Zhu Y, Zhang W, Sun D, Yun X, Xia Y, Wei Z, Dai Y. Arctigenin disrupts NLRP3 inflammasome assembly in colonic macrophages via downregulating fatty acid oxidation to prevent colitis-associated cancer. Cancer Letters 2020;491:162-79. [DOI: 10.1016/j.canlet.2020.08.033] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
166 Sünderhauf A, Raschdorf A, Hicken M, Schlichting H, Fetzer F, Brethack AK, Perner S, Kemper C, Ghebrehiwet B, Sina C, Derer S. GC1qR Cleavage by Caspase-1 Drives Aerobic Glycolysis in Tumor Cells. Front Oncol 2020;10:575854. [PMID: 33102234 DOI: 10.3389/fonc.2020.575854] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
167 Deng Z, Ni J, Wu X, Wei H, Peng J. GPA peptide inhibits NLRP3 inflammasome activation to ameliorate colitis through AMPK pathway. Aging (Albany NY) 2020;12:18522-44. [PMID: 32950971 DOI: 10.18632/aging.103825] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
168 Tweedell RE, Malireddi RKS, Kanneganti TD. A comprehensive guide to studying inflammasome activation and cell death. Nat Protoc 2020;15:3284-333. [PMID: 32895525 DOI: 10.1038/s41596-020-0374-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
169 Kang JW, Yan J, Ranjan K, Zhang X, Turner JR, Abraham C. Myeloid Cell Expression of LACC1 Is Required for Bacterial Clearance and Control of Intestinal Inflammation. Gastroenterology 2020;159:1051-67. [PMID: 32693188 DOI: 10.1053/j.gastro.2020.07.024] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
170 Sun X, Pang H, Li J, Luo S, Huang G, Li X, Xie Z, Zhou Z. The NLRP3 Inflammasome and Its Role in T1DM. Front Immunol 2020;11:1595. [PMID: 32973739 DOI: 10.3389/fimmu.2020.01595] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
171 Donovan C, Liu G, Shen S, Marshall JE, Kim RY, Alemao CA, Budden KF, Choi JP, Kohonen-Corish M, El-Omar EM, Yang IA, Hansbro PM. The role of the microbiome and the NLRP3 inflammasome in the gut and lung. J Leukoc Biol 2020;108:925-35. [PMID: 33405294 DOI: 10.1002/JLB.3MR0720-472RR] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 8.0] [Reference Citation Analysis]
172 Svegliati-Baroni G, Patrício B, Lioci G, Macedo MP, Gastaldelli A. Gut-Pancreas-Liver Axis as a Target for Treatment of NAFLD/NASH. Int J Mol Sci 2020;21:E5820. [PMID: 32823659 DOI: 10.3390/ijms21165820] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
173 Spalinger MR, Schwarzfischer M, Scharl M. The Role of Protein Tyrosine Phosphatases in Inflammasome Activation. Int J Mol Sci 2020;21:E5481. [PMID: 32751912 DOI: 10.3390/ijms21155481] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
174 Wu N, Chen D, Sun H, Tan J, Zhang Y, Zhang T, Han Y, Liu H, Ouyang X, Yang XD, Niu X, Zhong J, Wang Z, Su B. MAP3K2 augments Th1 cell differentiation via IL-18 to promote T cell-mediated colitis. Sci China Life Sci 2021;64:389-403. [PMID: 32737854 DOI: 10.1007/s11427-020-1720-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
175 Liwinski T, Zheng D, Elinav E. The microbiome and cytosolic innate immune receptors. Immunol Rev 2020;297:207-24. [PMID: 32658330 DOI: 10.1111/imr.12901] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 7.7] [Reference Citation Analysis]
176 Hamarsheh S, Zeiser R. NLRP3 Inflammasome Activation in Cancer: A Double-Edged Sword. Front Immunol 2020;11:1444. [PMID: 32733479 DOI: 10.3389/fimmu.2020.01444] [Cited by in Crossref: 75] [Cited by in F6Publishing: 79] [Article Influence: 25.0] [Reference Citation Analysis]
177 Rébé C, Ghiringhelli F. Interleukin-1β and Cancer. Cancers (Basel) 2020;12:E1791. [PMID: 32635472 DOI: 10.3390/cancers12071791] [Cited by in Crossref: 54] [Cited by in F6Publishing: 56] [Article Influence: 18.0] [Reference Citation Analysis]
178 Li Y, Xiao H, Dong J, Luo D, Wang H, Zhang S, Zhu T, Zhu C, Cui M, Fan S. Gut Microbiota Metabolite Fights Against Dietary Polysorbate 80-Aggravated Radiation Enteritis. Front Microbiol 2020;11:1450. [PMID: 32670255 DOI: 10.3389/fmicb.2020.01450] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
179 Neumann S, M. Peyroux E, J. Woodall M, J. Shields N, L. Young S, T. Pattison S. The Influence of Microbial Metabolites in the Gastrointestinal Microenvironment on Anticancer Immunity. Current Cancer Treatment 2020. [DOI: 10.5772/intechopen.88137] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
180 Qiao H, Huang Y, Chen X, Yang L, Wang Y, Xu R. Jiaweishaoyao Decoction Alleviates DSS-Induced Ulcerative Colitis via Inhibiting Inflammation. Gastroenterol Res Pract 2020;2020:7182874. [PMID: 32565784 DOI: 10.1155/2020/7182874] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
181 Fusco R, Siracusa R, Genovese T, Cuzzocrea S, Di Paola R. Focus on the Role of NLRP3 Inflammasome in Diseases. Int J Mol Sci 2020;21:E4223. [PMID: 32545788 DOI: 10.3390/ijms21124223] [Cited by in Crossref: 97] [Cited by in F6Publishing: 103] [Article Influence: 32.3] [Reference Citation Analysis]
182 Bai R, Sun D, Chen M, Shi X, Luo L, Yao Z, Liu Y, Ge X, Gao X, Hu GF, Zhou W, Sheng J, Xu Z. Myeloid cells protect intestinal epithelial barrier integrity through the angiogenin/plexin-B2 axis. EMBO J 2020;39:e103325. [PMID: 32510170 DOI: 10.15252/embj.2019103325] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
183 Wu ZY, Sang LX, Chang B. Isoflavones and inflammatory bowel disease. World J Clin Cases 2020; 8(11): 2081-2091 [PMID: 32548137 DOI: 10.12998/wjcc.v8.i11.2081] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
184 Liu Q, Zuo R, Wang K, Nong FF, Fu YJ, Huang SW, Pan ZF, Zhang Y, Luo X, Deng XL, Zhang XX, Zhou L, Chen Y. Oroxindin inhibits macrophage NLRP3 inflammasome activation in DSS-induced ulcerative colitis in mice via suppressing TXNIP-dependent NF-κB pathway. Acta Pharmacol Sin 2020;41:771-81. [PMID: 31937929 DOI: 10.1038/s41401-019-0335-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
185 Li X, Yang G, Wu L, Hong J, Zhao Y, Liu J, Kong X, Dong X, Zhi F, Ma X, Yang L, Zhang D. Regulatory effects of moxibustion on ubiquitin and NLRP3 proteins in colon of ulcerative colitis rats. J Acupunct Tuina Sci 2020;18:96-104. [DOI: 10.1007/s11726-020-1162-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
186 Zhong Y, Lu Y, Yang X, Tang Y, Zhao K, Yuan C, Zhong X. The roles of NLRP3 inflammasome in bacterial infection. Mol Immunol 2020;122:80-8. [PMID: 32305691 DOI: 10.1016/j.molimm.2020.03.020] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
187 Gorczynski RM, Hoffmann G. Combined IMIG and immune Ig attenuates inflammatory colitis in mice. Int Immunopharmacol 2020;83:106464. [PMID: 32278130 DOI: 10.1016/j.intimp.2020.106464] [Reference Citation Analysis]
188 Agrawal I, Jha S. Comprehensive review of ASC structure and function in immune homeostasis and disease. Mol Biol Rep 2020;47:3077-96. [PMID: 32124174 DOI: 10.1007/s11033-020-05345-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
189 Singhal M, Arora V, Im H. Gastrointestinal disorders-induced pain. Gene Reports 2020;18:100580. [DOI: 10.1016/j.genrep.2019.100580] [Reference Citation Analysis]
190 Umiker B, Lee HH, Cope J, Ajami NJ, Laine JP, Fregeau C, Ferguson H, Alves SE, Sciammetta N, Kleinschek M, Salmon M. The NLRP3 inflammasome mediates DSS-induced intestinal inflammation in Nod2 knockout mice. Innate Immun 2019;25:132-43. [PMID: 30774010 DOI: 10.1177/1753425919826367] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
191 Zhang J, Xu M, Zhou W, Li D, Zhang H, Chen Y, Ning L, Zhang Y, Li S, Yu M, Chen Y, Zeng H, Cen L, Zhou T, Zhou X, Lu C, Yu C, Li Y, Sun J, Kong X, Shen Z. Deficiency in the anti-apoptotic protein DJ-1 promotes intestinal epithelial cell apoptosis and aggravates inflammatory bowel disease via p53. J Biol Chem 2020;295:4237-51. [PMID: 32075910 DOI: 10.1074/jbc.RA119.010143] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
192 Komada T, Muruve DA. The role of inflammasomes in kidney disease. Nat Rev Nephrol. 2019;15:501-520. [PMID: 31164720 DOI: 10.1038/s41581-019-0158-z] [Cited by in Crossref: 128] [Cited by in F6Publishing: 138] [Article Influence: 42.7] [Reference Citation Analysis]
193 Huang M, Wang Q, Long F, Di Y, Wang J, Zhun Zhu Y, Liu X. Jmjd3 regulates inflammasome activation and aggravates DSS-induced colitis in mice. FASEB J. 2020;34:4107-4119. [PMID: 31971317 DOI: 10.1096/fj.201902200rr] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
194 Gouravani M, Khalili N, Razi S, Keshavarz-Fathi M, Khalili N, Rezaei N. The NLRP3 inflammasome: a therapeutic target for inflammation-associated cancers. Expert Rev Clin Immunol 2020;16:175-87. [PMID: 31928260 DOI: 10.1080/1744666X.2020.1713755] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
195 Shao BZ, Wang SL, Pan P, Yao J, Wu K, Li ZS, Bai Y, Linghu EQ. Targeting NLRP3 Inflammasome in Inflammatory Bowel Disease: Putting out the Fire of Inflammation. Inflammation. 2019;42:1147-1159. [PMID: 30937839 DOI: 10.1007/s10753-019-01008-y] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 15.3] [Reference Citation Analysis]
196 Siegmund B. Pathogenese chronisch-entzündlicher Darmerkrankungen. Chronisch-entzündliche Darmerkrankungen 2020. [DOI: 10.1007/978-3-662-59104-8_3] [Reference Citation Analysis]
197 Fujimoto K, Uematsu S. Innate Immunity at Mucosal Surfaces. Mucosal Vaccines 2020. [DOI: 10.1016/b978-0-12-811924-2.00006-7] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
198 Fung KY, Nguyen PM, Putoczki TL. Emerging Roles for Interleukin-18 in the Gastrointestinal Tumor Microenvironment. Adv Exp Med Biol 2020;1240:59-72. [PMID: 32060888 DOI: 10.1007/978-3-030-38315-2_5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
199 Mackay CR. Diet, the Gut Microbiome, and Autoimmune Diseases. The Autoimmune Diseases 2020. [DOI: 10.1016/b978-0-12-812102-3.00019-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
200 Xu YL, Ding CL, Qian CL, Qi ZT, Wang W. Retinoid acid induced 16 deficiency aggravates colitis and colitis-associated tumorigenesis in mice. Cell Death Dis 2019;10:958. [PMID: 31862898 DOI: 10.1038/s41419-019-2186-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
201 Menghini P, Corridoni D, Buttó LF, Osme A, Shivaswamy S, Lam M, Bamias G, Pizarro TT, Rodriguez-Palacios A, Dinarello CA, Cominelli F. Neutralization of IL-1α ameliorates Crohn's disease-like ileitis by functional alterations of the gut microbiome. Proc Natl Acad Sci U S A 2019:201915043. [PMID: 31843928 DOI: 10.1073/pnas.1915043116] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 7.0] [Reference Citation Analysis]
202 Huang H, Wang X, Zhang X, Zhang G, Jinbo M, Wang H, Yu P, Jiang W. Ganciclovir reduces irinotecan-induced intestinal toxicity by inhibiting NLRP3 activation. Cancer Chemother Pharmacol 2020;85:195-204. [DOI: 10.1007/s00280-019-03996-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
203 Hsu JL, Chou JW, Chen TF, Hsu JT, Su FY, Lan JL, Wu PC, Hu CM, Lee EY, Lee WH. Glutathione peroxidase 8 negatively regulates caspase-4/11 to protect against colitis. EMBO Mol Med 2020;12:e9386. [PMID: 31782617 DOI: 10.15252/emmm.201809386] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
204 Cheng H, Guan X, Chen D, Ma W. The Th17/Treg Cell Balance: A Gut Microbiota-Modulated Story. Microorganisms 2019;7:E583. [PMID: 31756956 DOI: 10.3390/microorganisms7120583] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 9.8] [Reference Citation Analysis]
205 Sun H, Kuk W, Rivera-Nieves J, Lopez-Ramirez MA, Eckmann L, Ginsberg MH. β7 Integrin Inhibition Can Increase Intestinal Inflammation by Impairing Homing of CD25(hi)FoxP3(+) Regulatory T Cells. Cell Mol Gastroenterol Hepatol 2020;9:369-85. [PMID: 31707128 DOI: 10.1016/j.jcmgh.2019.10.012] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
206 Ohashi K, Wang Z, Yang YM, Billet S, Tu W, Pimienta M, Cassel SL, Pandol SJ, Lu SC, Sutterwala FS, Bhowmick N, Seki E. NOD-like receptor C4 Inflammasome Regulates the Growth of Colon Cancer Liver Metastasis in NAFLD. Hepatology 2019;70:1582-99. [PMID: 31044438 DOI: 10.1002/hep.30693] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 8.0] [Reference Citation Analysis]
207 Lin Y, Li B, Yang X, Liu T, Shi T, Deng B, Zhang Y, Jia L, Jiang Z, He R. Non-hematopoietic STAT6 induces epithelial tight junction dysfunction and promotes intestinal inflammation and tumorigenesis. Mucosal Immunol 2019;12:1304-15. [PMID: 31534167 DOI: 10.1038/s41385-019-0204-y] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
208 Ren MT, Gu ML, Zhou XX, Yu MS, Pan HH, Ji F, Ding CY. Sirtuin 1 alleviates endoplasmic reticulum stress-mediated apoptosis of intestinal epithelial cells in ulcerative colitis. World J Gastroenterol 2019; 25(38): 5800-5813 [PMID: 31636473 DOI: 10.3748/wjg.v25.i38.5800] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 33] [Article Influence: 8.3] [Reference Citation Analysis]
209 Yue B, Luo X, Yu Z, Mani S, Wang Z, Dou W. Inflammatory Bowel Disease: A Potential Result from the Collusion between Gut Microbiota and Mucosal Immune System. Microorganisms. 2019;7:440. [PMID: 31614539 DOI: 10.3390/microorganisms7100440] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 9.0] [Reference Citation Analysis]
210 Singh V, Yeoh BS, Walker RE, Xiao X, Saha P, Golonka RM, Cai J, Bretin ACA, Cheng X, Liu Q, Flythe MD, Chassaing B, Shearer GC, Patterson AD, Gewirtz AT, Vijay-Kumar M. Microbiota fermentation-NLRP3 axis shapes the impact of dietary fibres on intestinal inflammation. Gut 2019;68:1801-12. [PMID: 30670576 DOI: 10.1136/gutjnl-2018-316250] [Cited by in Crossref: 101] [Cited by in F6Publishing: 99] [Article Influence: 25.3] [Reference Citation Analysis]
211 Hughes MM, Hooftman A, Angiari S, Tummala P, Zaslona Z, Runtsch MC, Mcgettrick AF, Sutton CE, Diskin C, Rooke M, Takahashi S, Sundararaj S, Casarotto MG, Dahlstrom JE, Palsson-mcdermott EM, Corr SC, Mills KH, Preston RJ, Neamati N, Xie Y, Baell JB, Board PG, O’neill LA. Glutathione Transferase Omega-1 Regulates NLRP3 Inflammasome Activation through NEK7 Deglutathionylation. Cell Reports 2019;29:151-161.e5. [DOI: 10.1016/j.celrep.2019.08.072] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 10.0] [Reference Citation Analysis]
212 Wang CM, Hong LH, Zhang ZM, Wang Y. [Research progress on the relationship between Porphyromonas gingivalis and the malignancy of the digestive system and possible pathogenetic mechanism]. Hua Xi Kou Qiang Yi Xue Za Zhi 2019;37:521-6. [PMID: 31721501 DOI: 10.7518/hxkq.2019.05.013] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
213 Pandey A, Shen C, Man SM. Inflammasomes in Colitis and Colorectal Cancer: Mechanism of Action and Therapies. Yale J Biol Med 2019;92:481-98. [PMID: 31543710] [Reference Citation Analysis]
214 Tang Y, Shi Y, Gao Y, Xu X, Han T, Li J, Liu C. Oxytocin system alleviates intestinal inflammation by regulating macrophages polarization in experimental colitis. Clin Sci (Lond) 2019;133:1977-92. [PMID: 31519790 DOI: 10.1042/CS20190756] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 6.3] [Reference Citation Analysis]
215 Li X, Mao M, Zhang Y, Yu K, Zhu W. Succinate Modulates Intestinal Barrier Function and Inflammation Response in Pigs. Biomolecules 2019;9:E486. [PMID: 31540325 DOI: 10.3390/biom9090486] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
216 Semper RP, Vieth M, Gerhard M, Mejías-Luque R. Helicobacter pylori Exploits the NLRC4 Inflammasome to Dampen Host Defenses. J Immunol 2019;203:2183-93. [PMID: 31511355 DOI: 10.4049/jimmunol.1900351] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
217 Tourkochristou E, Aggeletopoulou I, Konstantakis C, Triantos C. Role of NLRP3 inflammasome in inflammatory bowel diseases. World J Gastroenterol 2019;25:4796-804. [PMID: 31543674 DOI: 10.3748/wjg.v25.i33.4796] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 37] [Article Influence: 9.0] [Reference Citation Analysis]
218 Murdoch CC, Rawls JF. Commensal Microbiota Regulate Vertebrate Innate Immunity-Insights From the Zebrafish. Front Immunol 2019;10:2100. [PMID: 31555292 DOI: 10.3389/fimmu.2019.02100] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 8.0] [Reference Citation Analysis]
219 Fangxiao M, Yifan K, Jihong Z, Yan S, Yingchao L. Effect of Tripterygium wilfordii Polycoride on the NOXs-ROS-NLRP3 Inflammasome Signaling Pathway in Mice with Ulcerative Colitis. Evid Based Complement Alternat Med 2019;2019:9306283. [PMID: 31531121 DOI: 10.1155/2019/9306283] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
220 Marafini I, Sedda S, Dinallo V, Monteleone G. Inflammatory cytokines: from discoveries to therapies in IBD. Expert Opin Biol Ther 2019;19:1207-17. [PMID: 31373244 DOI: 10.1080/14712598.2019.1652267] [Cited by in Crossref: 58] [Cited by in F6Publishing: 52] [Article Influence: 14.5] [Reference Citation Analysis]
221 Zhou C, Fang J. The role of pyroptosis in gastrointestinal cancer and immune responses to intestinal microbial infection. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2019;1872:1-10. [DOI: 10.1016/j.bbcan.2019.05.001] [Cited by in Crossref: 63] [Cited by in F6Publishing: 68] [Article Influence: 15.8] [Reference Citation Analysis]
222 Guan Q, Warrington R, Moreno S, Qing G, Weiss C, Peng Z. Sustained suppression of IL-18 by employing a vaccine ameliorates intestinal inflammation in TNBS-induced murine colitis. Future Sci OA 2019;5:FSO405. [PMID: 31428451 DOI: 10.2144/fsoa-2018-0125] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
223 Winsor N, Krustev C, Bruce J, Philpott DJ, Girardin SE. Canonical and noncanonical inflammasomes in intestinal epithelial cells. Cell Microbiol 2019;21:e13079. [PMID: 31265745 DOI: 10.1111/cmi.13079] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 5.8] [Reference Citation Analysis]
224 Javanmard Khameneh H, Leong KWK, Mencarelli A, Vacca M, Mambwe B, Neo K, Tay A, Zolezzi F, Lee B, Mortellaro A. The Inflammasome Adaptor ASC Intrinsically Limits CD4+ T-Cell Proliferation to Help Maintain Intestinal Homeostasis. Front Immunol 2019;10:1566. [PMID: 31379813 DOI: 10.3389/fimmu.2019.01566] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
225 Chen J, He Y, Tu L, Duan L. Dual immune functions of IL-33 in inflammatory bowel disease. Histol Histopathol 2020;35:137-46. [PMID: 31294456 DOI: 10.14670/HH-18-149] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
226 Gyongyosi B, Cho Y, Lowe P, Calenda CD, Iracheta-Vellve A, Satishchandran A, Ambade A, Szabo G. Alcohol-induced IL-17A production in Paneth cells amplifies endoplasmic reticulum stress, apoptosis, and inflammasome-IL-18 activation in the proximal small intestine in mice. Mucosal Immunol 2019;12:930-44. [PMID: 31105269 DOI: 10.1038/s41385-019-0170-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
227 Pellegrini C, Fornai M, Antonioli L, Blandizzi C, Calderone V. Phytochemicals as Novel Therapeutic Strategies for NLRP3 Inflammasome-Related Neurological, Metabolic, and Inflammatory Diseases. Int J Mol Sci 2019;20:E2876. [PMID: 31200447 DOI: 10.3390/ijms20122876] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 12.0] [Reference Citation Analysis]
228 McEntee CP, Finlay CM, Lavelle EC. Divergent Roles for the IL-1 Family in Gastrointestinal Homeostasis and Inflammation. Front Immunol 2019;10:1266. [PMID: 31231388 DOI: 10.3389/fimmu.2019.01266] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 6.5] [Reference Citation Analysis]
229 Spalinger MR, Manzini R, Hering L, Riggs JB, Gottier C, Lang S, Atrott K, Fettelschoss A, Olomski F, Kündig TM, Fried M, McCole DF, Rogler G, Scharl M. PTPN2 Regulates Inflammasome Activation and Controls Onset of Intestinal Inflammation and Colon Cancer. Cell Rep 2018;22:1835-48. [PMID: 29444435 DOI: 10.1016/j.celrep.2018.01.052] [Cited by in Crossref: 56] [Cited by in F6Publishing: 61] [Article Influence: 14.0] [Reference Citation Analysis]
230 Piqué N, Berlanga M, Miñana-Galbis D. Health Benefits of Heat-Killed (Tyndallized) Probiotics: An Overview. Int J Mol Sci 2019;20:E2534. [PMID: 31126033 DOI: 10.3390/ijms20102534] [Cited by in Crossref: 181] [Cited by in F6Publishing: 192] [Article Influence: 45.3] [Reference Citation Analysis]
231 Karki R, Kanneganti TD. Diverging inflammasome signals in tumorigenesis and potential targeting. Nat Rev Cancer 2019;19:197-214. [PMID: 30842595 DOI: 10.1038/s41568-019-0123-y] [Cited by in Crossref: 275] [Cited by in F6Publishing: 288] [Article Influence: 68.8] [Reference Citation Analysis]
232 Melhem H, Kaya B, Ayata CK, Hruz P, Niess JH. Metabolite-Sensing G Protein-Coupled Receptors Connect the Diet-Microbiota-Metabolites Axis to Inflammatory Bowel Disease. Cells. 2019;8. [PMID: 31091682 DOI: 10.3390/cells8050450] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 8.0] [Reference Citation Analysis]
233 Nagarajan K, Soundarapandian K, Thorne RF, Li D, Li D. Activation of Pyroptotic Cell Death Pathways in Cancer: An Alternative Therapeutic Approach. Transl Oncol 2019;12:925-31. [PMID: 31085408 DOI: 10.1016/j.tranon.2019.04.010] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 13.3] [Reference Citation Analysis]
234 Wang Y, Hatabu T. Mulberry juice freeze-dried powder attenuates the disease severity by the maintaining of colon mucosa in mice with DSS-induced acute colitis. Bioscience, Biotechnology, and Biochemistry 2019;83:914-22. [DOI: 10.1080/09168451.2019.1580135] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
235 Tezcan G, Martynova EV, Gilazieva ZE, McIntyre A, Rizvanov AA, Khaiboullina SF. MicroRNA Post-transcriptional Regulation of the NLRP3 Inflammasome in Immunopathologies. Front Pharmacol 2019;10:451. [PMID: 31118894 DOI: 10.3389/fphar.2019.00451] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 9.0] [Reference Citation Analysis]
236 Mendes V, Galvão I, Vieira AT. Mechanisms by Which the Gut Microbiota Influences Cytokine Production and Modulates Host Inflammatory Responses. J Interferon Cytokine Res 2019;39:393-409. [PMID: 31013453 DOI: 10.1089/jir.2019.0011] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 9.0] [Reference Citation Analysis]
237 Malik A, Sharma D, Malireddi RKS, Guy CS, Chang TC, Olsen SR, Neale G, Vogel P, Kanneganti TD. SYK-CARD9 Signaling Axis Promotes Gut Fungi-Mediated Inflammasome Activation to Restrict Colitis and Colon Cancer. Immunity 2018;49:515-530.e5. [PMID: 30231985 DOI: 10.1016/j.immuni.2018.08.024] [Cited by in Crossref: 80] [Cited by in F6Publishing: 73] [Article Influence: 20.0] [Reference Citation Analysis]
238 Kaur H, Moreau R. Role of mTORC1 in intestinal epithelial repair and tumorigenesis. Cell Mol Life Sci 2019;76:2525-46. [DOI: 10.1007/s00018-019-03085-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
239 Serra D, Almeida LM, Dinis TCP. The Impact of Chronic Intestinal Inflammation on Brain Disorders: the Microbiota-Gut-Brain Axis. Mol Neurobiol 2019;56:6941-51. [DOI: 10.1007/s12035-019-1572-8] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 6.5] [Reference Citation Analysis]
240 Zheng QW, Hao WW, Wang KQ, Wu QY, Wang MR, Yuan ZW, Wen HZ. Impact of NLRP3 inflammasome on immune modulation mechanism in inflammatory bowel disease. Shijie Huaren Xiaohua Zazhi 2019; 27(6): 389-394 [DOI: 10.11569/wcjd.v27.i6.389] [Reference Citation Analysis]
241 Tran LS, Ying L, D’costa K, Wray-mccann G, Kerr G, Le L, Allison CC, Ferrand J, Chaudhry H, Emery J, De Paoli A, Creed S, Kaparakis-liaskos M, Como J, Dowling J, Johanesen PA, Kufer TA, Pedersen JS, Mansell A, Philpott DJ, Elgass K, Abud HE, Nachbur U, Croker BA, Masters SL, Ferrero RL. NOD1 mediates non-canonical inflammasome processing of interleukin-18 in epithelial cells toHelicobacter pyloriinfection.. [DOI: 10.1101/587212] [Reference Citation Analysis]
242 Hagihara Y, Yoshimatsu Y, Mikami Y, Takada Y, Mizuno S, Kanai T. Epigenetic regulation of T helper cells and intestinal pathogenicity. Semin Immunopathol 2019;41:379-99. [DOI: 10.1007/s00281-019-00732-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
243 Schulte L, Hohwieler M, Müller M, Klaus J. Intestinal Organoids as a Novel Complementary Model to Dissect Inflammatory Bowel Disease. Stem Cells Int 2019;2019:8010645. [PMID: 31015842 DOI: 10.1155/2019/8010645] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
244 Smigoc Schweiger D, Goricar K, Hovnik T, Mendez A, Bratina N, Brecelj J, Vidan-Jeras B, Battelino T, Dolzan V. Dual Role of PTPN22 but Not NLRP3 Inflammasome Polymorphisms in Type 1 Diabetes and Celiac Disease in Children. Front Pediatr 2019;7:63. [PMID: 30915320 DOI: 10.3389/fped.2019.00063] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
245 Ohashi W, Fukada T. Contribution of Zinc and Zinc Transporters in the Pathogenesis of Inflammatory Bowel Diseases. J Immunol Res 2019;2019:8396878. [PMID: 30984791 DOI: 10.1155/2019/8396878] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
246 Raut PK, Kim S, Choi DY, Jeong G, Park P. Growth of breast cancer cells by leptin is mediated via activation of the inflammasome: Critical roles of estrogen receptor signaling and reactive oxygen species production. Biochemical Pharmacology 2019;161:73-88. [DOI: 10.1016/j.bcp.2019.01.006] [Cited by in Crossref: 34] [Cited by in F6Publishing: 38] [Article Influence: 8.5] [Reference Citation Analysis]
247 Zhen Y, Zhang H. NLRP3 Inflammasome and Inflammatory Bowel Disease. Front Immunol. 2019;10:276. [PMID: 30873162 DOI: 10.3389/fimmu.2019.00276] [Cited by in Crossref: 252] [Cited by in F6Publishing: 247] [Article Influence: 63.0] [Reference Citation Analysis]
248 Zheng X, Hu M, Zang X, Fan Q, Liu Y, Che Y, Guan X, Hou Y, Wang G, Hao H. Kynurenic acid/GPR35 axis restricts NLRP3 inflammasome activation and exacerbates colitis in mice with social stress. Brain Behav Immun 2019;79:244-55. [PMID: 30790702 DOI: 10.1016/j.bbi.2019.02.009] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 8.0] [Reference Citation Analysis]
249 Tartey S, Kanneganti TD. Differential role of the NLRP3 inflammasome in infection and tumorigenesis. Immunology 2019;156:329-38. [PMID: 30666624 DOI: 10.1111/imm.13046] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 10.5] [Reference Citation Analysis]
250 Ringel-Scaia VM, Qin Y, Thomas CA, Huie KE, McDaniel DK, Eden K, Wade PA, Allen IC. Maternal Influence and Murine Housing Confound Impact of NLRP1 Inflammasome on Microbiome Composition. J Innate Immun 2019;11:416-31. [PMID: 30759441 DOI: 10.1159/000495850] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
251 Tretina K, Park ES, Maminska A, MacMicking JD. Interferon-induced guanylate-binding proteins: Guardians of host defense in health and disease. J Exp Med 2019;216:482-500. [PMID: 30755454 DOI: 10.1084/jem.20182031] [Cited by in Crossref: 106] [Cited by in F6Publishing: 108] [Article Influence: 26.5] [Reference Citation Analysis]
252 Deng J, Yu XQ, Wang PH. Inflammasome activation and Th17 responses. Mol Immunol 2019;107:142-64. [PMID: 30739833 DOI: 10.1016/j.molimm.2018.12.024] [Cited by in Crossref: 49] [Cited by in F6Publishing: 54] [Article Influence: 12.3] [Reference Citation Analysis]
253 Campbell EL, Colgan SP. Control and dysregulation of redox signalling in the gastrointestinal tract. Nat Rev Gastroenterol Hepatol 2019;16:106-20. [PMID: 30443019 DOI: 10.1038/s41575-018-0079-5] [Cited by in Crossref: 65] [Cited by in F6Publishing: 65] [Article Influence: 16.3] [Reference Citation Analysis]
254 Talwar H, Bouhamdan M, Bauerfeld C, Talreja J, Aoidi R, Houde N, Charron J, Samavati L. MEK2 Negatively Regulates Lipopolysaccharide-Mediated IL-1β Production through HIF-1α Expression. J Immunol 2019;202:1815-25. [PMID: 30710049 DOI: 10.4049/jimmunol.1801477] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
255 Chen Y, Sun H, Bai Y, Zhi F. Gut dysbiosis-derived exosomes trigger hepatic steatosis by transiting HMGB1 from intestinal to liver in mice. Biochemical and Biophysical Research Communications 2019;509:767-72. [DOI: 10.1016/j.bbrc.2018.12.180] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 7.5] [Reference Citation Analysis]
256 Huang X, Feng Z, Jiang Y, Li J, Xiang Q, Guo S, Yang C, Fei L, Guo G, Zheng L, Wu Y, Chen Y. VSIG4 mediates transcriptional inhibition of Nlrp3 and Il-1β in macrophages. Sci Adv 2019;5:eaau7426. [PMID: 30662948 DOI: 10.1126/sciadv.aau7426] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 9.5] [Reference Citation Analysis]
257 Vivarelli S, Salemi R, Candido S, Falzone L, Santagati M, Stefani S, Torino F, Banna GL, Tonini G, Libra M. Gut Microbiota and Cancer: From Pathogenesis to Therapy. Cancers (Basel) 2019;11:E38. [PMID: 30609850 DOI: 10.3390/cancers11010038] [Cited by in Crossref: 250] [Cited by in F6Publishing: 264] [Article Influence: 62.5] [Reference Citation Analysis]
258 Westfall S, Iqbal U, Sebastian M, Pasinetti GM. Gut microbiota mediated allostasis prevents stress-induced neuroinflammatory risk factors of Alzheimer's disease. Molecular Biology of Neurodegenerative Diseases: Visions for the Future, Part A. Elsevier; 2019. pp. 147-81. [DOI: 10.1016/bs.pmbts.2019.06.013] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
259 Hughes MM, Hooftman A, Angiari S, Tummala P, Zaslona Z, Runtsch M, Mc-dermott EP, Diskin C, Rooke M, Takahashi S, Sundararaj S, Casarotto MG, Dahlstrom JE, Corr SC, Sutton CE, Mcgettrick AF, Mills KH, Neamati N, Xie Y, Baell JB, Preston RJS, Board PG, O’neill LAJ. Glutathione Transferase Omega-1 Regulates NLRP3 Inflammasome Activation Through NEK7 Deglutathionylation. SSRN Journal. [DOI: 10.2139/ssrn.3323379] [Reference Citation Analysis]
260 Loss H, Aschenbach JR, Tedin K, Ebner F, Lodemann U. The Inflammatory Response to Enterotoxigenic E. coli and Probiotic E. faecium in a Coculture Model of Porcine Intestinal Epithelial and Dendritic Cells. Mediators Inflamm 2018;2018:9368295. [PMID: 30670931 DOI: 10.1155/2018/9368295] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
261 Wang S, Li H, Du C, Liu Q, Yang D, Chen L, Zhu Q, Wang Z. Effects of dietary supplementation with Lactobacillus acidophilus on the performance, intestinal physical barrier function, and the expression of NOD-like receptors in weaned piglets. PeerJ 2018;6:e6060. [PMID: 30588399 DOI: 10.7717/peerj.6060] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
262 Ahechu P, Zozaya G, Martí P, Hernández-Lizoáin JL, Baixauli J, Unamuno X, Frühbeck G, Catalán V. NLRP3 Inflammasome: A Possible Link Between Obesity-Associated Low-Grade Chronic Inflammation and Colorectal Cancer Development. Front Immunol 2018;9:2918. [PMID: 30619282 DOI: 10.3389/fimmu.2018.02918] [Cited by in Crossref: 57] [Cited by in F6Publishing: 60] [Article Influence: 11.4] [Reference Citation Analysis]
263 Khan S, Godfrey V, Zaki MH. Cytosolic Nucleic Acid Sensors in Inflammatory and Autoimmune Disorders. Int Rev Cell Mol Biol 2019;344:215-53. [PMID: 30798989 DOI: 10.1016/bs.ircmb.2018.10.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
264 Wang L, Wang Y, Wang Z, Qi Y, Zong B, Liu M, Li X, Zhang X, Liu C, Cao R, Ma Y. Growth differentiation factor 11 ameliorates experimental colitis by inhibiting NLRP3 inflammasome activation. Am J Physiol Gastrointest Liver Physiol 2018;315:G909-20. [PMID: 30188752 DOI: 10.1152/ajpgi.00159.2018] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
265 Wang J, Dong R, Zheng S. Roles of the inflammasome in the gut‑liver axis (Review). Mol Med Rep 2019;19:3-14. [PMID: 30483776 DOI: 10.3892/mmr.2018.9679] [Cited by in Crossref: 4] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
266 Moossavi M, Parsamanesh N, Bahrami A, Atkin SL, Sahebkar A. Role of the NLRP3 inflammasome in cancer. Mol Cancer 2018;17:158. [PMID: 30447690 DOI: 10.1186/s12943-018-0900-3] [Cited by in Crossref: 200] [Cited by in F6Publishing: 211] [Article Influence: 40.0] [Reference Citation Analysis]
267 Nanini HF, Bernardazzi C, Castro F, de Souza HSP. Damage-associated molecular patterns in inflammatory bowel disease: From biomarkers to therapeutic targets. World J Gastroenterol 2018; 24(41): 4622-4634 [PMID: 30416310 DOI: 10.3748/wjg.v24.i41.4622] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
268 Nakamura H, O'Donnell AM, Marayati NF, Tomuschat C, Coyle D, Puri P. Altered expression of inflammasomes in Hirschsprung's disease. Pediatr Surg Int 2019;35:15-20. [PMID: 30386901 DOI: 10.1007/s00383-018-4371-9] [Reference Citation Analysis]
269 Glal D, Sudhakar JN, Lu HH, Liu MC, Chiang HY, Liu YC, Cheng CF, Shui JW. ATF3 Sustains IL-22-Induced STAT3 Phosphorylation to Maintain Mucosal Immunity Through Inhibiting Phosphatases. Front Immunol 2018;9:2522. [PMID: 30455690 DOI: 10.3389/fimmu.2018.02522] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 5.4] [Reference Citation Analysis]
270 Mao L, Kitani A, Strober W, Fuss IJ. The Role of NLRP3 and IL-1β in the Pathogenesis of Inflammatory Bowel Disease. Front Immunol 2018;9:2566. [PMID: 30455704 DOI: 10.3389/fimmu.2018.02566] [Cited by in Crossref: 110] [Cited by in F6Publishing: 115] [Article Influence: 22.0] [Reference Citation Analysis]
271 Chen W, Zhuo M, Lu X, Xia X, Zhao Y, Huang Z, Xu J, Li W, Yu C. SRC-3 protects intestine from DSS-induced colitis by inhibiting inflammation and promoting goblet cell differentiation through enhancement of KLF4 expression. Int J Biol Sci 2018;14:2051-64. [PMID: 30585268 DOI: 10.7150/ijbs.28576] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
272 Fan TJ, Tchaptchet SY, Arsene D, Mishima Y, Liu B, Sartor RB, Carroll IM, Miao EA, Fodor AA, Hansen JJ. Environmental Factors Modify the Severity of Acute DSS Colitis in Caspase-11-Deficient Mice. Inflamm Bowel Dis 2018;24:2394-403. [PMID: 30312415 DOI: 10.1093/ibd/izy244] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
273 Chung IC, Yuan SN, OuYang CN, Lin HC, Huang KY, Chen YJ, Chung AK, Chu CL, Ojcius DM, Chang YS, Chen LC. Src-family kinase-Cbl axis negatively regulates NLRP3 inflammasome activation. Cell Death Dis 2018;9:1109. [PMID: 30382081 DOI: 10.1038/s41419-018-1163-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
274 Lopes de Oliveira GA, Alarcón de la Lastra C, Rosillo MÁ, Castejon Martinez ML, Sánchez-Hidalgo M, Rolim Medeiros JV, Villegas I. Preventive effect of bergenin against the development of TNBS-induced acute colitis in rats is associated with inflammatory mediators inhibition and NLRP3/ASC inflammasome signaling pathways. Chem Biol Interact 2019;297:25-33. [PMID: 30365937 DOI: 10.1016/j.cbi.2018.10.020] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 4.4] [Reference Citation Analysis]
275 Kim EH, Wong SW, Martinez J. Programmed Necrosis and Disease:We interrupt your regular programming to bring you necroinflammation. Cell Death Differ 2019;26:25-40. [PMID: 30349078 DOI: 10.1038/s41418-018-0179-3] [Cited by in Crossref: 67] [Cited by in F6Publishing: 70] [Article Influence: 13.4] [Reference Citation Analysis]
276 Mi C, Wang Z, Li MY, Zhang ZH, Ma J, Jin X. Zinc finger protein 91 positively regulates the production of IL-1β in macrophages by activation of MAPKs and non-canonical caspase-8 inflammasome. Br J Pharmacol 2018;175:4338-52. [PMID: 30182366 DOI: 10.1111/bph.14493] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
277 Finlayson-trick E, Connors J, Stadnyk A, Van Limbergen J. Regulation of Antimicrobial Pathways by Endogenous Heat Shock Proteins in Gastrointestinal Disorders. GastrointestDisord 2018;1:39-56. [DOI: 10.3390/gidisord1010005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
278 Luan J, Ju D. Inflammasome: A Double-Edged Sword in Liver Diseases. Front Immunol 2018;9:2201. [PMID: 30319645 DOI: 10.3389/fimmu.2018.02201] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 8.8] [Reference Citation Analysis]
279 Perera AP, Sajnani K, Dickinson J, Eri R, Körner H. NLRP3 inflammasome in colitis and colitis-associated colorectal cancer. Mamm Genome 2018;29:817-30. [DOI: 10.1007/s00335-018-9783-2] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 5.6] [Reference Citation Analysis]
280 Sakimoto T. Implications of Inflammasomes in Human Diseases: NLRP3 Inflammasome and Animal Models. Cornea 2018;37:S86-90. [DOI: 10.1097/ico.0000000000001717] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
281 Palazon-Riquelme P, Lopez-Castejon G. The inflammasomes, immune guardians at defence barriers. Immunology 2018;155:320-30. [PMID: 30098204 DOI: 10.1111/imm.12989] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
282 Kanak MA, Shindo Y, Saikumar P, Naziruddin B. Role of Inflammasomes in the Development of Gastrointestinal Diseases. In: Cordero MD, Alcocer-gómez E, editors. Inflammasomes: Clinical and Therapeutic Implications. Cham: Springer International Publishing; 2018. pp. 235-68. [DOI: 10.1007/978-3-319-89390-7_10] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
283 Zhang X, Zhang G, Ren Y, Lan T, Li D, Tian J, Jiang W. Darunavir alleviates irinotecan-induced intestinal toxicity in Vivo. European Journal of Pharmacology 2018;834:288-94. [DOI: 10.1016/j.ejphar.2018.07.044] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
284 Li Y, Wu J, Niu Y, Chen H, Tang Q, Zhong Y, Lambers TT, Cai W. Milk Fat Globule Membrane Inhibits NLRP3 Inflammasome Activation and Enhances Intestinal Barrier Function in a Rat Model of Short Bowel. JPEN J Parenter Enteral Nutr 2019;43:677-85. [PMID: 30144105 DOI: 10.1002/jpen.1435] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
285 Tzeng TC, Hasegawa Y, Iguchi R, Cheung A, Caffrey DR, Thatcher EJ, Mao W, Germain G, Tamburro ND, Okabe S, Heneka MT, Latz E, Futai K, Golenbock DT. Inflammasome-derived cytokine IL18 suppresses amyloid-induced seizures in Alzheimer-prone mice. Proc Natl Acad Sci U S A 2018;115:9002-7. [PMID: 30127003 DOI: 10.1073/pnas.1801802115] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 4.4] [Reference Citation Analysis]
286 Bevivino G, Monteleone G. Advances in understanding the role of cytokines in inflammatory bowel disease. Expert Rev Gastroenterol Hepatol. 2018;12:907-915. [PMID: 30024302 DOI: 10.1080/17474124.2018.1503053] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 7.2] [Reference Citation Analysis]
287 Liu C, Wang J, Yang Y, Liu X, Zhu Y, Zou J, Peng S, Le TH, Chen Y, Zhao S, He B, Mi Q, Zhang X, Du Q. Ginsenoside Rd ameliorates colitis by inducing p62-driven mitophagy-mediated NLRP3 inflammasome inactivation in mice. Biochem Pharmacol 2018;155:366-79. [PMID: 30012462 DOI: 10.1016/j.bcp.2018.07.010] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 9.6] [Reference Citation Analysis]
288 Mangan MSJ, Olhava EJ, Roush WR, Seidel HM, Glick GD, Latz E. Targeting the NLRP3 inflammasome in inflammatory diseases. Nat Rev Drug Discov 2018;17:588-606. [PMID: 30026524 DOI: 10.1038/nrd.2018.97] [Cited by in Crossref: 612] [Cited by in F6Publishing: 646] [Article Influence: 122.4] [Reference Citation Analysis]
289 Kaplanski G. Interleukin-18: Biological properties and role in disease pathogenesis. Immunol Rev 2018;281:138-53. [PMID: 29247988 DOI: 10.1111/imr.12616] [Cited by in Crossref: 234] [Cited by in F6Publishing: 248] [Article Influence: 46.8] [Reference Citation Analysis]
290 Inserra A, Rogers GB, Licinio J, Wong M. The Microbiota-Inflammasome Hypothesis of Major Depression. BioEssays 2018;40:1800027. [DOI: 10.1002/bies.201800027] [Cited by in Crossref: 58] [Cited by in F6Publishing: 58] [Article Influence: 11.6] [Reference Citation Analysis]
291 Zhang H, Chen X, Zong B, Yuan H, Wang Z, Wei Y, Wang X, Liu G, Zhang J, Li S, Cheng G, Wang Y, Ma Y. Gypenosides improve diabetic cardiomyopathy by inhibiting ROS-mediated NLRP3 inflammasome activation. J Cell Mol Med 2018;22:4437-48. [PMID: 29993180 DOI: 10.1111/jcmm.13743] [Cited by in Crossref: 53] [Cited by in F6Publishing: 62] [Article Influence: 10.6] [Reference Citation Analysis]
292 Pecora V, Valluzzi RL, Mennini M, Fierro V, Dahdah L. Debates in Allergy Medicine: Does oral immunotherapy shorten the duration of milk and egg allergy? The pro argument. World Allergy Organ J 2018;11:11. [PMID: 29977438 DOI: 10.1186/s40413-018-0191-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
293 Masarone M, Rosato V, Dallio M, Gravina AG, Aglitti A, Loguercio C, Federico A, Persico M. Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease. Oxid Med Cell Longev 2018;2018:9547613. [PMID: 29991976 DOI: 10.1155/2018/9547613] [Cited by in Crossref: 299] [Cited by in F6Publishing: 275] [Article Influence: 59.8] [Reference Citation Analysis]
294 Zhang J, Hou S, Gu J, Tian T, Yuan Q, Jia J, Qin Z, Chen Z. S100A4 promotes colon inflammation and colitis-associated colon tumorigenesis. Oncoimmunology 2018;7:e1461301. [PMID: 30221056 DOI: 10.1080/2162402X.2018.1461301] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
295 Sharma D, Kanneganti TD. Inflammatory cell death in intestinal pathologies. Immunol Rev 2017;280:57-73. [PMID: 29027223 DOI: 10.1111/imr.12602] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 6.4] [Reference Citation Analysis]
296 Caneparo V, Landolfo S, Gariglio M, De Andrea M. The Absent in Melanoma 2-Like Receptor IFN-Inducible Protein 16 as an Inflammasome Regulator in Systemic Lupus Erythematosus: The Dark Side of Sensing Microbes. Front Immunol 2018;9:1180. [PMID: 29892303 DOI: 10.3389/fimmu.2018.01180] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
297 Yuan YY, Xie KX, Wang SL, Yuan LW. Inflammatory caspase-related pyroptosis: mechanism, regulation and therapeutic potential for inflammatory bowel disease. Gastroenterol Rep (Oxf) 2018;6:167-76. [PMID: 30151200 DOI: 10.1093/gastro/goy011] [Cited by in Crossref: 59] [Cited by in F6Publishing: 63] [Article Influence: 11.8] [Reference Citation Analysis]
298 Udden SMN, Peng L, Gan JL, Shelton JM, Malter JS, Hooper LV, Zaki MH. NOD2 Suppresses Colorectal Tumorigenesis via Downregulation of the TLR Pathways. Cell Rep 2017;19:2756-70. [PMID: 28658623 DOI: 10.1016/j.celrep.2017.05.084] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 9.2] [Reference Citation Analysis]
299 Mamantopoulos M, Ronchi F, McCoy KD, Wullaert A. Inflammasomes make the case for littermate-controlled experimental design in studying host-microbiota interactions. Gut Microbes 2018;9:374-81. [PMID: 29672197 DOI: 10.1080/19490976.2017.1421888] [Cited by in Crossref: 11] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
300 Błażejewski AJ, Thiemann S, Schenk A, Pils MC, Gálvez EJC, Roy U, Heise U, de Zoete MR, Flavell RA, Strowig T. Microbiota Normalization Reveals that Canonical Caspase-1 Activation Exacerbates Chemically Induced Intestinal Inflammation. Cell Rep 2017;19:2319-30. [PMID: 28614717 DOI: 10.1016/j.celrep.2017.05.058] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 8.6] [Reference Citation Analysis]
301 Kolinska J, Zakostelecka M, Zemanova Z, Lisa V, Golias J, Kozakova H, Dvorak B. Cellular Differentiation of Non-Transformed Intestinal Epithelial Cells Is Regulated by Lactobacillus rhamnosus and L. casei Strains. Physiol Res. [DOI: 10.33549/physiolres.933643] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
302 Mao L, Kitani A, Similuk M, Oler AJ, Albenberg L, Kelsen J, Aktay A, Quezado M, Yao M, Montgomery-Recht K, Fuss IJ, Strober W. Loss-of-function CARD8 mutation causes NLRP3 inflammasome activation and Crohn's disease. J Clin Invest. 2018;128:1793-1806. [PMID: 29408806 DOI: 10.1172/jci98642] [Cited by in Crossref: 53] [Cited by in F6Publishing: 55] [Article Influence: 10.6] [Reference Citation Analysis]
303 Yang WH, Heithoff DM, Aziz PV, Sperandio M, Nizet V, Mahan MJ, Marth JD. Recurrent infection progressively disables host protection against intestinal inflammation. Science 2017;358:eaao5610. [PMID: 29269445 DOI: 10.1126/science.aao5610] [Cited by in Crossref: 45] [Cited by in F6Publishing: 48] [Article Influence: 9.0] [Reference Citation Analysis]
304 Mak'Anyengo R, Duewell P, Reichl C, Hörth C, Lehr HA, Fischer S, Clavel T, Denk G, Hohenester S, Kobold S, Endres S, Schnurr M, Bauer C. Nlrp3-dependent IL-1β inhibits CD103+ dendritic cell differentiation in the gut. JCI Insight 2018;3:96322. [PMID: 29515025 DOI: 10.1172/jci.insight.96322] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
305 Campuzano A, Wormley FL. Innate Immunity against Cryptococcus, from Recognition to Elimination. J Fungi (Basel) 2018;4:E33. [PMID: 29518906 DOI: 10.3390/jof4010033] [Cited by in Crossref: 29] [Cited by in F6Publishing: 36] [Article Influence: 5.8] [Reference Citation Analysis]
306 Sharma D, Malik A, Guy CS, Karki R, Vogel P, Kanneganti TD. Pyrin Inflammasome Regulates Tight Junction Integrity to Restrict Colitis and Tumorigenesis. Gastroenterology 2018;154:948-964.e8. [PMID: 29203393 DOI: 10.1053/j.gastro.2017.11.276] [Cited by in Crossref: 64] [Cited by in F6Publishing: 67] [Article Influence: 12.8] [Reference Citation Analysis]
307 Ramachandran RA, Lupfer C, Zaki H. The Inflammasome: Regulation of Nitric Oxide and Antimicrobial Host Defence. Adv Microb Physiol 2018;72:65-115. [PMID: 29778217 DOI: 10.1016/bs.ampbs.2018.01.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
308 Corridoni D, Chapman T, Ambrose T, Simmons A. Emerging Mechanisms of Innate Immunity and Their Translational Potential in Inflammatory Bowel Disease. Front Med (Lausanne) 2018;5:32. [PMID: 29515999 DOI: 10.3389/fmed.2018.00032] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
309 Rathinam VAK, Chan FK. Inflammasome, Inflammation, and Tissue Homeostasis. Trends Mol Med 2018;24:304-18. [PMID: 29433944 DOI: 10.1016/j.molmed.2018.01.004] [Cited by in Crossref: 84] [Cited by in F6Publishing: 68] [Article Influence: 16.8] [Reference Citation Analysis]
310 Yu SX, Chen W, Liu ZZ, Zhou FH, Yan SQ, Hu GQ, Qin XX, Zhang J, Ma K, Du CT, Gu JM, Deng XM, Han WY, Yang YJ. Non-Hematopoietic MLKL Protects Against Salmonella Mucosal Infection by Enhancing Inflammasome Activation. Front Immunol 2018;9:119. [PMID: 29456533 DOI: 10.3389/fimmu.2018.00119] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
311 Xu S, Wei S, Guo Y, Cui D, Yao J. Involvement of Nucleotide-Binding and Oligomerization Domain-Like Receptors in the Intestinal Injury of Severe Acute Pancreatitis in Rats. Pancreas 2018;47:245-51. [PMID: 29303910 DOI: 10.1097/MPA.0000000000000977] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
312 Marra F, Svegliati-Baroni G. Lipotoxicity and the gut-liver axis in NASH pathogenesis. J Hepatol 2018;68:280-95. [PMID: 29154964 DOI: 10.1016/j.jhep.2017.11.014] [Cited by in Crossref: 390] [Cited by in F6Publishing: 386] [Article Influence: 78.0] [Reference Citation Analysis]
313 Arnold C, Kienes I, Sowa AS, Kufer TA. NOD ‐Like Receptors. eLS 2018. [DOI: 10.1002/9780470015902.a0026236] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
314 Zhiyu W, Wang N, Wang Q, Peng C, Zhang J, Liu P, Ou A, Zhong S, Cordero MD, Lin Y. The inflammasome: an emerging therapeutic oncotarget for cancer prevention. Oncotarget 2016;7:50766-80. [PMID: 27206676 DOI: 10.18632/oncotarget.9391] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 6.2] [Reference Citation Analysis]
315 Liu X, Lu J, Liu Z, Zhao J, Sun H, Wu N, Liu H, Liu W, Hu Z, Meng G, Shen L, Miller AW, Su B, Li X, Kang Z. Intestinal Epithelial Cell-Derived LKB1 Suppresses Colitogenic Microbiota. J Immunol 2018;200:1889-900. [PMID: 29352002 DOI: 10.4049/jimmunol.1700547] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
316 Chen L, You Q, Hu L, Gao J, Meng Q, Liu W, Wu X, Xu Q. The Antioxidant Procyanidin Reduces Reactive Oxygen Species Signaling in Macrophages and Ameliorates Experimental Colitis in Mice. Front Immunol 2017;8:1910. [PMID: 29354126 DOI: 10.3389/fimmu.2017.01910] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 8.0] [Reference Citation Analysis]
317 Man SM. Inflammasomes in the gastrointestinal tract: infection, cancer and gut microbiota homeostasis. Nat Rev Gastroenterol Hepatol 2018;15:721-37. [PMID: 30185915 DOI: 10.1038/s41575-018-0054-1] [Cited by in Crossref: 130] [Cited by in F6Publishing: 132] [Article Influence: 26.0] [Reference Citation Analysis]
318 Gulati A, Kaur D, Krishna Prasad GVR, Mukhopadhaya A. PRR Function of Innate Immune Receptors in Recognition of Bacteria or Bacterial Ligands. Advances in Experimental Medicine and Biology 2018. [DOI: 10.1007/978-981-13-3065-0_18] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
319 Wang Z, Wang N, Zheng Y, Wang S. Inflammasome and Cancer. Exp Suppl 2018;108:281-302. [PMID: 30536176 DOI: 10.1007/978-3-319-89390-7_12] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
320 Tungland B. Intestinal-Based Diseases and Peripheral Infection Risk Associated with Gut Dysbiosis: Therapeutic use of Pre- and Probiotics and Fecal Microbiota Transplantation. Human Microbiota in Health and Disease 2018. [DOI: 10.1016/b978-0-12-814649-1.00006-5] [Reference Citation Analysis]
321 Cantorna MT, Bruce D. Vitamin D and Inflammatory Bowel Disease. Vitamin D 2018. [DOI: 10.1016/b978-0-12-809963-6.00108-5] [Reference Citation Analysis]
322 Marín-Aguilar F, Ruiz-Cabello J, Cordero MD. Aging and the Inflammasomes. Exp Suppl 2018;108:303-20. [PMID: 30536177 DOI: 10.1007/978-3-319-89390-7_13] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
323 Ahn H, Kwon HM, Lee E, Kim PH, Jeung EB, Lee GS. Role of inflammasome regulation on immune modulators. J Biomed Res 2018;32:401-10. [PMID: 30514828 DOI: 10.7555/JBR.32.20170120] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
324 Ringel-Scaia VM, McDaniel DK, Allen IC. The Goldilocks Conundrum: NLR Inflammasome Modulation of Gastrointestinal Inflammation during Inflammatory Bowel Disease. Crit Rev Immunol 2016;36:283-314. [PMID: 28322135 DOI: 10.1615/CritRevImmunol.2017019158] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
325 Liu W, Guo W, Hang N, Yang Y, Wu X, Shen Y, Cao J, Sun Y, Xu Q. MALT1 inhibitors prevent the development of DSS-induced experimental colitis in mice via inhibiting NF-κB and NLRP3 inflammasome activation. Oncotarget 2016;7:30536-49. [PMID: 27105502 DOI: 10.18632/oncotarget.8867] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 6.5] [Reference Citation Analysis]
326 McCarville JL, Ayres JS. Disease tolerance: concept and mechanisms. Curr Opin Immunol 2018;50:88-93. [PMID: 29253642 DOI: 10.1016/j.coi.2017.12.003] [Cited by in Crossref: 71] [Cited by in F6Publishing: 55] [Article Influence: 11.8] [Reference Citation Analysis]
327 Kim JY, Kim YM, Park JM, Han YM, Lee KC, Hahm KB, Hong S. Cancer preventive effect of recombinant TRAIL by ablation of oncogenic inflammation in colitis-associated cancer rather than anticancer effect. Oncotarget 2018;9:1705-16. [PMID: 29416724 DOI: 10.18632/oncotarget.23083] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
328 Yao X, Zhang C, Xing Y, Xue G, Zhang Q, Pan F, Wu G, Hu Y, Guo Q, Lu A, Zhang X, Zhou R, Tian Z, Zeng B, Wei H, Strober W, Zhao L, Meng G. Remodelling of the gut microbiota by hyperactive NLRP3 induces regulatory T cells to maintain homeostasis. Nat Commun. 2017;8:1896. [PMID: 29196621 DOI: 10.1038/s41467-017-01917-2] [Cited by in Crossref: 95] [Cited by in F6Publishing: 104] [Article Influence: 15.8] [Reference Citation Analysis]
329 Ranson N, Kunde D, Eri R. Regulation and Sensing of Inflammasomes and Their Impact on Intestinal Health. Int J Mol Sci 2017;18:E2379. [PMID: 29120406 DOI: 10.3390/ijms18112379] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
330 Ibrahim MK, Zambruni M, Melby CL, Melby PC. Impact of Childhood Malnutrition on Host Defense and Infection. Clin Microbiol Rev 2017;30:919-71. [PMID: 28768707 DOI: 10.1128/CMR.00119-16] [Cited by in Crossref: 138] [Cited by in F6Publishing: 150] [Article Influence: 23.0] [Reference Citation Analysis]
331 Lee JC, Lee HY, Kim TK, Kim MS, Park YM, Kim J, Park K, Kweon MN, Kim SH, Bae JW, Hur KY, Lee MS. Obesogenic diet-induced gut barrier dysfunction and pathobiont expansion aggravate experimental colitis. PLoS One 2017;12:e0187515. [PMID: 29107964 DOI: 10.1371/journal.pone.0187515] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 7.5] [Reference Citation Analysis]
332 Kuemmerle-Deschner JB, Verma D, Endres T, Broderick L, de Jesus AA, Hofer F, Blank N, Krause K, Rietschel C, Horneff G, Aksentijevich I, Lohse P, Goldbach-Mansky R, Hoffman HM, Benseler SM. Clinical and Molecular Phenotypes of Low-Penetrance Variants of NLRP3: Diagnostic and Therapeutic Challenges. Arthritis Rheumatol 2017;69:2233-40. [PMID: 28692792 DOI: 10.1002/art.40208] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 8.3] [Reference Citation Analysis]
333 Kattah MG, Malynn BA, Ma A. Ubiquitin-Modifying Enzymes and Regulation of the Inflammasome. J Mol Biol 2017;429:3471-85. [PMID: 29031697 DOI: 10.1016/j.jmb.2017.10.001] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 5.5] [Reference Citation Analysis]
334 Evavold CL, Kagan JC. How Inflammasomes Inform Adaptive Immunity. J Mol Biol 2018;430:217-37. [PMID: 28987733 DOI: 10.1016/j.jmb.2017.09.019] [Cited by in Crossref: 93] [Cited by in F6Publishing: 97] [Article Influence: 15.5] [Reference Citation Analysis]
335 Ni J, Wu GD, Albenberg L, Tomov VT. Gut microbiota and IBD: causation or correlation? Nat Rev Gastroenterol Hepatol 2017;14:573-84. [PMID: 28743984 DOI: 10.1038/nrgastro.2017.88] [Cited by in Crossref: 744] [Cited by in F6Publishing: 728] [Article Influence: 124.0] [Reference Citation Analysis]
336 Wang X, Yang C, Liao X, Han C, Yu T, Huang K, Yu L, Qin W, Zhu G, Su H, Liu X, Ye X, Chen B, Peng M, Peng T. NLRC and NLRX gene family mRNA expression and prognostic value in hepatocellular carcinoma. Cancer Med 2017;6:2660-72. [PMID: 28960882 DOI: 10.1002/cam4.1202] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
337 Pierantonelli I, Rychlicki C, Agostinelli L, Giordano DM, Gaggini M, Fraumene C, Saponaro C, Manghina V, Sartini L, Mingarelli E. Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD. Sci Rep. 2017;7:12200. [PMID: 28939830 DOI: 10.1038/s41598-017-11744-6] [Cited by in Crossref: 38] [Cited by in F6Publishing: 47] [Article Influence: 6.3] [Reference Citation Analysis]
338 Lei-Leston AC, Murphy AG, Maloy KJ. Epithelial Cell Inflammasomes in Intestinal Immunity and Inflammation. Front Immunol. 2017;8:1168. [PMID: 28979266 DOI: 10.3389/fimmu.2017.01168] [Cited by in Crossref: 80] [Cited by in F6Publishing: 85] [Article Influence: 13.3] [Reference Citation Analysis]
339 Rangan KJ, Hang HC. Biochemical Mechanisms of Pathogen Restriction by Intestinal Bacteria. Trends Biochem Sci 2017;42:887-98. [PMID: 28927699 DOI: 10.1016/j.tibs.2017.08.005] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
340 Kantono M, Guo B. Inflammasomes and Cancer: The Dynamic Role of the Inflammasome in Tumor Development. Front Immunol 2017;8:1132. [PMID: 28955343 DOI: 10.3389/fimmu.2017.01132] [Cited by in Crossref: 68] [Cited by in F6Publishing: 74] [Article Influence: 11.3] [Reference Citation Analysis]
341 Yang N, Xia Z, Shao N, Li B, Xue L, Peng Y, Zhi F, Yang Y. Carnosic acid prevents dextran sulfate sodium-induced acute colitis associated with the regulation of the Keap1/Nrf2 pathway. Sci Rep 2017;7:11036. [PMID: 28887507 DOI: 10.1038/s41598-017-11408-5] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 5.3] [Reference Citation Analysis]
342 Liu L, Li X. NLRP3 Inflammasome in Inflammatory Bowel Disease: Friend or Foe? Dig Dis Sci 2017;62:2211-4. [PMID: 28631084 DOI: 10.1007/s10620-017-4650-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
343 Li M, Wu Y, Hu Y, Zhao L, Zhang C. Initial gut microbiota structure affects sensitivity to DSS-induced colitis in a mouse model. Sci China Life Sci 2018;61:762-9. [PMID: 28842897 DOI: 10.1007/s11427-017-9097-0] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 8.0] [Reference Citation Analysis]
344 Spalinger MR, Lang S, Gottier C, Dai X, Rawlings DJ, Chan AC, Rogler G, Scharl M. PTPN22 regulates NLRP3-mediated IL1B secretion in an autophagy-dependent manner. Autophagy 2017;13:1590-601. [PMID: 28786745 DOI: 10.1080/15548627.2017.1341453] [Cited by in Crossref: 66] [Cited by in F6Publishing: 61] [Article Influence: 11.0] [Reference Citation Analysis]
345 Zhou W, Liu X, Zhang X, Tang J, Li Z, Wang Q, Hu R. Oroxylin A inhibits colitis by inactivating NLRP3 inflammasome. Oncotarget 2017;8:58903-17. [PMID: 28938606 DOI: 10.18632/oncotarget.19440] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
346 Shil NK, Pokharel SM, Bose S. Inflammasome Activation by Paramyxoviruses. Curr Clin Micro Rpt 2017;4:150-8. [DOI: 10.1007/s40588-017-0070-x] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
347 Jha S, Brickey WJ, Ting JP. Inflammasomes in Myeloid Cells: Warriors Within. Microbiol Spectr 2017;5. [PMID: 28102121 DOI: 10.1128/microbiolspec.MCHD-0049-2016] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
348 Ruiz PA, Morón B, Becker HM, Lang S, Atrott K, Spalinger MR, Scharl M, Wojtal KA, Fischbeck-Terhalle A, Frey-Wagner I, Hausmann M, Kraemer T, Rogler G. Titanium dioxide nanoparticles exacerbate DSS-induced colitis: role of the NLRP3 inflammasome. Gut 2017;66:1216-24. [PMID: 26848183 DOI: 10.1136/gutjnl-2015-310297] [Cited by in Crossref: 169] [Cited by in F6Publishing: 164] [Article Influence: 28.2] [Reference Citation Analysis]
349 Zmora N, Levy M, Pevsner-Fishcer M, Elinav E. Inflammasomes and intestinal inflammation. Mucosal Immunol 2017;10:865-83. [PMID: 28401932 DOI: 10.1038/mi.2017.19] [Cited by in Crossref: 61] [Cited by in F6Publishing: 62] [Article Influence: 10.2] [Reference Citation Analysis]
350 Thi HTH, Hong S. Inflammasome as a Therapeutic Target for Cancer Prevention and Treatment. J Cancer Prev 2017;22:62-73. [PMID: 28698859 DOI: 10.15430/JCP.2017.22.2.62] [Cited by in Crossref: 50] [Cited by in F6Publishing: 53] [Article Influence: 8.3] [Reference Citation Analysis]
351 Yu X, Zhao Q, Zhang X, Zhang H, Liu Y, Wu X, Li M, Li X, Zhang J, Ruan X, Zhang H. Celastrol ameliorates inflammation through inhibition of NLRP3 inflammasome activation. Oncotarget 2017;8:67300-14. [PMID: 28978034 DOI: 10.18632/oncotarget.18619] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]
352 Karki R, Malireddi RKS, Zhu Q, Kanneganti TD. NLRC3 regulates cellular proliferation and apoptosis to attenuate the development of colorectal cancer. Cell Cycle 2017;16:1243-51. [PMID: 28598238 DOI: 10.1080/15384101.2017.1317414] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 7.3] [Reference Citation Analysis]
353 Liu L, Dong Y, Ye M, Jin S, Yang J, Joosse ME, Sun Y, Zhang J, Lazarev M, Brant SR, Safar B, Marohn M, Mezey E, Li X. The Pathogenic Role of NLRP3 Inflammasome Activation in Inflammatory Bowel Diseases of Both Mice and Humans. J Crohns Colitis 2017;11:737-50. [PMID: 27993998 DOI: 10.1093/ecco-jcc/jjw219] [Cited by in Crossref: 39] [Cited by in F6Publishing: 62] [Article Influence: 6.5] [Reference Citation Analysis]
354 Clark A, Mach N. The Crosstalk between the Gut Microbiota and Mitochondria during Exercise. Front Physiol 2017;8:319. [PMID: 28579962 DOI: 10.3389/fphys.2017.00319] [Cited by in Crossref: 168] [Cited by in F6Publishing: 176] [Article Influence: 28.0] [Reference Citation Analysis]
355 Daïen CI, Pinget GV, Tan JK, Macia L. Detrimental Impact of Microbiota-Accessible Carbohydrate-Deprived Diet on Gut and Immune Homeostasis: An Overview. Front Immunol 2017;8:548. [PMID: 28553291 DOI: 10.3389/fimmu.2017.00548] [Cited by in Crossref: 85] [Cited by in F6Publishing: 87] [Article Influence: 14.2] [Reference Citation Analysis]
356 Tang AT, Choi JP, Kotzin JJ, Yang Y, Hong CC, Hobson N, Girard R, Zeineddine HA, Lightle R, Moore T, Cao Y, Shenkar R, Chen M, Mericko P, Yang J, Li L, Tanes C, Kobuley D, Võsa U, Whitehead KJ, Li DY, Franke L, Hart B, Schwaninger M, Henao-Mejia J, Morrison L, Kim H, Awad IA, Zheng X, Kahn ML. Endothelial TLR4 and the microbiome drive cerebral cavernous malformations. Nature 2017;545:305-10. [PMID: 28489816 DOI: 10.1038/nature22075] [Cited by in Crossref: 177] [Cited by in F6Publishing: 190] [Article Influence: 29.5] [Reference Citation Analysis]
357 Wang L, Cano M, Datta S, Wei H, Ebrahimi KB, Gorashi Y, Garlanda C, Handa JT. Pentraxin 3 recruits complement factor H to protect against oxidative stress-induced complement and inflammasome overactivation. J Pathol 2016;240:495-506. [PMID: 27659908 DOI: 10.1002/path.4811] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 4.5] [Reference Citation Analysis]
358 Neudecker V, Haneklaus M, Jensen O, Khailova L, Masterson JC, Tye H, Biette K, Jedlicka P, Brodsky KS, Gerich ME, Mack M, Robertson AAB, Cooper MA, Furuta GT, Dinarello CA, O'Neill LA, Eltzschig HK, Masters SL, McNamee EN. Myeloid-derived miR-223 regulates intestinal inflammation via repression of the NLRP3 inflammasome. J Exp Med. 2017;214:1737-1752. [PMID: 28487310 DOI: 10.1084/jem.20160462] [Cited by in Crossref: 228] [Cited by in F6Publishing: 237] [Article Influence: 38.0] [Reference Citation Analysis]
359 Ahn H, Jeon E, Kim JC, Kang SG, Yoon SI, Ko HJ, Kim PH, Lee GS. Lentinan from shiitake selectively attenuates AIM2 and non-canonical inflammasome activation while inducing pro-inflammatory cytokine production. Sci Rep 2017;7:1314. [PMID: 28465544 DOI: 10.1038/s41598-017-01462-4] [Cited by in Crossref: 35] [Cited by in F6Publishing: 42] [Article Influence: 5.8] [Reference Citation Analysis]
360 Lu JT, Xu AT, Shen J, Ran ZH. Crosstalk between intestinal epithelial cell and adaptive immune cell in intestinal mucosal immunity. J Gastroenterol Hepatol 2017;32:975-80. [PMID: 28072910 DOI: 10.1111/jgh.13723] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
361 Daley D, Mani VR, Mohan N, Akkad N, Pandian GSDB, Savadkar S, Lee KB, Torres-Hernandez A, Aykut B, Diskin B. NLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma. J Exp Med. 2017;214:1711-1724. [PMID: 28442553 DOI: 10.1084/jem.20161707] [Cited by in Crossref: 111] [Cited by in F6Publishing: 116] [Article Influence: 18.5] [Reference Citation Analysis]
362 Inoue M, Kanayama M, Shinohara ML. Inflammasomes. In: Parnham MJ, editor. Compendium of Inflammatory Diseases. Basel: Springer; 2016. pp. 619-33. [DOI: 10.1007/978-3-7643-8550-7_77] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
363 Sun X, Cai Y, Fleming C, Tong Z, Wang Z, Ding C, Qu M, Zhang HG, Suo J, Yan J. Innate γδT17 cells play a protective role in DSS-induced colitis via recruitment of Gr-1+CD11b+ myeloid suppressor cells. Oncoimmunology 2017;6:e1313369. [PMID: 28638741 DOI: 10.1080/2162402X.2017.1313369] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
364 Man SM, Karki R, Briard B, Burton A, Gingras S, Pelletier S, Kanneganti TD. Differential roles of caspase-1 and caspase-11 in infection and inflammation. Sci Rep 2017;7:45126. [PMID: 28345580 DOI: 10.1038/srep45126] [Cited by in Crossref: 86] [Cited by in F6Publishing: 90] [Article Influence: 14.3] [Reference Citation Analysis]
365 Datta S, Cano M, Ebrahimi K, Wang L, Handa JT. The impact of oxidative stress and inflammation on RPE degeneration in non-neovascular AMD. Prog Retin Eye Res 2017;60:201-18. [PMID: 28336424 DOI: 10.1016/j.preteyeres.2017.03.002] [Cited by in Crossref: 335] [Cited by in F6Publishing: 355] [Article Influence: 55.8] [Reference Citation Analysis]
366 Haneklaus M, O'Neil JD, Clark AR, Masters SL, O'Neill LAJ. The RNA-binding protein Tristetraprolin (TTP) is a critical negative regulator of the NLRP3 inflammasome. J Biol Chem 2017;292:6869-81. [PMID: 28302726 DOI: 10.1074/jbc.M116.772947] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 6.7] [Reference Citation Analysis]
367 Lin C, Zhang J. Inflammasomes in Inflammation-Induced Cancer. Front Immunol 2017;8:271. [PMID: 28360909 DOI: 10.3389/fimmu.2017.00271] [Cited by in Crossref: 53] [Cited by in F6Publishing: 63] [Article Influence: 8.8] [Reference Citation Analysis]
368 Seregin SS, Golovchenko N, Schaf B, Chen J, Eaton KA, Chen GY. NLRP6 function in inflammatory monocytes reduces susceptibility to chemically induced intestinal injury. Mucosal Immunol 2017;10:434-45. [PMID: 27353251 DOI: 10.1038/mi.2016.55] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 7.0] [Reference Citation Analysis]
369 Guo X, Chen S. Dedicator of Cytokinesis 2 in Cell Signaling Regulation and Disease Development: DOCK2 IN CELL SIGNALING. J Cell Physiol 2017;232:1931-40. [DOI: 10.1002/jcp.25512] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
370 O'Sullivan S, Wang J, Pigott MT, Docherty N, Boyle N, Lis SK, Gilmer JF, Medina C. Inhibition of matrix metalloproteinase-9 by a barbiturate-nitrate hybrid ameliorates dextran sulphate sodium-induced colitis: effect on inflammation-related genes. Br J Pharmacol. 2017;174:512-524. [PMID: 28079248 DOI: 10.1111/bph.13712] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
371 Du X, Chen W, Wang Y, Chen C, Guo L, Ju R, Li J, Zhang D, Zhu L, Ye C. Therapeutic efficacy of carboxyamidotriazole on 2,4,6-trinitrobenzene sulfonic acid-induced colitis model is associated with the inhibition of NLRP3 inflammasome and NF-κB activation. Int Immunopharmacol 2017;45:16-25. [PMID: 28152446 DOI: 10.1016/j.intimp.2017.01.015] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
372 Pellegrini C, Antonioli L, Lopez-Castejon G, Blandizzi C, Fornai M. Canonical and Non-Canonical Activation of NLRP3 Inflammasome at the Crossroad between Immune Tolerance and Intestinal Inflammation. Front Immunol 2017;8:36. [PMID: 28179906 DOI: 10.3389/fimmu.2017.00036] [Cited by in Crossref: 107] [Cited by in F6Publishing: 112] [Article Influence: 17.8] [Reference Citation Analysis]
373 Karki R, Man SM, Kanneganti TD. Inflammasomes and Cancer. Cancer Immunol Res 2017;5:94-9. [PMID: 28093447 DOI: 10.1158/2326-6066.CIR-16-0269] [Cited by in Crossref: 199] [Cited by in F6Publishing: 218] [Article Influence: 33.2] [Reference Citation Analysis]
374 Jha S, Brickey WJ, Ting JP. Inflammasomes in Myeloid Cells: Warriors Within. Myeloid Cells in Health and Disease 2017. [DOI: 10.1128/9781555819194.ch17] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
375 Diamanti MA, Gupta J, Bennecke M, De Oliveira T, Ramakrishnan M, Braczynski AK, Richter B, Beli P, Hu Y, Saleh M, Mittelbronn M, Dikic I, Greten FR. IKKα controls ATG16L1 degradation to prevent ER stress during inflammation. J Exp Med 2017;214:423-37. [PMID: 28082356 DOI: 10.1084/jem.20161867] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 7.5] [Reference Citation Analysis]
376 Yao X, Meng G. Inflammasomes in the Gut Mucosal Homeostasis. Adv Exp Med Biol 2017;1024:133-51. [PMID: 28921468 DOI: 10.1007/978-981-10-5987-2_6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
377 Jin L, Batra S, Jeyaseelan S. Deletion of Nlrp3 Augments Survival during Polymicrobial Sepsis by Decreasing Autophagy and Enhancing Phagocytosis. J Immunol 2017;198:1253-62. [PMID: 28031338 DOI: 10.4049/jimmunol.1601745] [Cited by in Crossref: 65] [Cited by in F6Publishing: 66] [Article Influence: 9.3] [Reference Citation Analysis]
378 Kim MS, Byun JS, Yoon YS, Yum DY, Chung MJ, Lee JC. A probiotic combination attenuates experimental colitis through inhibition of innate cytokine production. Benef Microbes 2017;8:231-41. [PMID: 28008786 DOI: 10.3920/BM2016.0031] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
379 Itani S, Watanabe T, Nadatani Y, Sugimura N, Shimada S, Takeda S, Otani K, Hosomi S, Nagami Y, Tanaka F, Kamata N, Yamagami H, Tanigawa T, Shiba M, Tominaga K, Fujiwara Y, Arakawa T. NLRP3 inflammasome has a protective effect against oxazolone-induced colitis: A possible role in ulcerative colitis. Sci Rep. 2016;6:39075. [PMID: 27966619 DOI: 10.1038/srep39075] [Cited by in Crossref: 52] [Cited by in F6Publishing: 56] [Article Influence: 7.4] [Reference Citation Analysis]
380 Karki R, Man SM, Malireddi RKS, Kesavardhana S, Zhu Q, Burton AR, Sharma BR, Qi X, Pelletier S, Vogel P, Rosenstiel P, Kanneganti TD. NLRC3 is an inhibitory sensor of PI3K-mTOR pathways in cancer. Nature 2016;540:583-7. [PMID: 27951586 DOI: 10.1038/nature20597] [Cited by in Crossref: 119] [Cited by in F6Publishing: 125] [Article Influence: 17.0] [Reference Citation Analysis]
381 Song H, Liu B, Huai W, Yu Z, Wang W, Zhao J, Han L, Jiang G, Zhang L, Gao C, Zhao W. The E3 ubiquitin ligase TRIM31 attenuates NLRP3 inflammasome activation by promoting proteasomal degradation of NLRP3. Nat Commun 2016;7:13727. [PMID: 27929086 DOI: 10.1038/ncomms13727] [Cited by in Crossref: 207] [Cited by in F6Publishing: 220] [Article Influence: 29.6] [Reference Citation Analysis]
382 Maroni L, Agostinelli L, Saccomanno S, Pinto C, Giordano DM, Rychlicki C, De Minicis S, Trozzi L, Banales JM, Melum E, Karlsen TH, Benedetti A, Baroni GS, Marzioni M. Nlrp3 Activation Induces Il-18 Synthesis and Affects the Epithelial Barrier Function in Reactive Cholangiocytes. Am J Pathol 2017;187:366-76. [PMID: 27912077 DOI: 10.1016/j.ajpath.2016.10.010] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
383 Chen GY. Regulation of the gut microbiome by inflammasomes. Free Radic Biol Med 2017;105:35-40. [PMID: 27845186 DOI: 10.1016/j.freeradbiomed.2016.11.011] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
384 Liang YD, Bai WJ, Li CG, Xu LH, Wei HX, Pan H, He XH, Ouyang DY. Piperine Suppresses Pyroptosis and Interleukin-1β Release upon ATP Triggering and Bacterial Infection. Front Pharmacol 2016;7:390. [PMID: 27812336 DOI: 10.3389/fphar.2016.00390] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 4.1] [Reference Citation Analysis]
385 Song Y, Kim Y, Kim SM, Ul Ain Q, Jang K, Yang C, Kim Y. RNAi-mediated silencing of TNF-α converting enzyme to down-regulate soluble TNF-α production for treatment of acute and chronic colitis. Journal of Controlled Release 2016;239:231-41. [DOI: 10.1016/j.jconrel.2016.08.017] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
386 Deswaerte V, Ruwanpura SM, Jenkins BJ. Transcriptional regulation of inflammasome-associated pattern recognition receptors, and the relevance to disease pathogenesis. Mol Immunol 2017;86:3-9. [PMID: 27697299 DOI: 10.1016/j.molimm.2016.09.023] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
387 Yin C, He N, Li P, Zhang C, Yu J, Hua M, Ji C, Ma D. Polymorphisms of Interlukin-1β rs16944 confer susceptibility to myelodysplastic syndromes. Life Sci 2016;165:109-12. [PMID: 27693669 DOI: 10.1016/j.lfs.2016.09.019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
388 Ferenczi S, Szegi K, Winkler Z, Barna T, Kovács KJ. Oligomannan Prebiotic Attenuates Immunological, Clinical and Behavioral Symptoms in Mouse Model of Inflammatory Bowel Disease. Sci Rep 2016;6:34132. [PMID: 27658624 DOI: 10.1038/srep34132] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
389 Yu JW, Lee MS. Mitochondria and the NLRP3 inflammasome: physiological and pathological relevance. Arch Pharm Res 2016;39:1503-18. [PMID: 27600432 DOI: 10.1007/s12272-016-0827-4] [Cited by in Crossref: 104] [Cited by in F6Publishing: 107] [Article Influence: 14.9] [Reference Citation Analysis]
390 Ratsimandresy RA, Indramohan M, Dorfleutner A, Stehlik C. The AIM2 inflammasome is a central regulator of intestinal homeostasis through the IL-18/IL-22/STAT3 pathway. Cell Mol Immunol 2017;14:127-42. [PMID: 27524110 DOI: 10.1038/cmi.2016.35] [Cited by in Crossref: 84] [Cited by in F6Publishing: 91] [Article Influence: 12.0] [Reference Citation Analysis]
391 Chen K, Shanmugam NK, Pazos MA, Hurley BP, Cherayil BJ. Commensal Bacteria-Induced Inflammasome Activation in Mouse and Human Macrophages Is Dependent on Potassium Efflux but Does Not Require Phagocytosis or Bacterial Viability. PLoS One 2016;11:e0160937. [PMID: 27505062 DOI: 10.1371/journal.pone.0160937] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
392 Kostadinova E, Chaput C, Gutbier B, Lippmann J, Sander LE, Mitchell TJ, Suttorp N, Witzenrath M, Opitz B. NLRP3 protects alveolar barrier integrity by an inflammasome-independent increase of epithelial cell adherence. Sci Rep 2016;6:30943. [PMID: 27476670 DOI: 10.1038/srep30943] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
393 Runtsch MC, Hu R, Alexander M, Wallace J, Kagele D, Petersen C, Valentine JF, Welker NC, Bronner MP, Chen X. MicroRNA-146a constrains multiple parameters of intestinal immunity and increases susceptibility to DSS colitis. Oncotarget. 2015;6:28556-28572. [PMID: 26456940 DOI: 10.18632/oncotarget.5597] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 4.9] [Reference Citation Analysis]
394 Eo H, Lee HJ, Lim Y. Ameliorative effect of dietary genistein on diabetes induced hyper-inflammation and oxidative stress during early stage of wound healing in alloxan induced diabetic mice. Biochem Biophys Res Commun 2016;478:1021-7. [PMID: 27431618 DOI: 10.1016/j.bbrc.2016.07.039] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 4.6] [Reference Citation Analysis]
395 Lasry A, Zinger A, Ben-Neriah Y. Inflammatory networks underlying colorectal cancer. Nat Immunol. 2016;17:230-240. [PMID: 26882261 DOI: 10.1038/ni.3384] [Cited by in Crossref: 311] [Cited by in F6Publishing: 324] [Article Influence: 44.4] [Reference Citation Analysis]
396 Bergstrom K, Liu X, Zhao Y, Gao N, Wu Q, Song K, Cui Y, Li Y, McDaniel JM, McGee S, Chen W, Huycke MM, Houchen CW, Zenewicz LA, West CM, Chen H, Braun J, Fu J, Xia L. Defective Intestinal Mucin-Type O-Glycosylation Causes Spontaneous Colitis-Associated Cancer in Mice. Gastroenterology 2016;151:152-164.e11. [PMID: 27059389 DOI: 10.1053/j.gastro.2016.03.039] [Cited by in Crossref: 78] [Cited by in F6Publishing: 81] [Article Influence: 11.1] [Reference Citation Analysis]
397 Müller AA, Dolowschiak T, Sellin ME, Felmy B, Verbree C, Gadient S, Westermann AJ, Vogel J, LeibundGut-Landmann S, Hardt WD. An NK Cell Perforin Response Elicited via IL-18 Controls Mucosal Inflammation Kinetics during Salmonella Gut Infection. PLoS Pathog 2016;12:e1005723. [PMID: 27341123 DOI: 10.1371/journal.ppat.1005723] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 4.9] [Reference Citation Analysis]
398 Lee HY, Kim J, Quan W, Lee JC, Kim MS, Kim SH, Bae JW, Hur KY, Lee MS. Autophagy deficiency in myeloid cells increases susceptibility to obesity-induced diabetes and experimental colitis. Autophagy 2016;12:1390-403. [PMID: 27337687 DOI: 10.1080/15548627.2016.1184799] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 7.6] [Reference Citation Analysis]
399 Salaro E, Rambaldi A, Falzoni S, Amoroso FS, Franceschini A, Sarti AC, Bonora M, Cavazzini F, Rigolin GM, Ciccone M, Audrito V, Deaglio S, Pelegrin P, Pinton P, Cuneo A, Di Virgilio F. Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death. Sci Rep 2016;6:26280. [PMID: 27221966 DOI: 10.1038/srep26280] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 4.4] [Reference Citation Analysis]
400 Toonen EJ, Mirea AM, Tack CJ, Stienstra R, Ballak DB, van Diepen JA, Hijmans A, Chavakis T, Dokter WH, Pham CT, Netea MG, Dinarello CA, Joosten LA. Activation of proteinase 3 contributes to Non-alcoholic Fatty Liver Disease (NAFLD) and insulin resistance. Mol Med 2016;22. [PMID: 27261776 DOI: 10.2119/molmed.2016.00033] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
401 Blandino G, Inturri R, Lazzara F, Di Rosa M, Malaguarnera L. Impact of gut microbiota on diabetes mellitus. Diabetes Metab. 2016;42:303-315. [PMID: 27179626 DOI: 10.1016/j.diabet.2016.04.004] [Cited by in Crossref: 132] [Cited by in F6Publishing: 110] [Article Influence: 18.9] [Reference Citation Analysis]
402 Zhan Y, Seregin SS, Chen J, Chen GY. Nod1 Limits Colitis-Associated Tumorigenesis by Regulating IFN-γ Production. J Immunol 2016;196:5121-9. [PMID: 27183588 DOI: 10.4049/jimmunol.1501822] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
403 Tang W, Wang H, Ha HL, Tassi I, Bhardwaj R, Claudio E, Siebenlist U. The B-cell tumor promoter Bcl-3 suppresses inflammation-associated colon tumorigenesis in epithelial cells. Oncogene 2016;35:6203-11. [PMID: 27132515 DOI: 10.1038/onc.2016.152] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
404 Boyapati RK, Rossi AG, Satsangi J, Ho GT. Gut mucosal DAMPs in IBD: from mechanisms to therapeutic implications. Mucosal Immunol 2016;9:567-82. [PMID: 26931062 DOI: 10.1038/mi.2016.14] [Cited by in Crossref: 84] [Cited by in F6Publishing: 88] [Article Influence: 12.0] [Reference Citation Analysis]
405 Higashimori A, Watanabe T, Nadatani Y, Takeda S, Otani K, Tanigawa T, Yamagami H, Shiba M, Tominaga K, Fujiwara Y, Arakawa T. Mechanisms of NLRP3 inflammasome activation and its role in NSAID-induced enteropathy. Mucosal Immunol 2016;9:659-68. [PMID: 26349656 DOI: 10.1038/mi.2015.89] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 6.0] [Reference Citation Analysis]
406 Karin M, Clevers H. Reparative inflammation takes charge of tissue regeneration. Nature. 2016;529:307-315. [PMID: 26791721 DOI: 10.1038/nature17039] [Cited by in Crossref: 447] [Cited by in F6Publishing: 462] [Article Influence: 63.9] [Reference Citation Analysis]
407 Sugimoto MA, Sousa LP, Pinho V, Perretti M, Teixeira MM. Resolution of Inflammation: What Controls Its Onset? Front Immunol 2016;7:160. [PMID: 27199985 DOI: 10.3389/fimmu.2016.00160] [Cited by in Crossref: 299] [Cited by in F6Publishing: 320] [Article Influence: 42.7] [Reference Citation Analysis]
408 Nagai M, Obata Y, Takahashi D, Hase K. Fine-tuning of the mucosal barrier and metabolic systems using the diet-microbial metabolite axis. Int Immunopharmacol 2016;37:79-86. [PMID: 27133028 DOI: 10.1016/j.intimp.2016.04.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
409 Sivaprakasam S, Prasad PD, Singh N. Benefits of short-chain fatty acids and their receptors in inflammation and carcinogenesis. Pharmacol Ther 2016;164:144-51. [PMID: 27113407 DOI: 10.1016/j.pharmthera.2016.04.007] [Cited by in Crossref: 249] [Cited by in F6Publishing: 264] [Article Influence: 35.6] [Reference Citation Analysis]
410 Mager LF, Wasmer MH, Rau TT, Krebs P. Cytokine-Induced Modulation of Colorectal Cancer. Front Oncol. 2016;6:96. [PMID: 27148488 DOI: 10.3389/fonc.2016.00096] [Cited by in Crossref: 137] [Cited by in F6Publishing: 147] [Article Influence: 19.6] [Reference Citation Analysis]
411 Man SM, Karki R, Kanneganti TD. DNA-sensing inflammasomes: regulation of bacterial host defense and the gut microbiota. Pathog Dis 2016;74:ftw028. [PMID: 27056948 DOI: 10.1093/femspd/ftw028] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 3.7] [Reference Citation Analysis]
412 Claes AK, Zhou JY, Philpott DJ. NOD-Like Receptors: Guardians of Intestinal Mucosal Barriers. Physiology (Bethesda) 2015;30:241-50. [PMID: 25933824 DOI: 10.1152/physiol.00025.2014] [Cited by in Crossref: 26] [Cited by in F6Publishing: 32] [Article Influence: 3.7] [Reference Citation Analysis]
413 Nowarski R, Jackson R, Gagliani N, de Zoete MR, Palm NW, Bailis W, Low JS, Harman CC, Graham M, Elinav E, Flavell RA. Epithelial IL-18 Equilibrium Controls Barrier Function in Colitis. Cell 2015;163:1444-56. [PMID: 26638073 DOI: 10.1016/j.cell.2015.10.072] [Cited by in Crossref: 313] [Cited by in F6Publishing: 325] [Article Influence: 44.7] [Reference Citation Analysis]
414 Spalinger MR, Kasper S, Gottier C, Lang S, Atrott K, Vavricka SR, Scharl S, Raselli T, Frey-Wagner I, Gutte PM, Grütter MG, Beer HD, Contassot E, Chan AC, Dai X, Rawlings DJ, Mair F, Becher B, Falk W, Fried M, Rogler G, Scharl M. NLRP3 tyrosine phosphorylation is controlled by protein tyrosine phosphatase PTPN22. J Clin Invest 2016;126:1783-800. [PMID: 27043286 DOI: 10.1172/JCI83669] [Cited by in Crossref: 135] [Cited by in F6Publishing: 139] [Article Influence: 19.3] [Reference Citation Analysis]
415 Yang J, Kim M, Kim E, Cheon J, Lee Y, Kim Y, Lee S, Seo S, Shin S, Choi S, Kim B, Chang S, Ko H, Bae J, Kweon M. Enteric Viruses Ameliorate Gut Inflammation via Toll-like Receptor 3 and Toll-like Receptor 7-Mediated Interferon-β Production. Immunity 2016;44:889-900. [DOI: 10.1016/j.immuni.2016.03.009] [Cited by in Crossref: 133] [Cited by in F6Publishing: 133] [Article Influence: 19.0] [Reference Citation Analysis]
416 Du Q, Wang Q, Fan H, Wang J, Liu X, Wang H, Wang Y, Hu R. Dietary cholesterol promotes AOM-induced colorectal cancer through activating the NLRP3 inflammasome. Biochemical Pharmacology 2016;105:42-54. [DOI: 10.1016/j.bcp.2016.02.017] [Cited by in Crossref: 45] [Cited by in F6Publishing: 50] [Article Influence: 6.4] [Reference Citation Analysis]
417 Liu W, Li H, Hong SH, Piszczek GP, Chen W, Rodgers GP. Olfactomedin 4 deletion induces colon adenocarcinoma in ApcMin/+ mice. Oncogene. 2016;35:5237-5247. [PMID: 26973250 DOI: 10.1038/onc.2016.58] [Cited by in Crossref: 47] [Cited by in F6Publishing: 52] [Article Influence: 6.7] [Reference Citation Analysis]
418 Koblansky AA, Truax AD, Liu R, Montgomery SA, Ding S, Wilson JE, Brickey WJ, Mühlbauer M, McFadden RM, Hu P, Li Z, Jobin C, Lund PK, Ting JP. The Innate Immune Receptor NLRX1 Functions as a Tumor Suppressor by Reducing Colon Tumorigenesis and Key Tumor-Promoting Signals. Cell Rep 2016;14:2562-75. [PMID: 26971998 DOI: 10.1016/j.celrep.2016.02.064] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 6.9] [Reference Citation Analysis]
419 Gonçalves P, Di Santo JP. An Intestinal Inflammasome - The ILC3-Cytokine Tango. Trends Mol Med 2016;22:269-71. [PMID: 26965960 DOI: 10.1016/j.molmed.2016.02.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
420 Aliberti J. Immunity and Tolerance Induced by Intestinal Mucosal Dendritic Cells. Mediators Inflamm 2016;2016:3104727. [PMID: 27034589 DOI: 10.1155/2016/3104727] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
421 Oh JY, Ko JH, Ryu JS, Lee HJ, Kim MK, Wee WR. Transcription Profiling of NOD-like Receptors in the Human Cornea with Disease. Ocul Immunol Inflamm 2017;25:364-9. [PMID: 26902715 DOI: 10.3109/09273948.2015.1130844] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
422 Chen Z, Yu K, Zhu F, Gorczynski R. Over-Expression of CD200 Protects Mice from Dextran Sodium Sulfate Induced Colitis. PLoS One 2016;11:e0146681. [PMID: 26841120 DOI: 10.1371/journal.pone.0146681] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
423 Vaikunthanathan T, Safinia N, Lombardi G, Lechler RI. Microbiota, immunity and the liver. Immunol Lett. 2016;171:36-49. [PMID: 26835593 DOI: 10.1016/j.imlet.2016.01.008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
424 Ngoh EN, Weisser SB, Lo Y, Kozicky LK, Jen R, Brugger HK, Menzies SC, McLarren KW, Nackiewicz D, van Rooijen N, Jacobson K, Ehses JA, Turvey SE, Sly LM. Activity of SHIP, Which Prevents Expression of Interleukin 1β, Is Reduced in Patients With Crohn's Disease. Gastroenterology 2016;150:465-76. [PMID: 26481854 DOI: 10.1053/j.gastro.2015.09.049] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
425 Wang Y, Wang H, Qian C, Tang J, Zhou W, Liu X, You Q, Hu R. 3-(2-Oxo-2-phenylethylidene)-2,3,6,7-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4(11bH)-one (compound 1), a novel potent Nrf2/ARE inducer, protects against DSS-induced colitis via inhibiting NLRP3 inflammasome. Biochemical Pharmacology 2016;101:71-86. [DOI: 10.1016/j.bcp.2015.11.015] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 6.0] [Reference Citation Analysis]
426 He Y, Zeng MY, Yang D, Motro B, Núñez G. NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux. Nature 2016;530:354-7. [PMID: 26814970 DOI: 10.1038/nature16959] [Cited by in Crossref: 602] [Cited by in F6Publishing: 624] [Article Influence: 86.0] [Reference Citation Analysis]
427 Subramaniam R, Mizoguchi A, Mizoguchi E. Mechanistic roles of epithelial and immune cell signaling during the development of colitis-associated cancer. Cancer Res Front. 2016;2:1-21. [PMID: 27110580 DOI: 10.17980/2016.1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
428 Storek KM, Monack DM. Bacterial recognition pathways that lead to inflammasome activation. Immunol Rev 2015;265:112-29. [PMID: 25879288 DOI: 10.1111/imr.12289] [Cited by in Crossref: 82] [Cited by in F6Publishing: 86] [Article Influence: 11.7] [Reference Citation Analysis]
429 Márquez-Flores YK, Villegas I, Cárdeno A, Rosillo MÁ, Alarcón-de-la-Lastra C. Apigenin supplementation protects the development of dextran sulfate sodium-induced murine experimental colitis by inhibiting canonical and non-canonical inflammasome signaling pathways. J Nutr Biochem 2016;30:143-52. [PMID: 27012631 DOI: 10.1016/j.jnutbio.2015.12.002] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 6.4] [Reference Citation Analysis]
430 Dagenais M, Dupaul-Chicoine J, Champagne C, Skeldon A, Morizot A, Saleh M. A critical role for cellular inhibitor of protein 2 (cIAP2) in colitis-associated colorectal cancer and intestinal homeostasis mediated by the inflammasome and survival pathways. Mucosal Immunol 2016;9:146-58. [PMID: 26037070 DOI: 10.1038/mi.2015.46] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
431 de Souza HS, Fiocchi C. Immunopathogenesis of IBD: current state of the art. Nat Rev Gastroenterol Hepatol 2016;13:13-27. [PMID: 26627550 DOI: 10.1038/nrgastro.2015.186] [Cited by in Crossref: 805] [Cited by in F6Publishing: 745] [Article Influence: 115.0] [Reference Citation Analysis]
432 Kurashima Y, Kiyono H. Physiological and Pathological Inflammation at the Mucosal Frontline. Chronic Inflammation 2016. [DOI: 10.1007/978-4-431-56068-5_43] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
433 Jiang X, Zhong L, Sun D, Rong L. Magnesium lithospermate B acts against dextran sodiumsulfate-induced ulcerative colitis by inhibiting activation of the NRLP3/ASC/Caspase-1 pathway. Environmental Toxicology and Pharmacology 2016;41:72-7. [DOI: 10.1016/j.etap.2015.10.009] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
434 Müller A, Hartung ML. Helicobacter pylori and the Host Immune Response. Helicobacter pylori Research 2016. [DOI: 10.1007/978-4-431-55936-8_12] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
435 Han YM, Park JM, Cha JY, Jeong M, Go EJ, Hahm KB. Endogenous conversion of ω-6 to ω-3 polyunsaturated fatty acids in fat-1 mice attenuated intestinal polyposis by either inhibiting COX-2/β-catenin signaling or activating 15-PGDH/IL-18. Int J Cancer 2016;138:2247-56. [PMID: 26650508 DOI: 10.1002/ijc.29956] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
436 Sharma N, Jha S. NLR-regulated pathways in cancer: opportunities and obstacles for therapeutic interventions. Cell Mol Life Sci 2016;73:1741-64. [PMID: 26708292 DOI: 10.1007/s00018-015-2123-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
437 Gu QY, Zhang J, Feng YC. Role of NLRP3 inflammasome in Bifidobacterium longum-regulated visceral hypersensitivity of postinfectious irritable bowel syndrome. Artif Cells Nanomed Biotechnol 2016;44:1933-7. [PMID: 26697916 DOI: 10.3109/21691401.2015.1111238] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
438 Voronov E, Apte RN. IL-1 in Colon Inflammation, Colon Carcinogenesis and Invasiveness of Colon Cancer. Cancer Microenviron 2015;8:187-200. [PMID: 26686225 DOI: 10.1007/s12307-015-0177-7] [Cited by in Crossref: 76] [Cited by in F6Publishing: 69] [Article Influence: 9.5] [Reference Citation Analysis]
439 Yu SX, Du CT, Chen W, Lei QQ, Li N, Qi S, Zhang XJ, Hu GQ, Deng XM, Han WY, Yang YJ. Genipin inhibits NLRP3 and NLRC4 inflammasome activation via autophagy suppression. Sci Rep 2015;5:17935. [PMID: 26659006 DOI: 10.1038/srep17935] [Cited by in Crossref: 56] [Cited by in F6Publishing: 63] [Article Influence: 7.0] [Reference Citation Analysis]
440 Sharma D, Malik A, Steury MD, Lucas PC, Parameswaran N. Protective Role of β-arrestin2 in Colitis Through Modulation of T-cell Activation. Inflamm Bowel Dis 2015;21:2766-77. [PMID: 26296063 DOI: 10.1097/MIB.0000000000000563] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
441 Li Q, Zhang X, Wang W, Li L, Xu Q, Wu X, Gu Y. CPT-11 activates NLRP3 inflammasome through JNK and NF-κB signalings. Toxicology and Applied Pharmacology 2015;289:133-41. [DOI: 10.1016/j.taap.2015.09.025] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
442 Medina-Contreras O, Harusato A, Nishio H, Flannigan KL, Ngo V, Leoni G, Neumann PA, Geem D, Lili LN, Ramadas RA. Cutting Edge: IL-36 Receptor Promotes Resolution of Intestinal Damage. J Immunol. 2016;196:34-38. [PMID: 26590314 DOI: 10.4049/jimmunol.1501312] [Cited by in Crossref: 93] [Cited by in F6Publishing: 96] [Article Influence: 11.6] [Reference Citation Analysis]
443 Hu S, Peng L, Kwak YT, Tekippe EM, Pasare C, Malter JS, Hooper LV, Zaki MH. The DNA Sensor AIM2 Maintains Intestinal Homeostasis via Regulation of Epithelial Antimicrobial Host Defense. Cell Rep 2015;13:1922-36. [PMID: 26655906 DOI: 10.1016/j.celrep.2015.10.040] [Cited by in Crossref: 76] [Cited by in F6Publishing: 69] [Article Influence: 9.5] [Reference Citation Analysis]
444 Santana PT, Martel J, Lai HC, Perfettini JL, Kanellopoulos JM, Young JD, Coutinho-Silva R, Ojcius DM. Is the inflammasome relevant for epithelial cell function? Microbes Infect 2016;18:93-101. [PMID: 26546965 DOI: 10.1016/j.micinf.2015.10.007] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 3.4] [Reference Citation Analysis]
445 Harrison OJ, Srinivasan N, Pott J, Schiering C, Krausgruber T, Ilott NE, Maloy KJ. Epithelial-derived IL-18 regulates Th17 cell differentiation and Foxp3⁺ Treg cell function in the intestine. Mucosal Immunol 2015;8:1226-36. [PMID: 25736457 DOI: 10.1038/mi.2015.13] [Cited by in Crossref: 138] [Cited by in F6Publishing: 138] [Article Influence: 17.3] [Reference Citation Analysis]
446 Vanhove W, Peeters PM, Staelens D, Schraenen A, Van der Goten J, Cleynen I, De Schepper S, Van Lommel L, Reynaert NL, Schuit F, Van Assche G, Ferrante M, De Hertogh G, Wouters EF, Rutgeerts P, Vermeire S, Nys K, Arijs I. Strong Upregulation of AIM2 and IFI16 Inflammasomes in the Mucosa of Patients with Active Inflammatory Bowel Disease. Inflamm Bowel Dis 2015;21:2673-82. [PMID: 26313692 DOI: 10.1097/MIB.0000000000000535] [Cited by in Crossref: 68] [Cited by in F6Publishing: 65] [Article Influence: 8.5] [Reference Citation Analysis]
447 Schneider KM, Bieghs V, Heymann F, Hu W, Dreymueller D, Liao L, Frissen M, Ludwig A, Gassler N, Pabst O, Latz E, Sellge G, Penders J, Tacke F, Trautwein C. CX3CR1 is a gatekeeper for intestinal barrier integrity in mice: Limiting steatohepatitis by maintaining intestinal homeostasis. Hepatology 2015;62:1405-16. [PMID: 26178698 DOI: 10.1002/hep.27982] [Cited by in Crossref: 69] [Cited by in F6Publishing: 70] [Article Influence: 8.6] [Reference Citation Analysis]
448 Gimenez F, Bhela S, Dogra P, Harvey L, Varanasi SK, Jaggi U, Rouse BT. The inflammasome NLRP3 plays a protective role against a viral immunopathological lesion. J Leukoc Biol 2016;99:647-57. [PMID: 26516184 DOI: 10.1189/jlb.3HI0715-321R] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]
449 Cui J, Chen Y, Wang HY, Wang RF. Mechanisms and pathways of innate immune activation and regulation in health and cancer. Hum Vaccin Immunother. 2014;10:3270-3285. [PMID: 25625930 DOI: 10.4161/21645515.2014.979640] [Cited by in Crossref: 159] [Cited by in F6Publishing: 171] [Article Influence: 19.9] [Reference Citation Analysis]
450 Dupaul-chicoine J, Arabzadeh A, Dagenais M, Douglas T, Champagne C, Morizot A, Rodrigue-gervais I, Breton V, Colpitts S, Beauchemin N, Saleh M. The Nlrp3 Inflammasome Suppresses Colorectal Cancer Metastatic Growth in the Liver by Promoting Natural Killer Cell Tumoricidal Activity. Immunity 2015;43:751-63. [DOI: 10.1016/j.immuni.2015.08.013] [Cited by in Crossref: 172] [Cited by in F6Publishing: 153] [Article Influence: 21.5] [Reference Citation Analysis]
451 Ray A, Dittel BN. Interrelatedness between dysbiosis in the gut microbiota due to immunodeficiency and disease penetrance of colitis. Immunology 2015;146:359-68. [PMID: 26211540 DOI: 10.1111/imm.12511] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 4.0] [Reference Citation Analysis]
452 Wan J, Wu W, Che Y, Kang N, Zhang R. Low dose photodynamic-therapy induce immune escape of tumor cells in a HIF-1α dependent manner through PI3K/Akt pathway. International Immunopharmacology 2015;28:44-51. [DOI: 10.1016/j.intimp.2015.05.025] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
453 Laukens D, Brinkman BM, Raes J, De Vos M, Vandenabeele P. Heterogeneity of the gut microbiome in mice: guidelines for optimizing experimental design. FEMS Microbiol Rev 2016;40:117-32. [PMID: 26323480 DOI: 10.1093/femsre/fuv036] [Cited by in Crossref: 236] [Cited by in F6Publishing: 242] [Article Influence: 29.5] [Reference Citation Analysis]
454 Peeters PM, Wouters EF, Reynaert NL. Immune Homeostasis in Epithelial Cells: Evidence and Role of Inflammasome Signaling Reviewed. J Immunol Res 2015;2015:828264. [PMID: 26355424 DOI: 10.1155/2015/828264] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
455 Arora K, Sinha C, Zhang W, Moon CS, Ren A, Yarlagadda S, Dostmann WR, Adebiyi A, Haberman Y, Denson LA, Wang X, Naren AP. Altered cGMP dynamics at the plasma membrane contribute to diarrhea in ulcerative colitis. Am J Pathol 2015;185:2790-804. [PMID: 26261085 DOI: 10.1016/j.ajpath.2015.06.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
456 Vieira AT, Macia L, Galvão I, Martins FS, Canesso MC, Amaral FA, Garcia CC, Maslowski KM, De Leon E, Shim D, Nicoli JR, Harper JL, Teixeira MM, Mackay CR. A Role for Gut Microbiota and the Metabolite-Sensing Receptor GPR43 in a Murine Model of Gout. Arthritis Rheumatol 2015;67:1646-56. [PMID: 25914377 DOI: 10.1002/art.39107] [Cited by in Crossref: 150] [Cited by in F6Publishing: 157] [Article Influence: 18.8] [Reference Citation Analysis]
457 Jarry A, Bossard C, Droy-Dupré L, Volteau C, Bourreille A, Meurette G, Mosnier JF, Laboisse CL. Heterogeneity of subordination of the IL-18/IFN-γ axis to caspase-1 among patients with Crohn's disease. Lab Invest 2015;95:1207-17. [PMID: 26168332 DOI: 10.1038/labinvest.2015.89] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
458 Sellin ME, Maslowski KM, Maloy KJ, Hardt WD. Inflammasomes of the intestinal epithelium. Trends Immunol 2015;36:442-50. [PMID: 26166583 DOI: 10.1016/j.it.2015.06.002] [Cited by in Crossref: 63] [Cited by in F6Publishing: 52] [Article Influence: 7.9] [Reference Citation Analysis]
459 Idris A, Ghazali NB, Koh D. Interleukin 1β-A Potential Salivary Biomarker for Cancer Progression? Biomark Cancer 2015;7:25-9. [PMID: 26244033 DOI: 10.4137/BIC.S25375] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
460 Wilson JE, Petrucelli AS, Chen L, Koblansky AA, Truax AD, Oyama Y, Rogers AB, Brickey WJ, Wang Y, Schneider M, Mühlbauer M, Chou WC, Barker BR, Jobin C, Allbritton NL, Ramsden DA, Davis BK, Ting JP. Inflammasome-independent role of AIM2 in suppressing colon tumorigenesis via DNA-PK and Akt. Nat Med 2015;21:906-13. [PMID: 26107252 DOI: 10.1038/nm.3908] [Cited by in Crossref: 179] [Cited by in F6Publishing: 188] [Article Influence: 22.4] [Reference Citation Analysis]
461 Man SM, Zhu Q, Zhu L, Liu Z, Karki R, Malik A, Sharma D, Li L, Malireddi RK, Gurung P, Neale G, Olsen SR, Carter RA, McGoldrick DJ, Wu G, Finkelstein D, Vogel P, Gilbertson RJ, Kanneganti TD. Critical Role for the DNA Sensor AIM2 in Stem Cell Proliferation and Cancer. Cell 2015;162:45-58. [PMID: 26095253 DOI: 10.1016/j.cell.2015.06.001] [Cited by in Crossref: 202] [Cited by in F6Publishing: 211] [Article Influence: 25.3] [Reference Citation Analysis]
462 Guo W, Hu S, Elgehama A, Shao F, Ren R, Liu W, Zhang W, Wang X, Tan R, Xu Q, Sun Y, Jiao R. Fumigaclavine C ameliorates dextran sulfate sodium-induced murine experimental colitis via NLRP3 inflammasome inhibition. J Pharmacol Sci 2015;129:101-6. [PMID: 26320672 DOI: 10.1016/j.jphs.2015.05.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
463 Guo W, Sun Y, Liu W, Wu X, Guo L, Cai P, Wu X, Wu X, Shen Y, Shu Y, Gu Y, Xu Q. Small molecule-driven mitophagy-mediated NLRP3 inflammasome inhibition is responsible for the prevention of colitis-associated cancer. Autophagy 2014;10:972-85. [PMID: 24879148 DOI: 10.4161/auto.28374] [Cited by in Crossref: 178] [Cited by in F6Publishing: 184] [Article Influence: 22.3] [Reference Citation Analysis]
464 Sun H, Lou Y, Porturas T, Morrissey S, Luo G, Qi J, Ruan Q, Shi S, Chen YH. Exacerbated experimental colitis in TNFAIP8-deficient mice. J Immunol 2015;194:5736-42. [PMID: 25948814 DOI: 10.4049/jimmunol.1401986] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
465 Suzuki N, Murata-Kamiya N, Yanagiya K, Suda W, Hattori M, Kanda H, Bingo A, Fujii Y, Maeda S, Koike K. Mutual reinforcement of inflammation and carcinogenesis by the Helicobacter pylori CagA oncoprotein. Sci Rep. 2015;5:10024. [PMID: 25944120 DOI: 10.1038/srep10024] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 5.4] [Reference Citation Analysis]
466 Saavedra PH, Demon D, Van Gorp H, Lamkanfi M. Protective and detrimental roles of inflammasomes in disease. Semin Immunopathol 2015;37:313-22. [PMID: 25895577 DOI: 10.1007/s00281-015-0485-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
467 Seo SU, Kamada N, Muñoz-Planillo R, Kim YG, Kim D, Koizumi Y, Hasegawa M, Himpsl SD, Browne HP, Lawley TD, Mobley HL, Inohara N, Núñez G. Distinct Commensals Induce Interleukin-1β via NLRP3 Inflammasome in Inflammatory Monocytes to Promote Intestinal Inflammation in Response to Injury. Immunity 2015;42:744-55. [PMID: 25862092 DOI: 10.1016/j.immuni.2015.03.004] [Cited by in Crossref: 202] [Cited by in F6Publishing: 212] [Article Influence: 25.3] [Reference Citation Analysis]
468 Guan K, Wei C, Zheng Z, Song T, Wu F, Zhang Y, Cao Y, Ma S, Chen W, Xu Q, Xia W, Gu J, He X, Zhong H. MAVS Promotes Inflammasome Activation by Targeting ASC for K63-Linked Ubiquitination via the E3 Ligase TRAF3. J Immunol 2015;194:4880-90. [PMID: 25847972 DOI: 10.4049/jimmunol.1402851] [Cited by in Crossref: 58] [Cited by in F6Publishing: 61] [Article Influence: 7.3] [Reference Citation Analysis]
469 Macia L, Tan J, Vieira AT, Leach K, Stanley D, Luong S, Maruya M, Ian McKenzie C, Hijikata A, Wong C, Binge L, Thorburn AN, Chevalier N, Ang C, Marino E, Robert R, Offermanns S, Teixeira MM, Moore RJ, Flavell RA, Fagarasan S, Mackay CR. Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome. Nat Commun. 2015;6:6734. [PMID: 25828455 DOI: 10.1038/ncomms7734] [Cited by in Crossref: 715] [Cited by in F6Publishing: 736] [Article Influence: 89.4] [Reference Citation Analysis]
470 Grau A, Tabib A, Grau I, Reiner I, Mevorach D. Apoptotic cells induce NF-κB and inflammasome negative signaling. PLoS One 2015;10:e0122440. [PMID: 25822487 DOI: 10.1371/journal.pone.0122440] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
471 Yim HC, Williams BR. Protein kinase R and the inflammasome. J Interferon Cytokine Res 2014;34:447-54. [PMID: 24905201 DOI: 10.1089/jir.2014.0008] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 4.6] [Reference Citation Analysis]
472 Schmitz S, Werling D, Allenspach K. Effects of ex-vivo and in-vivo treatment with probiotics on the inflammasome in dogs with chronic enteropathy. PLoS One 2015;10:e0120779. [PMID: 25799280 DOI: 10.1371/journal.pone.0120779] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]
473 Allam R, Maillard MH, Tardivel A, Chennupati V, Bega H, Yu CW, Velin D, Schneider P, Maslowski KM. Epithelial NAIPs protect against colonic tumorigenesis. J Exp Med 2015;212:369-83. [PMID: 25732303 DOI: 10.1084/jem.20140474] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 5.5] [Reference Citation Analysis]
474 Williams TM, Leeth RA, Rothschild DE, Coutermarsh-Ott SL, McDaniel DK, Simmons AE, Heid B, Cecere TE, Allen IC. The NLRP1 inflammasome attenuates colitis and colitis-associated tumorigenesis. J Immunol 2015;194:3369-80. [PMID: 25725098 DOI: 10.4049/jimmunol.1402098] [Cited by in Crossref: 90] [Cited by in F6Publishing: 94] [Article Influence: 11.3] [Reference Citation Analysis]
475 Chewning JH, Weaver CT. Development and survival of Th17 cells within the intestines: the influence of microbiome- and diet-derived signals. J Immunol 2014;193:4769-77. [PMID: 25381358 DOI: 10.4049/jimmunol.1401835] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 5.1] [Reference Citation Analysis]
476 Paramel GV, Sirsjö A, Fransén K. Role of genetic alterations in the NLRP3 and CARD8 genes in health and disease. Mediators Inflamm 2015;2015:846782. [PMID: 25788762 DOI: 10.1155/2015/846782] [Cited by in Crossref: 49] [Cited by in F6Publishing: 52] [Article Influence: 6.1] [Reference Citation Analysis]
477 Sun Y, Zhao Y, Yao J, Zhao L, Wu Z, Wang Y, Pan D, Miao H, Guo Q, Lu N. Wogonoside protects against dextran sulfate sodium-induced experimental colitis in mice by inhibiting NF-κB and NLRP3 inflammasome activation. Biochem Pharmacol 2015;94:142-54. [PMID: 25677765 DOI: 10.1016/j.bcp.2015.02.002] [Cited by in Crossref: 105] [Cited by in F6Publishing: 105] [Article Influence: 13.1] [Reference Citation Analysis]
478 Muñoz M, Eidenschenk C, Ota N, Wong K, Lohmann U, Kühl AA, Wang X, Manzanillo P, Li Y, Rutz S, Zheng Y, Diehl L, Kayagaki N, van Lookeren-Campagne M, Liesenfeld O, Heimesaat M, Ouyang W. Interleukin-22 induces interleukin-18 expression from epithelial cells during intestinal infection. Immunity 2015;42:321-31. [PMID: 25680273 DOI: 10.1016/j.immuni.2015.01.011] [Cited by in Crossref: 119] [Cited by in F6Publishing: 129] [Article Influence: 14.9] [Reference Citation Analysis]
479 Jha S, Pan-Yun Ting J. Holding the inflammatory system in check: NLRs keep it cool. F1000Prime Rep 2015;7:15. [PMID: 25750733 DOI: 10.12703/P7-15] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
480 Jackson DJ, Glanville N, Trujillo-torralbo M, Shamji BWH, del-Rosario J, Mallia P, Edwards MJ, Walton RP, Edwards MR, Johnston SL. Interleukin-18 Is Associated With Protection Against Rhinovirus-Induced Colds and Asthma Exacerbations. Clinical Infectious Diseases 2015;60:1528-31. [DOI: 10.1093/cid/civ062] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
481 Francescone R, Hou V, Grivennikov SI. Cytokines, IBD, and colitis-associated cancer. Inflamm Bowel Dis 2015;21:409-18. [PMID: 25563695 DOI: 10.1097/MIB.0000000000000236] [Cited by in Crossref: 178] [Cited by in F6Publishing: 178] [Article Influence: 22.3] [Reference Citation Analysis]
482 Rescigno M. Dendritic cell-epithelial cell crosstalk in the gut. Immunol Rev 2014;260:118-28. [PMID: 24942686 DOI: 10.1111/imr.12181] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 5.5] [Reference Citation Analysis]
483 Kiesler P, Fuss IJ, Strober W. Experimental Models of Inflammatory Bowel Diseases. Cell Mol Gastroenterol Hepatol 2015;1:154-70. [PMID: 26000334 DOI: 10.1016/j.jcmgh.2015.01.006] [Cited by in Crossref: 385] [Cited by in F6Publishing: 375] [Article Influence: 48.1] [Reference Citation Analysis]
484 Ozaki E, Campbell M, Doyle SL. Targeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectives. J Inflamm Res. 2015;8:15-27. [PMID: 25653548 DOI: 10.2147/jir.s51250] [Cited by in Crossref: 78] [Cited by in F6Publishing: 162] [Article Influence: 9.8] [Reference Citation Analysis]
485 Williams TM, Leeth RA, Rothschild DE, McDaniel DK, Coutermarsh-Ott SL, Simmons AE, Kable KH, Heid B, Allen IC. Caspase-11 attenuates gastrointestinal inflammation and experimental colitis pathogenesis. Am J Physiol Gastrointest Liver Physiol 2015;308:G139-50. [PMID: 25414099 DOI: 10.1152/ajpgi.00234.2014] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 4.9] [Reference Citation Analysis]
486 Celkova L, Doyle SL, Campbell M. NLRP3 Inflammasome and Pathobiology in AMD. J Clin Med 2015;4:172-92. [PMID: 26237026 DOI: 10.3390/jcm4010172] [Cited by in Crossref: 50] [Cited by in F6Publishing: 54] [Article Influence: 6.3] [Reference Citation Analysis]
487 Moriwaki K, Balaji S, McQuade T, Malhotra N, Kang J, Chan FK. The necroptosis adaptor RIPK3 promotes injury-induced cytokine expression and tissue repair. Immunity 2014;41:567-78. [PMID: 25367573 DOI: 10.1016/j.immuni.2014.09.016] [Cited by in Crossref: 162] [Cited by in F6Publishing: 263] [Article Influence: 20.3] [Reference Citation Analysis]
488 Boirivant M. Experimental Models of Gastrointestinal Inflammatory Diseases. Mucosal Immunology 2015. [DOI: 10.1016/b978-0-12-415847-4.00079-3] [Reference Citation Analysis]
489 Hurwitz JL, Orihuela C, Dirita VJ, Tuomanen E. Bacterial Interactions with Mucosal Epithelial Cells. Mucosal Immunology. Elsevier; 2015. pp. 955-73. [DOI: 10.1016/b978-0-12-415847-4.00049-5] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
490 Nakanishi Y, Sato T, Ohteki T. Commensal Gram-positive bacteria initiates colitis by inducing monocyte/macrophage mobilization. Mucosal Immunol 2015;8:152-60. [PMID: 24938744 DOI: 10.1038/mi.2014.53] [Cited by in Crossref: 69] [Cited by in F6Publishing: 73] [Article Influence: 8.6] [Reference Citation Analysis]
491 Rescigno M. Microbial Sensing and Regulation of Mucosal Immune Responses by Intestinal Epithelial Cells. Mucosal Immunology 2015. [DOI: 10.1016/b978-0-12-415847-4.00028-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
492 Abraham C, Vogel SN, Perkins DJ. Signaling Mechanisms Regulating Innate Immune Responses. Mucosal Immunology 2015. [DOI: 10.1016/b978-0-12-415847-4.00030-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
493 Opipari A, Franchi L. Role of inflammasomes in intestinal inflammation and Crohn's disease. Inflamm Bowel Dis 2015;21:173-81. [PMID: 25517598 DOI: 10.1097/MIB.0000000000000230] [Cited by in Crossref: 59] [Cited by in F6Publishing: 55] [Article Influence: 7.4] [Reference Citation Analysis]
494 Oficjalska K, Raverdeau M, Aviello G, Wade SC, Hickey A, Sheehan KM, Corr SC, Kay EW, O'Neill LA, Mills KH, Creagh EM. Protective role for caspase-11 during acute experimental murine colitis. J Immunol 2015;194:1252-60. [PMID: 25548224 DOI: 10.4049/jimmunol.1400501] [Cited by in Crossref: 62] [Cited by in F6Publishing: 64] [Article Influence: 6.9] [Reference Citation Analysis]
495 Guo W, Liu W, Jin B, Geng J, Li J, Ding H, Wu X, Xu Q, Sun Y, Gao J. Asiatic acid ameliorates dextran sulfate sodium-induced murine experimental colitis via suppressing mitochondria-mediated NLRP3 inflammasome activation. Int Immunopharmacol. 2015;24:232-238. [PMID: 25523461 DOI: 10.1016/j.intimp.2014.12.009] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 4.7] [Reference Citation Analysis]
496 Everard A, Geurts L, Caesar R, Van Hul M, Matamoros S, Duparc T, Denis RG, Cochez P, Pierard F, Castel J, Bindels LB, Plovier H, Robine S, Muccioli GG, Renauld JC, Dumoutier L, Delzenne NM, Luquet S, Bäckhed F, Cani PD. Intestinal epithelial MyD88 is a sensor switching host metabolism towards obesity according to nutritional status. Nat Commun 2014;5:5648. [PMID: 25476696 DOI: 10.1038/ncomms6648] [Cited by in Crossref: 175] [Cited by in F6Publishing: 178] [Article Influence: 19.4] [Reference Citation Analysis]
497 Sánchez de Medina F, Romero-Calvo I, Mascaraque C, Martínez-Augustin O. Intestinal inflammation and mucosal barrier function. Inflamm Bowel Dis 2014;20:2394-404. [PMID: 25222662 DOI: 10.1097/MIB.0000000000000204] [Cited by in Crossref: 234] [Cited by in F6Publishing: 226] [Article Influence: 26.0] [Reference Citation Analysis]
498 Davis BK, Philipson C, Hontecillas R, Eden K, Bassaganya-Riera J, Allen IC. Emerging significance of NLRs in inflammatory bowel disease. Inflamm Bowel Dis 2014;20:2412-32. [PMID: 25153506 DOI: 10.1097/MIB.0000000000000151] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 4.3] [Reference Citation Analysis]
499 Rapsinski GJ, Wynosky-Dolfi MA, Oppong GO, Tursi SA, Wilson RP, Brodsky IE, Tükel Ç. Toll-like receptor 2 and NLRP3 cooperate to recognize a functional bacterial amyloid, curli. Infect Immun 2015;83:693-701. [PMID: 25422268 DOI: 10.1128/IAI.02370-14] [Cited by in Crossref: 79] [Cited by in F6Publishing: 79] [Article Influence: 8.8] [Reference Citation Analysis]
500 Becker HM, Apladas A, Scharl M, Fried M, Rogler G. Probiotic Escherichia coli Nissle 1917 and commensal E. coli K12 differentially affect the inflammasome in intestinal epithelial cells. Digestion 2014;89:110-8. [PMID: 24503609 DOI: 10.1159/000357521] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
501 Wei F, Zhang Y, Jian J, Mundra JJ, Tian Q, Lin J, Lafaille JJ, Tang W, Zhao W, Yu X, Liu CJ. PGRN protects against colitis progression in mice in an IL-10 and TNFR2 dependent manner. Sci Rep 2014;4:7023. [PMID: 25387791 DOI: 10.1038/srep07023] [Cited by in Crossref: 42] [Cited by in F6Publishing: 48] [Article Influence: 4.7] [Reference Citation Analysis]
502 Wang J, Li F, Wei H, Lian ZX, Sun R, Tian Z. Respiratory influenza virus infection induces intestinal immune injury via microbiota-mediated Th17 cell-dependent inflammation. J Exp Med 2014;211:2397-410. [PMID: 25366965 DOI: 10.1084/jem.20140625] [Cited by in Crossref: 256] [Cited by in F6Publishing: 272] [Article Influence: 28.4] [Reference Citation Analysis]
503 Demon D, Kuchmiy A, Fossoul A, Zhu Q, Kanneganti TD, Lamkanfi M. Caspase-11 is expressed in the colonic mucosa and protects against dextran sodium sulfate-induced colitis. Mucosal Immunol 2014;7:1480-91. [PMID: 24850431 DOI: 10.1038/mi.2014.36] [Cited by in Crossref: 65] [Cited by in F6Publishing: 75] [Article Influence: 7.2] [Reference Citation Analysis]
504 Dagenais M, Douglas T, Saleh M. Role of programmed necrosis and cell death in intestinal inflammation. Curr Opin Gastroenterol 2014;30:566-75. [PMID: 25291357 DOI: 10.1097/MOG.0000000000000117] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
505 Levy M, Thaiss CA, Katz MN, Suez J, Elinav E. Inflammasomes and the microbiota--partners in the preservation of mucosal homeostasis. Semin Immunopathol 2015;37:39-46. [PMID: 25315349 DOI: 10.1007/s00281-014-0451-7] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
506 Roulis M, Nikolaou C, Kotsaki E, Kaffe E, Karagianni N, Koliaraki V, Salpea K, Ragoussis J, Aidinis V, Martini E, Becker C, Herschman HR, Vetrano S, Danese S, Kollias G. Intestinal myofibroblast-specific Tpl2-Cox-2-PGE2 pathway links innate sensing to epithelial homeostasis. Proc Natl Acad Sci U S A 2014;111:E4658-67. [PMID: 25316791 DOI: 10.1073/pnas.1415762111] [Cited by in Crossref: 59] [Cited by in F6Publishing: 63] [Article Influence: 6.6] [Reference Citation Analysis]
507 Huang LY, He Q, Liang SJ, Su YX, Xiong LX, Wu QQ, Wu QY, Tao J, Wang JP, Tang YB, Lv XF, Liu J, Guan YY, Pang RP, Zhou JG. ClC-3 chloride channel/antiporter defect contributes to inflammatory bowel disease in humans and mice. Gut 2014;63:1587-95. [PMID: 24440986 DOI: 10.1136/gutjnl-2013-305168] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 3.9] [Reference Citation Analysis]
508 Csak T, Pillai A, Ganz M, Lippai D, Petrasek J, Park JK, Kodys K, Dolganiuc A, Kurt-Jones EA, Szabo G. Both bone marrow-derived and non-bone marrow-derived cells contribute to AIM2 and NLRP3 inflammasome activation in a MyD88-dependent manner in dietary steatohepatitis. Liver Int 2014;34:1402-13. [PMID: 24650018 DOI: 10.1111/liv.12537] [Cited by in Crossref: 53] [Cited by in F6Publishing: 55] [Article Influence: 5.9] [Reference Citation Analysis]
509 Ferreira CM, Vieira AT, Vinolo MA, Oliveira FA, Curi R, Martins Fdos S. The central role of the gut microbiota in chronic inflammatory diseases. J Immunol Res. 2014;2014:689492. [PMID: 25309932 DOI: 10.1155/2014/689492] [Cited by in Crossref: 110] [Cited by in F6Publishing: 122] [Article Influence: 12.2] [Reference Citation Analysis]
510 Thorburn AN, Macia L, Mackay CR. Diet, metabolites, and "western-lifestyle" inflammatory diseases. Immunity. 2014;40:833-842. [PMID: 24950203 DOI: 10.1016/j.immuni.2014.05.014] [Cited by in Crossref: 573] [Cited by in F6Publishing: 490] [Article Influence: 63.7] [Reference Citation Analysis]
511 Wang Y, Wang K, Han GC, Wang RX, Xiao H, Hou CM, Guo RF, Dou Y, Shen BF, Li Y, Chen GJ. Neutrophil infiltration favors colitis-associated tumorigenesis by activating the interleukin-1 (IL-1)/IL-6 axis. Mucosal Immunol 2014;7:1106-15. [PMID: 24424523 DOI: 10.1038/mi.2013.126] [Cited by in Crossref: 88] [Cited by in F6Publishing: 93] [Article Influence: 9.8] [Reference Citation Analysis]
512 Zhang J, Fu S, Sun S, Li Z, Guo B. Inflammasome activation has an important role in the development of spontaneous colitis. Mucosal Immunol 2014;7:1139-50. [PMID: 24472848 DOI: 10.1038/mi.2014.1] [Cited by in Crossref: 93] [Cited by in F6Publishing: 97] [Article Influence: 10.3] [Reference Citation Analysis]
513 Kabat AM, Srinivasan N, Maloy KJ. Modulation of immune development and function by intestinal microbiota. Trends Immunol. 2014;35:507-517. [PMID: 25172617 DOI: 10.1016/j.it.2014.07.010] [Cited by in Crossref: 195] [Cited by in F6Publishing: 177] [Article Influence: 21.7] [Reference Citation Analysis]
514 Naglik JR. Candida Immunity. New Journal of Science 2014;2014:1-27. [DOI: 10.1155/2014/390241] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
515 Derangère V, Chevriaux A, Courtaut F, Bruchard M, Berger H, Chalmin F, Causse SZ, Limagne E, Végran F, Ladoire S, Simon B, Boireau W, Hichami A, Apetoh L, Mignot G, Ghiringhelli F, Rébé C. Liver X receptor β activation induces pyroptosis of human and murine colon cancer cells. Cell Death Differ 2014;21:1914-24. [PMID: 25124554 DOI: 10.1038/cdd.2014.117] [Cited by in Crossref: 88] [Cited by in F6Publishing: 91] [Article Influence: 9.8] [Reference Citation Analysis]
516 Weidlich S, Bulau AM, Schwerd T, Althans J, Kappler R, Koletzko S, Mayr D, Bufler P. Intestinal expression of the anti-inflammatory interleukin-1 homologue IL-37 in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2014;59:e18-26. [PMID: 24732025 DOI: 10.1097/MPG.0000000000000387] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 4.0] [Reference Citation Analysis]
517 Liu Y, Fang X, Yuan J, Sun Z, Li C, Li R, Li L, Zhu C, Wan R, Guo R, Jin L, Li S. The role of corticotropin-releasing hormone receptor 1 in the development of colitis-associated cancer in mouse model. Endocrine-Related Cancer 2014;21:639-51. [DOI: 10.1530/erc-14-0239] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
518 Shapiro H, Thaiss CA, Levy M, Elinav E. The cross talk between microbiota and the immune system: metabolites take center stage. Curr Opin Immunol 2014;30:54-62. [PMID: 25064714 DOI: 10.1016/j.coi.2014.07.003] [Cited by in Crossref: 125] [Cited by in F6Publishing: 128] [Article Influence: 13.9] [Reference Citation Analysis]
519 Guo B, Li Z. Endoplasmic reticulum stress in hepatic steatosis and inflammatory bowel diseases. Front Genet 2014;5:242. [PMID: 25120559 DOI: 10.3389/fgene.2014.00242] [Cited by in Crossref: 43] [Cited by in F6Publishing: 50] [Article Influence: 4.8] [Reference Citation Analysis]
520 Gagliani N, Hu B, Huber S, Elinav E, Flavell RA. The fire within: microbes inflame tumors. Cell 2014;157:776-83. [PMID: 24813605 DOI: 10.1016/j.cell.2014.03.006] [Cited by in Crossref: 89] [Cited by in F6Publishing: 98] [Article Influence: 9.9] [Reference Citation Analysis]
521 Saxena M, Yeretssian G. NOD-Like Receptors: Master Regulators of Inflammation and Cancer. Front Immunol 2014;5:327. [PMID: 25071785 DOI: 10.3389/fimmu.2014.00327] [Cited by in Crossref: 151] [Cited by in F6Publishing: 157] [Article Influence: 16.8] [Reference Citation Analysis]
522 Corridoni D, Arseneau KO, Cifone MG, Cominelli F. The dual role of nod-like receptors in mucosal innate immunity and chronic intestinal inflammation. Front Immunol. 2014;5:317. [PMID: 25071778 DOI: 10.3389/fimmu.2014.00317] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 4.9] [Reference Citation Analysis]
523 Ayres JS. Inflammasome-microbiota interplay in host physiologies. Cell Host Microbe. 2013;14:491-497. [PMID: 24237695 DOI: 10.1016/j.chom.2013.10.013] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 3.7] [Reference Citation Analysis]
524 Song-Zhao GX, Srinivasan N, Pott J, Baban D, Frankel G, Maloy KJ. Nlrp3 activation in the intestinal epithelium protects against a mucosal pathogen. Mucosal Immunol 2014;7:763-74. [PMID: 24280937 DOI: 10.1038/mi.2013.94] [Cited by in Crossref: 88] [Cited by in F6Publishing: 92] [Article Influence: 9.8] [Reference Citation Analysis]
525 Nordlander S, Pott J, Maloy KJ. NLRC4 expression in intestinal epithelial cells mediates protection against an enteric pathogen. Mucosal Immunol 2014;7:775-85. [PMID: 24280936 DOI: 10.1038/mi.2013.95] [Cited by in Crossref: 99] [Cited by in F6Publishing: 105] [Article Influence: 11.0] [Reference Citation Analysis]
526 Li B, Alli R, Vogel P, Geiger TL. IL-10 modulates DSS-induced colitis through a macrophage-ROS-NO axis. Mucosal Immunol 2014;7:869-78. [PMID: 24301657 DOI: 10.1038/mi.2013.103] [Cited by in Crossref: 114] [Cited by in F6Publishing: 119] [Article Influence: 12.7] [Reference Citation Analysis]
527 Lou Y, Sun H, Morrissey S, Porturas T, Liu S, Hua X, Chen YH. Critical roles of TIPE2 protein in murine experimental colitis. J Immunol 2014;193:1064-70. [PMID: 24973456 DOI: 10.4049/jimmunol.1400415] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 3.9] [Reference Citation Analysis]
528 Thinwa J, Segovia JA, Bose S, Dube PH. Integrin-mediated first signal for inflammasome activation in intestinal epithelial cells. J Immunol 2014;193:1373-82. [PMID: 24965773 DOI: 10.4049/jimmunol.1400145] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 5.0] [Reference Citation Analysis]
529 Gagliani N, Palm NW, de Zoete MR, Flavell RA. Inflammasomes and intestinal homeostasis: regulating and connecting infection, inflammation and the microbiota. Int Immunol. 2014;26:495-499. [PMID: 24948595 DOI: 10.1093/intimm/dxu066] [Cited by in Crossref: 33] [Cited by in F6Publishing: 37] [Article Influence: 3.7] [Reference Citation Analysis]
530 Castaño-Rodríguez N, Kaakoush NO, Goh KL, Fock KM, Mitchell HM. The NOD-like receptor signalling pathway in Helicobacter pylori infection and related gastric cancer: a case-control study and gene expression analyses. PLoS One 2014;9:e98899. [PMID: 24901306 DOI: 10.1371/journal.pone.0098899] [Cited by in Crossref: 61] [Cited by in F6Publishing: 66] [Article Influence: 6.8] [Reference Citation Analysis]
531 Parlato M, Yeretssian G. NOD-like receptors in intestinal homeostasis and epithelial tissue repair. Int J Mol Sci. 2014;15:9594-9627. [PMID: 24886810 DOI: 10.3390/ijms15069594] [Cited by in Crossref: 53] [Cited by in F6Publishing: 57] [Article Influence: 5.9] [Reference Citation Analysis]
532 Chen Y, Wang SX, Mu R, Luo X, Liu ZS, Liang B, Zhuo HL, Hao XP, Wang Q, Fang DF. Dysregulation of the miR-324-5p-CUEDC2 axis leads to macrophage dysfunction and is associated with colon cancer. Cell Rep. 2014;7:1982-1993. [PMID: 24882011 DOI: 10.1016/j.celrep.2014.05.007] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 5.2] [Reference Citation Analysis]
533 Hedl M, Zheng S, Abraham C. The IL18RAP region disease polymorphism decreases IL-18RAP/IL-18R1/IL-1R1 expression and signaling through innate receptor-initiated pathways. J Immunol. 2014;192:5924-5932. [PMID: 24842757 DOI: 10.4049/jimmunol.1302727] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 4.3] [Reference Citation Analysis]
534 Zambetti LP, Mortellaro A. NLRPs, microbiota, and gut homeostasis: unravelling the connection. J Pathol 2014;233:321-30. [PMID: 24740681 DOI: 10.1002/path.4357] [Cited by in Crossref: 46] [Cited by in F6Publishing: 49] [Article Influence: 5.1] [Reference Citation Analysis]
535 Bakker PJ, Butter LM, Claessen N, Teske GJ, Sutterwala FS, Florquin S, Leemans JC. A tissue-specific role for Nlrp3 in tubular epithelial repair after renal ischemia/reperfusion. Am J Pathol 2014;184:2013-22. [PMID: 24823805 DOI: 10.1016/j.ajpath.2014.04.005] [Cited by in Crossref: 60] [Cited by in F6Publishing: 57] [Article Influence: 6.7] [Reference Citation Analysis]
536 Pineton de Chambrun G, Body-Malapel M, Frey-Wagner I, Djouina M, Deknuydt F, Atrott K, Esquerre N, Altare F, Neut C, Arrieta MC, Kanneganti TD, Rogler G, Colombel JF, Cortot A, Desreumaux P, Vignal C. Aluminum enhances inflammation and decreases mucosal healing in experimental colitis in mice. Mucosal Immunol 2014;7:589-601. [PMID: 24129165 DOI: 10.1038/mi.2013.78] [Cited by in Crossref: 68] [Cited by in F6Publishing: 66] [Article Influence: 7.6] [Reference Citation Analysis]
537 Allen IC. Non-Inflammasome Forming NLRs in Inflammation and Tumorigenesis. Front Immunol 2014;5:169. [PMID: 24795716 DOI: 10.3389/fimmu.2014.00169] [Cited by in Crossref: 52] [Cited by in F6Publishing: 56] [Article Influence: 5.8] [Reference Citation Analysis]
538 Aguilera M, Darby T, Melgar S. The complex role of inflammasomes in the pathogenesis of Inflammatory Bowel Diseases - lessons learned from experimental models. Cytokine Growth Factor Rev. 2014;25:715-730. [PMID: 24803013 DOI: 10.1016/j.cytogfr.2014.04.003] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 5.1] [Reference Citation Analysis]
539 Chen KW, Richards AA, Zamoshnikova A, Schroder K. Inflammasomes and Inflammation. Cancer and Inflammation Mechanisms 2014. [DOI: 10.1002/9781118826621.ch8] [Reference Citation Analysis]
540 Lertpiriyapong K, Handt L, Feng Y, Mitchell TW, Lodge KE, Shen Z, Dewhirst FE, Muthupalani S, Fox JG. Pathogenic properties of enterohepatic Helicobacter spp. isolated from rhesus macaques with intestinal adenocarcinoma. J Med Microbiol 2014;63:1004-16. [PMID: 24696515 DOI: 10.1099/jmm.0.072462-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
541 Wang ZK, Yang YS, Stefka AT, Sun G, Peng LH. Review article: fungal microbiota and digestive diseases. Aliment Pharmacol Ther 2014;39:751-66. [PMID: 24612332 DOI: 10.1111/apt.12665] [Cited by in Crossref: 81] [Cited by in F6Publishing: 75] [Article Influence: 9.0] [Reference Citation Analysis]
542 Hanamsagar R, Aldrich A, Kielian T. Critical role for the AIM2 inflammasome during acute CNS bacterial infection. J Neurochem 2014;129:704-11. [PMID: 24484406 DOI: 10.1111/jnc.12669] [Cited by in Crossref: 66] [Cited by in F6Publishing: 66] [Article Influence: 7.3] [Reference Citation Analysis]
543 Kaminskyy VO, Zhivotovsky B. Free radicals in cross talk between autophagy and apoptosis. Antioxid Redox Signal. 2014;21:86-102. [PMID: 24359220 DOI: 10.1089/ars.2013.5746] [Cited by in Crossref: 239] [Cited by in F6Publishing: 256] [Article Influence: 26.6] [Reference Citation Analysis]
544 Antoni L, Nuding S, Wehkamp J, Stange EF. Intestinal barrier in inflammatory bowel disease. World J Gastroenterol 2014; 20(5): 1165-1179 [PMID: 24574793 DOI: 10.3748/wjg.v20.i5.1165] [Cited by in CrossRef: 226] [Cited by in F6Publishing: 235] [Article Influence: 25.1] [Reference Citation Analysis]
545 McLean MH, Neurath MF, Durum SK. Targeting interleukins for the treatment of inflammatory bowel disease-what lies beyond anti-TNF therapy? Inflamm Bowel Dis 2014;20:389-97. [PMID: 24356385 DOI: 10.1097/01.MIB.0000437616.37000.41] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 3.2] [Reference Citation Analysis]
546 Kolb R, Liu GH, Janowski AM, Sutterwala FS, Zhang W. Inflammasomes in cancer: a double-edged sword. Protein Cell 2014;5:12-20. [PMID: 24474192 DOI: 10.1007/s13238-013-0001-4] [Cited by in Crossref: 162] [Cited by in F6Publishing: 175] [Article Influence: 18.0] [Reference Citation Analysis]
547 Rudraraju R, Jones BG, Surman SL, Sealy RE, Thomas PG, Hurwitz JL. Respiratory tract epithelial cells express retinaldehyde dehydrogenase ALDH1A and enhance IgA production by stimulated B cells in the presence of vitamin A. PLoS One 2014;9:e86554. [PMID: 24466150 DOI: 10.1371/journal.pone.0086554] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 3.4] [Reference Citation Analysis]
548 Chen GY. Role of Nlrp6 and Nlrp12 in the maintenance of intestinal homeostasis. Eur J Immunol 2014;44:321-7. [PMID: 24338634 DOI: 10.1002/eji.201344135] [Cited by in Crossref: 46] [Cited by in F6Publishing: 49] [Article Influence: 5.1] [Reference Citation Analysis]
549 Denmark VK, Mayer L. Inflammatory Bowel Diseases. The Autoimmune Diseases 2014. [DOI: 10.1016/b978-0-12-384929-8.00060-5] [Reference Citation Analysis]
550 Türker N, Toh ZQ, Karagiannis TC, Licciardi PV. Anti-inflammatory Effects of Probiotics and Their Metabolites: Possible Role for Epigenetic Effects. Molecular mechanisms and physiology of disease 2014. [DOI: 10.1007/978-1-4939-0706-9_5] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
551 Shalaby KH. Pattern Recognition Receptors and Aging. Immunology of Aging 2014. [DOI: 10.1007/978-3-642-39495-9_8] [Reference Citation Analysis]
552 Basso D, Zambon C, Plebani M. Inflammatory bowel diseases: from pathogenesis to laboratory testing. Clinical Chemistry and Laboratory Medicine 2014;52. [DOI: 10.1515/cclm-2013-0588] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
553 Shaker ME, Ashamallah SA, Houssen ME. Celastrol ameliorates murine colitis via modulating oxidative stress, inflammatory cytokines and intestinal homeostasis. Chem Biol Interact. 2014;210:26-33. [PMID: 24384223 DOI: 10.1016/j.cbi.2013.12.007] [Cited by in Crossref: 63] [Cited by in F6Publishing: 56] [Article Influence: 6.3] [Reference Citation Analysis]
554 Liu D, Rhebergen AM, Eisenbarth SC. Licensing Adaptive Immunity by NOD-Like Receptors. Front Immunol 2013;4:486. [PMID: 24409181 DOI: 10.3389/fimmu.2013.00486] [Cited by in Crossref: 39] [Cited by in F6Publishing: 43] [Article Influence: 3.9] [Reference Citation Analysis]
555 de Zoete MR, Flavell RA. Interactions between Nod-Like Receptors and Intestinal Bacteria. Front Immunol. 2013;4:462. [PMID: 24381573 DOI: 10.3389/fimmu.2013.00462] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
556 Yang Q, Yu C, Yang Z, Wei Q, Mu K, Zhang Y, Zhao W, Wang X, Huai W, Han L. Deregulated NLRP3 and NLRP1 inflammasomes and their correlations with disease activity in systemic lupus erythematosus. J Rheumatol 2014;41:444-52. [PMID: 24334646 DOI: 10.3899/jrheum.130310] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 5.4] [Reference Citation Analysis]
557 Alipour M, Lou Y, Zimmerman D, Bording-Jorgensen MW, Sergi C, Liu JJ, Wine E. A balanced IL-1β activity is required for host response to Citrobacter rodentium infection. PLoS One 2013;8:e80656. [PMID: 24312491 DOI: 10.1371/journal.pone.0080656] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
558 Valatas V, Vakas M, Kolios G. The value of experimental models of colitis in predicting efficacy of biological therapies for inflammatory bowel diseases. Am J Physiol Gastrointest Liver Physiol 2013;305:G763-85. [PMID: 23989010 DOI: 10.1152/ajpgi.00004.2013] [Cited by in Crossref: 74] [Cited by in F6Publishing: 75] [Article Influence: 7.4] [Reference Citation Analysis]
559 Levy M, Thaiss CA, Elinav E. The Microbiota: A New Player in the Etiology of Colorectal Cancer. Curr Colorectal Cancer Rep 2014;10:1-8. [DOI: 10.1007/s11888-013-0196-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
560 Janowski AM, Kolb R, Zhang W, Sutterwala FS. Beneficial and Detrimental Roles of NLRs in Carcinogenesis. Front Immunol 2013;4:370. [PMID: 24273542 DOI: 10.3389/fimmu.2013.00370] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 4.2] [Reference Citation Analysis]
561 Hara H, Tsuchiya K, Kawamura I, Fang R, Hernandez-Cuellar E, Shen Y, Mizuguchi J, Schweighoffer E, Tybulewicz V, Mitsuyama M. Phosphorylation of the adaptor ASC acts as a molecular switch that controls the formation of speck-like aggregates and inflammasome activity. Nat Immunol 2013;14:1247-55. [PMID: 24185614 DOI: 10.1038/ni.2749] [Cited by in Crossref: 252] [Cited by in F6Publishing: 259] [Article Influence: 25.2] [Reference Citation Analysis]
562 Haasken S, Sutterwala FS. Damage control: management of cellular stress by the NLRP3 inflammasome. Eur J Immunol 2013;43:2003-5. [PMID: 23928964 DOI: 10.1002/eji.201343848] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
563 Wei Q, Mu K, Li T, Zhang Y, Yang Z, Jia X, Zhao W, Huai W, Guo P, Han L. Deregulation of the NLRP3 inflammasome in hepatic parenchymal cells during liver cancer progression. Lab Invest. 2014;94:52-62. [PMID: 24166187 DOI: 10.1038/labinvest.2013.126] [Cited by in Crossref: 154] [Cited by in F6Publishing: 164] [Article Influence: 15.4] [Reference Citation Analysis]
564 Zhan Y, Chen PJ, Sadler WD, Wang F, Poe S, Núñez G, Eaton KA, Chen GY. Gut microbiota protects against gastrointestinal tumorigenesis caused by epithelial injury. Cancer Res 2013;73:7199-210. [PMID: 24165160 DOI: 10.1158/0008-5472.CAN-13-0827] [Cited by in Crossref: 75] [Cited by in F6Publishing: 78] [Article Influence: 7.5] [Reference Citation Analysis]
565 Kurashima Y, Goto Y, Kiyono H. Mucosal innate immune cells regulate both gut homeostasis and intestinal inflammation. Eur J Immunol. 2013;43:3108-3115. [PMID: 24414823 DOI: 10.1002/eji.201343782] [Cited by in Crossref: 80] [Cited by in F6Publishing: 86] [Article Influence: 8.0] [Reference Citation Analysis]
566 Zhong Y, Kinio A, Saleh M. Functions of NOD-Like Receptors in Human Diseases. Front Immunol 2013;4:333. [PMID: 24137163 DOI: 10.3389/fimmu.2013.00333] [Cited by in Crossref: 170] [Cited by in F6Publishing: 181] [Article Influence: 17.0] [Reference Citation Analysis]
567 Lupfer C, Kanneganti TD. Unsolved Mysteries in NLR Biology. Front Immunol 2013;4:285. [PMID: 24062750 DOI: 10.3389/fimmu.2013.00285] [Cited by in Crossref: 87] [Cited by in F6Publishing: 91] [Article Influence: 8.7] [Reference Citation Analysis]
568 Dupaul-Chicoine J, Dagenais M, Saleh M. Crosstalk between the intestinal microbiota and the innate immune system in intestinal homeostasis and inflammatory bowel disease. Inflamm Bowel Dis 2013;19:2227-37. [PMID: 23669404 DOI: 10.1097/MIB.0b013e31828dcac7] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 4.7] [Reference Citation Analysis]
569 Pierini R, Perret M, Djebali S, Juruj C, Michallet MC, Förster I, Marvel J, Walzer T, Henry T. ASC controls IFN-γ levels in an IL-18-dependent manner in caspase-1-deficient mice infected with Francisella novicida. J Immunol 2013;191:3847-57. [PMID: 23975862 DOI: 10.4049/jimmunol.1203326] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
570 Kolb R, Liu G, Janowski AM, Sutterwala FS, Zhang W. Inflammasomes in cancer: a double-edged sword. Protein Cell 2013. [DOI: 10.1007/s13238-013-3051-8] [Reference Citation Analysis]
571 Broz P, Monack DM. Newly described pattern recognition receptors team up against intracellular pathogens. Nat Rev Immunol 2013;13:551-65. [DOI: 10.1038/nri3479] [Cited by in Crossref: 308] [Cited by in F6Publishing: 325] [Article Influence: 30.8] [Reference Citation Analysis]
572 Lopetuso LR, Chowdhry S, Pizarro TT. Opposing Functions of Classic and Novel IL-1 Family Members in Gut Health and Disease. Front Immunol 2013;4:181. [PMID: 23847622 DOI: 10.3389/fimmu.2013.00181] [Cited by in Crossref: 93] [Cited by in F6Publishing: 96] [Article Influence: 9.3] [Reference Citation Analysis]
573 Anand PK, Kanneganti TD. NLRP6 in infection and inflammation. Microbes Infect 2013;15:661-8. [PMID: 23811097 DOI: 10.1016/j.micinf.2013.06.009] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 3.3] [Reference Citation Analysis]
574 Benetti E, Chiazza F, Patel NS, Collino M. The NLRP3 Inflammasome as a novel player of the intercellular crosstalk in metabolic disorders. Mediators Inflamm. 2013;2013:678627. [PMID: 23843683 DOI: 10.1155/2013/678627] [Cited by in Crossref: 68] [Cited by in F6Publishing: 82] [Article Influence: 6.8] [Reference Citation Analysis]
575 Tsutsui H, Nakanishi K. Immunotherapeutic applications of IL-18. Immunotherapy 2012;4:1883-94. [PMID: 23240755 DOI: 10.2217/imt.12.137] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
576 Licandro G, Ling Khor H, Beretta O, Lai J, Derks H, Laudisi F, Conforti-Andreoni C, Liang Qian H, Teng GG, Ricciardi-Castagnoli P, Mortellaro A. The NLRP3 inflammasome affects DNA damage responses after oxidative and genotoxic stress in dendritic cells. Eur J Immunol 2013;43:2126-37. [PMID: 23619996 DOI: 10.1002/eji.201242918] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 3.9] [Reference Citation Analysis]
577 Hu B, Elinav E, Huber S, Strowig T, Hao L, Hafemann A, Jin C, Wunderlich C, Wunderlich T, Eisenbarth SC, Flavell RA. Microbiota-induced activation of epithelial IL-6 signaling links inflammasome-driven inflammation with transmissible cancer. Proceedings of the National Academy of Sciences of the United States of America. 2013;110:9862-9867. [PMID: 23696660 DOI: 10.1073/pnas.1307575110] [Cited by in Crossref: 220] [Cited by in F6Publishing: 235] [Article Influence: 22.0] [Reference Citation Analysis]
578 Sollberger G, Strittmatter GE, Garstkiewicz M, Sand J, Beer HD. Caspase-1: the inflammasome and beyond. Innate Immun. 2014;20:115-125. [PMID: 23676582 DOI: 10.1177/1753425913484374] [Cited by in Crossref: 135] [Cited by in F6Publishing: 141] [Article Influence: 13.5] [Reference Citation Analysis]
579 Long TM, Chakrabarti A, Ezelle HJ, Brennan-Laun SE, Raufman JP, Polyakova I, Silverman RH, Hassel BA. RNase-L deficiency exacerbates experimental colitis and colitis-associated cancer. Inflamm Bowel Dis 2013;19:1295-305. [PMID: 23567782 DOI: 10.1097/MIB.0b013e318281f2fd] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
580 Ey B, Eyking A, Klepak M, Salzman NH, Göthert JR, Rünzi M, Schmid KW, Gerken G, Podolsky DK, Cario E. Loss of TLR2 worsens spontaneous colitis in MDR1A deficiency through commensally induced pyroptosis. J Immunol. 2013;190:5676-5688. [PMID: 23636052 DOI: 10.4049/jimmunol.1201592] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 4.3] [Reference Citation Analysis]
581 Wang Y, Yang C, Mao K, Chen S, Meng G, Sun B. Cellular localization of NLRP3 inflammasome. Protein Cell 2013;4:425-31. [PMID: 23609011 DOI: 10.1007/s13238-013-2113-2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 34] [Article Influence: 2.9] [Reference Citation Analysis]
582 Di Virgilio F, Alexander SPH. The Therapeutic Potential of Modifying Inflammasomes and NOD-Like Receptors. Pharmacol Rev 2013;65:872-905. [DOI: 10.1124/pr.112.006171] [Cited by in Crossref: 111] [Cited by in F6Publishing: 112] [Article Influence: 11.1] [Reference Citation Analysis]
583 Hori JI, Zamboni DS, Carrão DB, Goldman GH, Berretta AA. The Inhibition of Inflammasome by Brazilian Propolis (EPP-AF). Evid Based Complement Alternat Med 2013;2013:418508. [PMID: 23690844 DOI: 10.1155/2013/418508] [Cited by in Crossref: 35] [Cited by in F6Publishing: 40] [Article Influence: 3.5] [Reference Citation Analysis]
584 Sun Q, Gao W, Loughran P, Shapiro R, Fan J, Billiar TR, Scott MJ. Caspase 1 activation is protective against hepatocyte cell death by up-regulating beclin 1 protein and mitochondrial autophagy in the setting of redox stress. J Biol Chem 2013;288:15947-58. [PMID: 23589298 DOI: 10.1074/jbc.M112.426791] [Cited by in Crossref: 52] [Cited by in F6Publishing: 59] [Article Influence: 5.2] [Reference Citation Analysis]
585 Fung I, Garrett JP, Shahane A, Kwan M. Do bugs control our fate? The influence of the microbiome on autoimmunity. Curr Allergy Asthma Rep 2012;12:511-9. [PMID: 22886439 DOI: 10.1007/s11882-012-0291-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
586 Liu JJ, Davis EM, Wine E, Lou Y, Rudzinski JK, Alipour M, Boulanger P, Thiesen AL, Sergi C, Fedorak RN, Muruve D, Madsen KL, Irvin RT. Epithelial cell extrusion leads to breaches in the intestinal epithelium. Inflamm Bowel Dis 2013;19:912-21. [PMID: 23511029 DOI: 10.1097/MIB.0b013e3182807600] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
587 Nunes T, de Souza HS. Inflammasome in intestinal inflammation and cancer. Mediators Inflamm 2013;2013:654963. [PMID: 23606794 DOI: 10.1155/2013/654963] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 3.6] [Reference Citation Analysis]
588 Liu W, Guo W, Wu J, Luo Q, Tao F, Gu Y, Shen Y, Li J, Tan R, Xu Q, Sun Y. A novel benzo[d]imidazole derivate prevents the development of dextran sulfate sodium-induced murine experimental colitis via inhibition of NLRP3 inflammasome. Biochem Pharmacol 2013;85:1504-12. [PMID: 23506741 DOI: 10.1016/j.bcp.2013.03.008] [Cited by in Crossref: 92] [Cited by in F6Publishing: 95] [Article Influence: 9.2] [Reference Citation Analysis]
589 Yeretssian G. Effector functions of NLRs in the intestine: innate sensing, cell death, and disease. Immunol Res 2012;54:25-36. [PMID: 22454103 DOI: 10.1007/s12026-012-8317-3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
590 Marion-Letellier R, Savoye G, Beck PL, Panaccione R, Ghosh S. Polyunsaturated fatty acids in inflammatory bowel diseases: a reappraisal of effects and therapeutic approaches. Inflamm Bowel Dis 2013;19:650-61. [PMID: 23328774 DOI: 10.1097/MIB.0b013e3182810122] [Cited by in Crossref: 76] [Cited by in F6Publishing: 64] [Article Influence: 7.6] [Reference Citation Analysis]
591 Biasi F, Leonarduzzi G, Oteiza PI, Poli G. Inflammatory bowel disease: mechanisms, redox considerations, and therapeutic targets. Antioxid Redox Signal. 2013;19:1711-1747. [PMID: 23305298 DOI: 10.1089/ars.2012.4530] [Cited by in Crossref: 143] [Cited by in F6Publishing: 150] [Article Influence: 14.3] [Reference Citation Analysis]
592 Wu J, Yan Z, Schwartz DE, Yu J, Malik AB, Hu G. Activation of NLRP3 inflammasome in alveolar macrophages contributes to mechanical stretch-induced lung inflammation and injury. J Immunol 2013;190:3590-9. [PMID: 23436933 DOI: 10.4049/jimmunol.1200860] [Cited by in Crossref: 156] [Cited by in F6Publishing: 168] [Article Influence: 15.6] [Reference Citation Analysis]
593 Becker C, Watson AJ, Neurath MF. Complex roles of caspases in the pathogenesis of inflammatory bowel disease. Gastroenterology 2013;144:283-93. [PMID: 23219999 DOI: 10.1053/j.gastro.2012.11.035] [Cited by in Crossref: 65] [Cited by in F6Publishing: 67] [Article Influence: 6.5] [Reference Citation Analysis]
594 Mao K, Chen S, Chen M, Ma Y, Wang Y, Huang B, He Z, Zeng Y, Hu Y, Sun S. Nitric oxide suppresses NLRP3 inflammasome activation and protects against LPS-induced septic shock. Cell Res. 2013;23:201-212. [PMID: 23318584 DOI: 10.1038/cr.2013.6] [Cited by in Crossref: 253] [Cited by in F6Publishing: 268] [Article Influence: 25.3] [Reference Citation Analysis]
595 Tseng WA, Thein T, Kinnunen K, Lashkari K, Gregory MS, D'Amore PA, Ksander BR. NLRP3 inflammasome activation in retinal pigment epithelial cells by lysosomal destabilization: implications for age-related macular degeneration. Invest Ophthalmol Vis Sci 2013;54:110-20. [PMID: 23221073 DOI: 10.1167/iovs.12-10655] [Cited by in Crossref: 174] [Cited by in F6Publishing: 164] [Article Influence: 17.4] [Reference Citation Analysis]
596 Dupaul-chicoine J, Saleh M. Inflammatory Mediators in Tumorigenesis and Metastasis. Experimental and Clinical Metastasis 2013. [DOI: 10.1007/978-1-4614-3685-0_9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
597 Cario E. Microbiota and innate immunity in intestinal inflammation and neoplasia. Curr Opin Gastroenterol 2013;29:85-91. [PMID: 23207600 DOI: 10.1097/MOG.0b013e32835a670e] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 3.8] [Reference Citation Analysis]
598 Elinav E, Henao-Mejia J, Flavell RA. Integrative inflammasome activity in the regulation of intestinal mucosal immune responses. Mucosal Immunol 2013;6:4-13. [PMID: 23212196 DOI: 10.1038/mi.2012.115] [Cited by in Crossref: 69] [Cited by in F6Publishing: 73] [Article Influence: 6.9] [Reference Citation Analysis]
599 Deng T, Cui J, Lyon CJ, Zhang N, Wang HY, Wang R, Hsueh WA. Inflammasomes and Obesity. Obesity, Inflammation and Cancer 2013. [DOI: 10.1007/978-1-4614-6819-6_2] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
600 Fukata M, Arditi M. The role of pattern recognition receptors in intestinal inflammation. Mucosal Immunol 2013;6:451-63. [PMID: 23515136 DOI: 10.1038/mi.2013.13] [Cited by in Crossref: 143] [Cited by in F6Publishing: 147] [Article Influence: 14.3] [Reference Citation Analysis]
601 Inoue M, Kanayama M, Shinohara ML. Inflammasomes. Encyclopedia of Inflammatory Diseases 2013. [DOI: 10.1007/978-3-0348-0620-6_77-1] [Reference Citation Analysis]
602 Seidelin JB, Coskun M, Nielsen OH. Mucosal healing in ulcerative colitis: pathophysiology and pharmacology. Adv Clin Chem 2013;59:101-23. [PMID: 23461134 DOI: 10.1016/b978-0-12-405211-6.00004-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
603 Xu X, Xu P, Ma C, Tang J, Zhang X. Gut microbiota, host health, and polysaccharides. Biotechnol Adv. 2013;31:318-337. [PMID: 23280014 DOI: 10.1016/j.biotechadv.2012.12.009] [Cited by in Crossref: 142] [Cited by in F6Publishing: 148] [Article Influence: 12.9] [Reference Citation Analysis]
604 Wang W, Wang X, Chun J, Vilaysane A, Clark S, French G, Bracey NA, Trpkov K, Bonni S, Duff HJ. Inflammasome-independent NLRP3 augments TGF-β signaling in kidney epithelium. J Immunol. 2013;190:1239-1249. [PMID: 23264657 DOI: 10.4049/jimmunol.1201959] [Cited by in Crossref: 164] [Cited by in F6Publishing: 167] [Article Influence: 14.9] [Reference Citation Analysis]
605 Masters SL, Gerlic M, Metcalf D, Preston S, Pellegrini M, O'Donnell JA, McArthur K, Baldwin TM, Chevrier S, Nowell CJ, Cengia LH, Henley KJ, Collinge JE, Kastner DL, Feigenbaum L, Hilton DJ, Alexander WS, Kile BT, Croker BA. NLRP1 inflammasome activation induces pyroptosis of hematopoietic progenitor cells. Immunity 2012;37:1009-23. [PMID: 23219391 DOI: 10.1016/j.immuni.2012.08.027] [Cited by in Crossref: 212] [Cited by in F6Publishing: 222] [Article Influence: 19.3] [Reference Citation Analysis]
606 Kongara S, Karantza V. The interplay between autophagy and ROS in tumorigenesis. Front Oncol 2012;2:171. [PMID: 23181220 DOI: 10.3389/fonc.2012.00171] [Cited by in Crossref: 124] [Cited by in F6Publishing: 136] [Article Influence: 11.3] [Reference Citation Analysis]
607 Oertli M, Müller A. Helicobacter pylori targets dendritic cells to induce immune tolerance, promote persistence and confer protection against allergic asthma. Gut Microbes 2012;3:566-71. [PMID: 22895083 DOI: 10.4161/gmic.21750] [Cited by in Crossref: 37] [Cited by in F6Publishing: 41] [Article Influence: 3.4] [Reference Citation Analysis]
608 Walsh D, McCarthy J, O'Driscoll C, Melgar S. Pattern recognition receptors--molecular orchestrators of inflammation in inflammatory bowel disease. Cytokine Growth Factor Rev 2013;24:91-104. [PMID: 23102645 DOI: 10.1016/j.cytogfr.2012.09.003] [Cited by in Crossref: 81] [Cited by in F6Publishing: 88] [Article Influence: 7.4] [Reference Citation Analysis]
609 Muniz LR, Knosp C, Yeretssian G. Intestinal antimicrobial peptides during homeostasis, infection, and disease. Front Immunol. 2012;3:310. [PMID: 23087688 DOI: 10.3389/fimmu.2012.00310] [Cited by in Crossref: 129] [Cited by in F6Publishing: 132] [Article Influence: 11.7] [Reference Citation Analysis]
610 Hiemstra IH, Bouma G, Geerts D, Kraal G, Haan JMD. Nod2 improves barrier function of intestinal epithelial cells via enhancement of TLR responses. Molecular Immunology 2012;52:264-72. [DOI: 10.1016/j.molimm.2012.06.007] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
611 Schmidt RL, Lenz LL. Distinct licensing of IL-18 and IL-1β secretion in response to NLRP3 inflammasome activation. PLoS One 2012;7:e45186. [PMID: 23028835 DOI: 10.1371/journal.pone.0045186] [Cited by in Crossref: 61] [Cited by in F6Publishing: 63] [Article Influence: 5.5] [Reference Citation Analysis]
612 Shui JW, Larange A, Kim G, Vela JL, Zahner S, Cheroutre H, Kronenberg M. HVEM signalling at mucosal barriers provides host defence against pathogenic bacteria. Nature 2012;488:222-5. [PMID: 22801499 DOI: 10.1038/nature11242] [Cited by in Crossref: 95] [Cited by in F6Publishing: 100] [Article Influence: 8.6] [Reference Citation Analysis]
613 Irvine KM, Schroder K, Powell EE. Liver repercussions of defective gut surveillance. Hepatology 2012;56:1174-7. [PMID: 22930647 DOI: 10.1002/hep.25944] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
614 Szabo G, Csak T. Inflammasomes in liver diseases. J Hepatol 2012;57:642-54. [PMID: 22634126 DOI: 10.1016/j.jhep.2012.03.035] [Cited by in Crossref: 335] [Cited by in F6Publishing: 345] [Article Influence: 30.5] [Reference Citation Analysis]
615 Savic S, Dickie LJ, Wittmann M, Mcdermott MF. Autoinflammatory syndromes and cellular responses to stress: pathophysiology, diagnosis and new treatment perspectives. Best Practice & Research Clinical Rheumatology 2012;26:505-33. [DOI: 10.1016/j.berh.2012.07.009] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 4.1] [Reference Citation Analysis]
616 Dohi T, Burkly LC. The TWEAK/Fn14 pathway as an aggravating and perpetuating factor in inflammatory diseases; focus on inflammatory bowel diseases. Journal of Leukocyte Biology 2012;92:265-79. [DOI: 10.1189/jlb.0112042] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 3.8] [Reference Citation Analysis]
617 Ayres JS, Trinidad NJ, Vance RE. Lethal inflammasome activation by a multidrug-resistant pathobiont upon antibiotic disruption of the microbiota. Nat Med 2012;18:799-806. [PMID: 22522562 DOI: 10.1038/nm.2729] [Cited by in Crossref: 148] [Cited by in F6Publishing: 154] [Article Influence: 13.5] [Reference Citation Analysis]
618 Pott J, Hornef M. Innate immune signalling at the intestinal epithelium in homeostasis and disease. EMBO Rep. 2012;13:684-698. [PMID: 22801555 DOI: 10.1038/embor.2012.96] [Cited by in Crossref: 129] [Cited by in F6Publishing: 135] [Article Influence: 11.7] [Reference Citation Analysis]
619 Vasseur E, Boniotto M, Patin E, Laval G, Quach H, Manry J, Crouau-Roy B, Quintana-Murci L. The evolutionary landscape of cytosolic microbial sensors in humans. Am J Hum Genet 2012;91:27-37. [PMID: 22748209 DOI: 10.1016/j.ajhg.2012.05.008] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
620 Bamias G, Corridoni D, Pizarro TT, Cominelli F. New insights into the dichotomous role of innate cytokines in gut homeostasis and inflammation. Cytokine. 2012;59:451-459. [PMID: 22795953 DOI: 10.1016/j.cyto.2012.06.014] [Cited by in Crossref: 77] [Cited by in F6Publishing: 77] [Article Influence: 7.0] [Reference Citation Analysis]
621 Ehrentraut SF, Colgan SP. Implications of protein post-translational modifications in IBD. Inflamm Bowel Dis 2012;18:1378-88. [PMID: 22223542 DOI: 10.1002/ibd.22859] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
622 Elson CO, Cong Y. Host-microbiota interactions in inflammatory bowel disease. Gut Microbes 2012;3:332-44. [PMID: 22572873 DOI: 10.4161/gmic.20228] [Cited by in Crossref: 85] [Cited by in F6Publishing: 86] [Article Influence: 7.7] [Reference Citation Analysis]
623 Ippagunta SK, Malireddi RKS, Shaw PJ, Neale GA, Walle LV, Fukui Y, Green DR, Lamkanfi M, Kanneganti T. Addendum: Defective Dock2 expression in a subset of ASC-deficient mouse lines. Nat Immunol 2012;13:701-2. [DOI: 10.1038/ni.2389] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
624 Calvo JA, Meira LB, Lee CY, Moroski-Erkul CA, Abolhassani N, Taghizadeh K, Eichinger LW, Muthupalani S, Nordstrand LM, Klungland A, Samson LD. DNA repair is indispensable for survival after acute inflammation. J Clin Invest 2012;122:2680-9. [PMID: 22684101 DOI: 10.1172/JCI63338] [Cited by in Crossref: 59] [Cited by in F6Publishing: 61] [Article Influence: 5.4] [Reference Citation Analysis]
625 Rubino SJ, Selvanantham T, Girardin SE, Philpott DJ. Nod-like receptors in the control of intestinal inflammation. Curr Opin Immunol. 2012;24:398-404. [PMID: 22677577 DOI: 10.1016/j.coi.2012.04.010] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 5.2] [Reference Citation Analysis]
626 Carvalho FA, Nalbantoglu I, Aitken JD, Uchiyama R, Su Y, Doho GH, Vijay-Kumar M, Gewirtz AT. Cytosolic flagellin receptor NLRC4 protects mice against mucosal and systemic challenges. Mucosal Immunol 2012;5:288-98. [PMID: 22318495 DOI: 10.1038/mi.2012.8] [Cited by in Crossref: 91] [Cited by in F6Publishing: 97] [Article Influence: 8.3] [Reference Citation Analysis]
627 Tarallo V, Hirano Y, Gelfand BD, Dridi S, Kerur N, Kim Y, Cho WG, Kaneko H, Fowler BJ, Bogdanovich S, Albuquerque RJ, Hauswirth WW, Chiodo VA, Kugel JF, Goodrich JA, Ponicsan SL, Chaudhuri G, Murphy MP, Dunaief JL, Ambati BK, Ogura Y, Yoo JW, Lee DK, Provost P, Hinton DR, Núñez G, Baffi JZ, Kleinman ME, Ambati J. DICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88. Cell 2012;149:847-59. [PMID: 22541070 DOI: 10.1016/j.cell.2012.03.036] [Cited by in Crossref: 413] [Cited by in F6Publishing: 449] [Article Influence: 37.5] [Reference Citation Analysis]
628 Kim JM. [Inflammatory bowel diseases and inflammasome]. Korean J Gastroenterol 2011;58:300-10. [PMID: 22198227 DOI: 10.4166/kjg.2011.58.6.300] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
629 Macia L, Thorburn AN, Binge LC, Marino E, Rogers KE, Maslowski KM, Vieira AT, Kranich J, Mackay CR. Microbial influences on epithelial integrity and immune function as a basis for inflammatory diseases. Immunol Rev. 2012;245:164-176. [PMID: 22168419 DOI: 10.1111/j.1600-065X.2011.01080.x] [Cited by in Crossref: 159] [Cited by in F6Publishing: 164] [Article Influence: 14.5] [Reference Citation Analysis]
630 Nishio J, Honda K. Immunoregulation by the gut microbiota. Cell Mol Life Sci. 2012;69:3635-3650. [PMID: 22527722 DOI: 10.1007/s00018-012-0993-6] [Cited by in Crossref: 52] [Cited by in F6Publishing: 59] [Article Influence: 4.7] [Reference Citation Analysis]
631 Hanamsagar R, Hanke ML, Kielian T. Toll-like receptor (TLR) and inflammasome actions in the central nervous system. Trends Immunol 2012;33:333-42. [PMID: 22521509 DOI: 10.1016/j.it.2012.03.001] [Cited by in Crossref: 138] [Cited by in F6Publishing: 146] [Article Influence: 12.5] [Reference Citation Analysis]
632 Choudhry N, Petry F, van Rooijen N, McDonald V. A protective role for interleukin 18 in interferon γ-mediated innate immunity to Cryptosporidium parvum that is independent of natural killer cells. J Infect Dis 2012;206:117-24. [PMID: 22517912 DOI: 10.1093/infdis/jis300] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 3.3] [Reference Citation Analysis]
633 Heinsbroek SE, Oei A, Roelofs JJ, Dhawan S, te Velde A, Gordon S, de Jonge WJ. Genetic deletion of dectin-1 does not affect the course of murine experimental colitis. BMC Gastroenterol 2012;12:33. [PMID: 22507600 DOI: 10.1186/1471-230X-12-33] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
634 Lamkanfi M, Kanneganti TD. The inflammasome: a remote control for metabolic syndrome. Cell Res. 2012;22:1095-1098. [PMID: 22491474 DOI: 10.1038/cr.2012.55] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
635 Wen H, Ting JP, O'Neill LA. A role for the NLRP3 inflammasome in metabolic diseases--did Warburg miss inflammation? Nat Immunol 2012;13:352-7. [PMID: 22430788 DOI: 10.1038/ni.2228] [Cited by in Crossref: 323] [Cited by in F6Publishing: 346] [Article Influence: 29.4] [Reference Citation Analysis]
636 Zitvogel L, Kepp O, Galluzzi L, Kroemer G. Inflammasomes in carcinogenesis and anticancer immune responses. Nat Immunol 2012;13:343-51. [PMID: 22430787 DOI: 10.1038/ni.2224] [Cited by in Crossref: 382] [Cited by in F6Publishing: 398] [Article Influence: 34.7] [Reference Citation Analysis]
637 Hitzler I, Sayi A, Kohler E, Engler DB, Koch KN, Hardt WD, Müller A. Caspase-1 has both proinflammatory and regulatory properties in Helicobacter infections, which are differentially mediated by its substrates IL-1β and IL-18. J Immunol. 2012;188:3594-3602. [PMID: 22403439 DOI: 10.4049/jimmunol.1103212] [Cited by in Crossref: 101] [Cited by in F6Publishing: 106] [Article Influence: 9.2] [Reference Citation Analysis]
638 Hudcovic T, Kolinska J, Klepetar J, Stepankova R, Rezanka T, Srutkova D, Schwarzer M, Erban V, Du Z, Wells JM. Protective effect of Clostridium tyrobutyricum in acute dextran sodium sulphate-induced colitis: differential regulation of tumour necrosis factor-α and interleukin-18 in BALB/c and severe combined immunodeficiency mice. Clin Exp Immunol. 2012;167:356-365. [PMID: 22236013 DOI: 10.1111/j.1365-2249.2011.04498.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 43] [Article Influence: 3.5] [Reference Citation Analysis]
639 Labbé K, McIntire CR, Doiron K, Leblanc PM, Saleh M. Cellular inhibitors of apoptosis proteins cIAP1 and cIAP2 are required for efficient caspase-1 activation by the inflammasome. Immunity 2011;35:897-907. [PMID: 22195745 DOI: 10.1016/j.immuni.2011.10.016] [Cited by in Crossref: 119] [Cited by in F6Publishing: 121] [Article Influence: 10.8] [Reference Citation Analysis]
640 Moens E, Veldhoen M. Epithelial barrier biology: good fences make good neighbours. Immunology. 2012;135:1-8. [PMID: 22044254 DOI: 10.1111/j.1365-2567.2011.03506.x] [Cited by in Crossref: 83] [Cited by in F6Publishing: 92] [Article Influence: 7.5] [Reference Citation Analysis]
641 Oertli M, Sundquist M, Hitzler I, Engler DB, Arnold IC, Reuter S, Maxeiner J, Hansson M, Taube C, Quiding-Järbrink M. DC-derived IL-18 drives Treg differentiation, murine Helicobacter pylori-specific immune tolerance, and asthma protection. J Clin Invest. 2012;122:1082-1096. [PMID: 22307326 DOI: 10.1172/jci61029] [Cited by in Crossref: 211] [Cited by in F6Publishing: 226] [Article Influence: 19.2] [Reference Citation Analysis]
642 Kirkland D, Benson A, Mirpuri J, Pifer R, Hou B, DeFranco AL, Yarovinsky F. B cell-intrinsic MyD88 signaling prevents the lethal dissemination of commensal bacteria during colonic damage. Immunity. 2012;36:228-238. [PMID: 22306056 DOI: 10.1016/j.immuni.2011.11.019] [Cited by in Crossref: 88] [Cited by in F6Publishing: 91] [Article Influence: 8.0] [Reference Citation Analysis]
643 Strowig T, Henao-Mejia J, Elinav E, Flavell R. Inflammasomes in health and disease. Nature. 2012;481:278-286. [PMID: 22258606 DOI: 10.1038/nature10759] [Cited by in Crossref: 1530] [Cited by in F6Publishing: 1591] [Article Influence: 139.1] [Reference Citation Analysis]
644 Zaki MH, Vogel P, Malireddi RK, Body-Malapel M, Anand PK, Bertin J, Green DR, Lamkanfi M, Kanneganti TD. The NOD-like receptor NLRP12 attenuates colon inflammation and tumorigenesis. Cancer Cell. 2011;20:649-660. [PMID: 22094258 DOI: 10.1016/j.ccr.2011.10.022] [Cited by in Crossref: 266] [Cited by in F6Publishing: 286] [Article Influence: 24.2] [Reference Citation Analysis]
645 Dahan S, Denmark VK, Mayer L. Immunobiology of Epithelial Cells in Inflammatory Bowel Disease. Crohn's Disease and Ulcerative Colitis 2012. [DOI: 10.1007/978-1-4614-0998-4_14] [Reference Citation Analysis]
646 Dunn JH, Ellis LZ, Fujita M. Inflammasomes as molecular mediators of inflammation and cancer: Potential role in melanoma. Cancer Letters 2012;314:24-33. [DOI: 10.1016/j.canlet.2011.10.001] [Cited by in Crossref: 85] [Cited by in F6Publishing: 86] [Article Influence: 7.7] [Reference Citation Analysis]
647 Wang HY, Wang R. Innate Immune Signaling and Negative Regulators in Cancer. Innate Immune Regulation and Cancer Immunotherapy 2012. [DOI: 10.1007/978-1-4419-9914-6_6] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
648 Strowig T, Flavell RA. Inflammasomes in Inflammatory Bowel Disease. Crohn's Disease and Ulcerative Colitis 2012. [DOI: 10.1007/978-1-4614-0998-4_7] [Reference Citation Analysis]
649 Lamkanfi M, Vande Walle L, Kanneganti TD. Deregulated inflammasome signaling in disease. Immunol Rev 2011;243:163-73. [PMID: 21884175 DOI: 10.1111/j.1600-065X.2011.01042.x] [Cited by in Crossref: 102] [Cited by in F6Publishing: 110] [Article Influence: 8.5] [Reference Citation Analysis]
650 Chow MT, Möller A, Smyth MJ. Inflammation and immune surveillance in cancer. Semin Cancer Biol 2012;22:23-32. [PMID: 22210181 DOI: 10.1016/j.semcancer.2011.12.004] [Cited by in Crossref: 128] [Cited by in F6Publishing: 141] [Article Influence: 10.7] [Reference Citation Analysis]
651 Duerr CU, Hornef MW. The mammalian intestinal epithelium as integral player in the establishment and maintenance of host-microbial homeostasis. Semin Immunol. 2012;24:25-35. [PMID: 22138188 DOI: 10.1016/j.smim.2011.11.002] [Cited by in Crossref: 46] [Cited by in F6Publishing: 49] [Article Influence: 3.8] [Reference Citation Analysis]
652 Zaki MH, Lamkanfi M, Kanneganti TD. Inflammasomes and Intestinal Tumorigenesis. Drug Discov Today Dis Mech 2011;8:e71-8. [PMID: 22768019 DOI: 10.1016/j.ddmec.2011.11.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
653 Chen GY, Núñez G. Inflammasomes in intestinal inflammation and cancer. Gastroenterology 2011;141:1986-99. [PMID: 22005480 DOI: 10.1053/j.gastro.2011.10.002] [Cited by in Crossref: 110] [Cited by in F6Publishing: 113] [Article Influence: 9.2] [Reference Citation Analysis]
654 Mason DR, Beck PL, Muruve DA. Nucleotide-binding oligomerization domain-like receptors and inflammasomes in the pathogenesis of non-microbial inflammation and diseases. J Innate Immun. 2012;4:16-30. [PMID: 22067846 DOI: 10.1159/000334247] [Cited by in Crossref: 65] [Cited by in F6Publishing: 72] [Article Influence: 5.4] [Reference Citation Analysis]
655 Brinkman BM, Hildebrand F, Kubica M, Goosens D, Del Favero J, Declercq W, Raes J, Vandenabeele P. Caspase deficiency alters the murine gut microbiome. Cell Death Dis 2011;2:e220. [PMID: 22012254 DOI: 10.1038/cddis.2011.101] [Cited by in Crossref: 52] [Cited by in F6Publishing: 55] [Article Influence: 4.3] [Reference Citation Analysis]
656 Marques R, Boneca IG. Expression and functional importance of innate immune receptors by intestinal epithelial cells. Cell Mol Life Sci 2011;68:3661-73. [PMID: 21984599 DOI: 10.1007/s00018-011-0829-9] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 3.2] [Reference Citation Analysis]
657 Kersse K, Bertrand MJ, Lamkanfi M, Vandenabeele P. NOD-like receptors and the innate immune system: Coping with danger, damage and death. Cytokine & Growth Factor Reviews 2011;22:257-76. [DOI: 10.1016/j.cytogfr.2011.09.003] [Cited by in Crossref: 143] [Cited by in F6Publishing: 146] [Article Influence: 11.9] [Reference Citation Analysis]
658 Li XD, Chiu YH, Ismail AS, Behrendt CL, Wight-Carter M, Hooper LV, Chen ZJ. Mitochondrial antiviral signaling protein (MAVS) monitors commensal bacteria and induces an immune response that prevents experimental colitis. Proc Natl Acad Sci U S A 2011;108:17390-5. [PMID: 21960441 DOI: 10.1073/pnas.1107114108] [Cited by in Crossref: 69] [Cited by in F6Publishing: 71] [Article Influence: 5.8] [Reference Citation Analysis]
659 Stockinger S, Hornef MW, Chassin C. Establishment of intestinal homeostasis during the neonatal period. Cell Mol Life Sci 2011;68:3699-712. [DOI: 10.1007/s00018-011-0831-2] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 3.5] [Reference Citation Analysis]
660 Harrison OJ, Maloy KJ. Innate immune activation in intestinal homeostasis. J Innate Immun. 2011;3:585-593. [PMID: 21912101 DOI: 10.1159/000330913] [Cited by in Crossref: 24] [Cited by in F6Publishing: 31] [Article Influence: 2.0] [Reference Citation Analysis]
661 Ippagunta SK, Malireddi RK, Shaw PJ, Neale GA, Vande Walle L, Green DR, Fukui Y, Lamkanfi M, Kanneganti TD. The inflammasome adaptor ASC regulates the function of adaptive immune cells by controlling Dock2-mediated Rac activation and actin polymerization. Nat Immunol 2011;12:1010-6. [PMID: 21892172 DOI: 10.1038/ni.2095] [Cited by in Crossref: 89] [Cited by in F6Publishing: 89] [Article Influence: 7.4] [Reference Citation Analysis]
662 Stienstra R, van Diepen JA, Tack CJ, Zaki MH, van de Veerdonk FL, Perera D, Neale GA, Hooiveld GJ, Hijmans A, Vroegrijk I, van den Berg S, Romijn J, Rensen PC, Joosten LA, Netea MG, Kanneganti TD. Inflammasome is a central player in the induction of obesity and insulin resistance. Proc Natl Acad Sci USA. 2011;108:15324-15329. [PMID: 21876127 DOI: 10.1073/pnas.1100255108] [Cited by in Crossref: 485] [Cited by in F6Publishing: 515] [Article Influence: 40.4] [Reference Citation Analysis]
663 Saleh M. The machinery of Nod-like receptors: refining the paths to immunity and cell death: The machinery of Nod-like receptors. Immunological Reviews 2011;243:235-46. [DOI: 10.1111/j.1600-065x.2011.01045.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 54] [Article Influence: 4.1] [Reference Citation Analysis]
664 Menu P, Vince JE. The NLRP3 inflammasome in health and disease: the good, the bad and the ugly. Clin Exp Immunol 2011;166:1-15. [PMID: 21762124 DOI: 10.1111/j.1365-2249.2011.04440.x] [Cited by in Crossref: 253] [Cited by in F6Publishing: 275] [Article Influence: 21.1] [Reference Citation Analysis]
665 Tschopp J. Mitochondria: Sovereign of inflammation? Eur J Immunol 2011;41:1196-202. [PMID: 21469137 DOI: 10.1002/eji.201141436] [Cited by in Crossref: 227] [Cited by in F6Publishing: 235] [Article Influence: 18.9] [Reference Citation Analysis]
666 Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature. 2011;474:307-317. [PMID: 21677747 DOI: 10.1038/nature] [Cited by in F6Publishing: 56] [Reference Citation Analysis]
667 Maloy KJ, Powrie F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature. 2011;474:298-306. [PMID: 21677746 DOI: 10.1038/nature10208] [Cited by in Crossref: 1218] [Cited by in F6Publishing: 1268] [Article Influence: 101.5] [Reference Citation Analysis]
668 Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature. 2011;474:307-317. [PMID: 21677747 DOI: 10.1038/nature10209] [Cited by in Crossref: 1605] [Cited by in F6Publishing: 1683] [Article Influence: 133.8] [Reference Citation Analysis]
669 Kufer TA, Sansonetti PJ. NLR functions beyond pathogen recognition. Nat Immunol. 2011;12:121-128. [PMID: 21245903 DOI: 10.1038/ni.1985] [Cited by in Crossref: 145] [Cited by in F6Publishing: 156] [Article Influence: 12.1] [Reference Citation Analysis]
670 van Lookeren Campagne M, Dixit VM. Immunology: In command of commensals. Nature 2011;474:42-3. [PMID: 21637249 DOI: 10.1038/474042a] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
671 Zaki MH, Lamkanfi M, Kanneganti TD. The Nlrp3 inflammasome: contributions to intestinal homeostasis. Trends Immunol. 2011;32:171-179. [PMID: 21388882 DOI: 10.1016/j.it.2011.02.002] [Cited by in Crossref: 182] [Cited by in F6Publishing: 193] [Article Influence: 15.2] [Reference Citation Analysis]
672 Davis BK, Wen H, Ting JP. The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu Rev Immunol. 2011;29:707-735. [PMID: 21219188 DOI: 10.1146/annurev-immunol-031210-101405] [Cited by in Crossref: 1122] [Cited by in F6Publishing: 1183] [Article Influence: 93.5] [Reference Citation Analysis]
673 Werts C, Rubino S, Ling A, Girardin SE, Philpott DJ. Nod-like receptors in intestinal homeostasis, inflammation, and cancer. J Leukoc Biol. 2011;90:471-482. [PMID: 21653239 DOI: 10.1189/jlb.0411183] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 3.5] [Reference Citation Analysis]
674 Witzenrath M, Pache F, Lorenz D, Koppe U, Gutbier B, Tabeling C, Reppe K, Meixenberger K, Dorhoi A, Ma J, Holmes A, Trendelenburg G, Heimesaat MM, Bereswill S, van der Linden M, Tschopp J, Mitchell TJ, Suttorp N, Opitz B. The NLRP3 Inflammasome Is Differentially Activated by Pneumolysin Variants and Contributes to Host Defense in Pneumococcal Pneumonia. J I 2011;187:434-40. [DOI: 10.4049/jimmunol.1003143] [Cited by in Crossref: 193] [Cited by in F6Publishing: 195] [Article Influence: 16.1] [Reference Citation Analysis]
675 Hirota SA, Ng J, Lueng A, Khajah M, Parhar K, Li Y, Lam V, Potentier MS, Ng K, Bawa M, McCafferty DM, Rioux KP, Ghosh S, Xavier RJ, Colgan SP, Tschopp J, Muruve D, MacDonald JA, Beck PL. NLRP3 inflammasome plays a key role in the regulation of intestinal homeostasis. Inflamm Bowel Dis 2011;17:1359-72. [PMID: 20872834 DOI: 10.1002/ibd.21478] [Cited by in Crossref: 304] [Cited by in F6Publishing: 306] [Article Influence: 25.3] [Reference Citation Analysis]
676 Saleh M, Elson CO. Experimental inflammatory bowel disease: insights into the host-microbiota dialog. Immunity. 2011;34:293-302. [PMID: 21435584 DOI: 10.1016/j.immuni.2011.03.008] [Cited by in Crossref: 117] [Cited by in F6Publishing: 123] [Article Influence: 9.8] [Reference Citation Analysis]
677 Normand S, Delanoye-Crespin A, Bressenot A, Huot L, Grandjean T, Peyrin-Biroulet L, Lemoine Y, Hot D, Chamaillard M. Nod-like receptor pyrin domain-containing protein 6 (NLRP6) controls epithelial self-renewal and colorectal carcinogenesis upon injury. Proc Natl Acad Sci USA. 2011;108:9601-9606. [PMID: 21593405 DOI: 10.1073/pnas.1100981108] [Cited by in Crossref: 251] [Cited by in F6Publishing: 269] [Article Influence: 20.9] [Reference Citation Analysis]
678 Elinav E, Strowig T, Kau AL, Henao-Mejia J, Thaiss CA, Booth CJ, Peaper DR, Bertin J, Eisenbarth SC, Gordon JI, Flavell RA. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell. 2011;145:745-757. [PMID: 21565393 DOI: 10.1016/j.cell.2011.04.022] [Cited by in Crossref: 1392] [Cited by in F6Publishing: 1451] [Article Influence: 116.0] [Reference Citation Analysis]
679 Anders HJ, Muruve DA. The inflammasomes in kidney disease. J Am Soc Nephrol. 2011;22:1007-1018. [PMID: 21566058 DOI: 10.1681/asn.2010080798] [Cited by in Crossref: 262] [Cited by in F6Publishing: 276] [Article Influence: 21.8] [Reference Citation Analysis]
680 Rescigno M. The intestinal epithelial barrier in the control of homeostasis and immunity. Trends Immunol. 2011;32:256-264. [PMID: 21565554 DOI: 10.1016/j.it.2011.04.003] [Cited by in Crossref: 181] [Cited by in F6Publishing: 162] [Article Influence: 15.1] [Reference Citation Analysis]
681 Chen GY, Liu M, Wang F, Bertin J, Núñez G. A functional role for Nlrp6 in intestinal inflammation and tumorigenesis. J Immunol 2011;186:7187-94. [PMID: 21543645 DOI: 10.4049/jimmunol.1100412] [Cited by in Crossref: 300] [Cited by in F6Publishing: 318] [Article Influence: 25.0] [Reference Citation Analysis]
682 Chen M, Wang H, Chen W, Meng G. Regulation of adaptive immunity by the NLRP3 inflammasome. International Immunopharmacology 2011;11:549-54. [DOI: 10.1016/j.intimp.2010.11.025] [Cited by in Crossref: 58] [Cited by in F6Publishing: 53] [Article Influence: 4.8] [Reference Citation Analysis]
683 Abraham C, Medzhitov R. Interactions between the host innate immune system and microbes in inflammatory bowel disease. Gastroenterology 2011;140:1729-37. [PMID: 21530739 DOI: 10.1053/j.gastro.2011.02.012] [Cited by in Crossref: 368] [Cited by in F6Publishing: 387] [Article Influence: 30.7] [Reference Citation Analysis]
684 Lee MS. Role of innate immunity in diabetes and metabolism: recent progress in the study of inflammasomes. Immune Netw 2011;11:95-9. [PMID: 21637386 DOI: 10.4110/in.2011.11.2.95] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
685 Lamkanfi M. Emerging inflammasome effector mechanisms. Nat Rev Immunol 2011;11:213-20. [PMID: 21350580 DOI: 10.1038/nri2936] [Cited by in Crossref: 300] [Cited by in F6Publishing: 318] [Article Influence: 25.0] [Reference Citation Analysis]
686 Romani L. Immunity to fungal infections. Nat Rev Immunol. 2011;11:275-288. [PMID: 21394104 DOI: 10.1038/nri2939] [Cited by in Crossref: 823] [Cited by in F6Publishing: 857] [Article Influence: 68.6] [Reference Citation Analysis]
687 Man SM, Kaakoush NO, Mitchell HM. The role of bacteria and pattern-recognition receptors in Crohn's disease. Nat Rev Gastroenterol Hepatol 2011;8:152-68. [PMID: 21304476 DOI: 10.1038/nrgastro.2011.3] [Cited by in Crossref: 111] [Cited by in F6Publishing: 114] [Article Influence: 9.3] [Reference Citation Analysis]
688 Skeldon A, Saleh M. The inflammasomes: molecular effectors of host resistance against bacterial, viral, parasitic, and fungal infections. Front Microbiol 2011;2:15. [PMID: 21716947 DOI: 10.3389/fmicb.2011.00015] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 3.3] [Reference Citation Analysis]
689 Vande Walle L, Lamkanfi M. Inflammasomes: caspase-1-activating platforms with critical roles in host defense. Front Microbiol 2011;2:3. [PMID: 21687402 DOI: 10.3389/fmicb.2011.00003] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
690 Bruce D, Cantorna MT. Vitamin D and Inflammatory Bowel Disease. Vitamin D 2011. [DOI: 10.1016/b978-0-12-381978-9.10096-4] [Reference Citation Analysis]
691 Shaw PJ, McDermott MF, Kanneganti TD. Inflammasomes and autoimmunity. Trends Mol Med 2011;17:57-64. [PMID: 21163704 DOI: 10.1016/j.molmed.2010.11.001] [Cited by in Crossref: 152] [Cited by in F6Publishing: 144] [Article Influence: 11.7] [Reference Citation Analysis]
692 Wullaert A, Bonnet MC, Pasparakis M. NF-κB in the regulation of epithelial homeostasis and inflammation. Cell Res. 2011;21:146-158. [PMID: 21151201 DOI: 10.1038/cr.2010.175] [Cited by in Crossref: 328] [Cited by in F6Publishing: 339] [Article Influence: 25.2] [Reference Citation Analysis]
693 Saleh M, Trinchieri G. Innate immune mechanisms of colitis and colitis-associated colorectal cancer. Nat Rev Immunol 2011;11:9-20. [PMID: 21151034 DOI: 10.1038/nri2891] [Cited by in Crossref: 268] [Cited by in F6Publishing: 289] [Article Influence: 20.6] [Reference Citation Analysis]
694 Hu B, Elinav E, Huber S, Booth CJ, Strowig T, Jin C, Eisenbarth SC, Flavell RA. Inflammation-induced tumorigenesis in the colon is regulated by caspase-1 and NLRC4. Proc Natl Acad Sci U S A 2010;107:21635-40. [PMID: 21118981 DOI: 10.1073/pnas.1016814108] [Cited by in Crossref: 298] [Cited by in F6Publishing: 311] [Article Influence: 22.9] [Reference Citation Analysis]
695 Cario E. Heads up! How the intestinal epithelium safeguards mucosal barrier immunity through the inflammasome and beyond. Curr Opin Gastroenterol 2010;26:583-90. [PMID: 20664345 DOI: 10.1097/MOG.0b013e32833d4b88] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.0] [Reference Citation Analysis]
696 Asquith M, Powrie F. An innately dangerous balancing act: intestinal homeostasis, inflammation, and colitis-associated cancer. J Exp Med 2010;207:1573-7. [PMID: 20679404 DOI: 10.1084/jem.20101330] [Cited by in Crossref: 105] [Cited by in F6Publishing: 111] [Article Influence: 8.1] [Reference Citation Analysis]
697 Knodler LA, Vallance BA, Celli J, Winfree S, Hansen B, Montero M, Steele-Mortimer O. Dissemination of invasive Salmonella via bacterial-induced extrusion of mucosal epithelia. Proc Natl Acad Sci U S A 2010;107:17733-8. [PMID: 20876119 DOI: 10.1073/pnas.1006098107] [Cited by in Crossref: 293] [Cited by in F6Publishing: 305] [Article Influence: 22.5] [Reference Citation Analysis]
698 Zaki MH, Vogel P, Body-Malapel M, Lamkanfi M, Kanneganti TD. IL-18 production downstream of the Nlrp3 inflammasome confers protection against colorectal tumor formation. J Immunol 2010;185:4912-20. [PMID: 20855874 DOI: 10.4049/jimmunol.1002046] [Cited by in Crossref: 261] [Cited by in F6Publishing: 279] [Article Influence: 20.1] [Reference Citation Analysis]
699 Malireddi RK, Ippagunta S, Lamkanfi M, Kanneganti TD. Cutting edge: proteolytic inactivation of poly(ADP-ribose) polymerase 1 by the Nlrp3 and Nlrc4 inflammasomes. J Immunol 2010;185:3127-30. [PMID: 20713892 DOI: 10.4049/jimmunol.1001512] [Cited by in Crossref: 89] [Cited by in F6Publishing: 90] [Article Influence: 6.8] [Reference Citation Analysis]
700 Salcedo R, Worschech A, Cardone M, Jones Y, Gyulai Z, Dai RM, Wang E, Ma W, Haines D, O’hUigin C. MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18. J Exp Med. 2010;207:1625-1636. [PMID: 20624890 DOI: 10.1084/jem.20100199] [Cited by in Crossref: 315] [Cited by in F6Publishing: 330] [Article Influence: 24.2] [Reference Citation Analysis]
701 Leavy O. Mucosal immunology: Inflammasome activation in the gut. Nat Rev Immunol 2010;10:293. [PMID: 20425920 DOI: 10.1038/nri2776] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
702 Siegmund B. Interleukin-18 in intestinal inflammation: friend and foe? Immunity. 2010;32:300-302. [PMID: 20346770 DOI: 10.1016/j.immuni.2010.03.010] [Cited by in Crossref: 73] [Cited by in F6Publishing: 78] [Article Influence: 5.6] [Reference Citation Analysis]